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Abstract.
The literature on the toxicology and biochemical 
effects of chlorofluoroalkanes and closely related 
compounds of toxicological interest has been reviewed.
The chlorofluoroalkanes used in aerosol propellant 
mixtures were the subject of this study.
A simple, accurate quantitative g.l.c. assay was 
developed for the measurement of trichlorofluoromethane 
and 1 ,2-dichloro-1 ,1 ,2 ,2-tetrafluoroethane in extracts 
of tissues and the expired air. The separation and 
quantitation of mixtures of chlorofluoroalkanes was 
investigated.
The distribution and excretion of trichlorofluoro- 
methane and 1 ,2 -dichloro-l,1 ,2 ,2-tetrafluoroethane was 
determined after administration of these compounds by the 
oral route.
Attempts were made to detect metabolism of trichloro- 
fluoromethane in in vitro incubations. Although it was 
feasible to detect 0 .2% of a possible metabolite (dichloro- 
fluoromethane), no formation of this metabolite was 
detected in incubations of trichlorofluoromethane with 
microsomal preparations from several rodent species.
Lipid peroxidation was investigated as a measure of 
free radical formation. Trichlorofluoromethane was
found to have little effect on this parameter.
Simple toxicological experiments showed the 
chlorofluoroalkanes to be relatively non-toxic even at
very high dose levels. Total tissue lipid was not 
affected by trichlorofluoromethane.
The chlorofluoroalkanes gave spectral interactions 
with cytochrome P-450, both in the oxidised and 
reduced states. The chlorofluoroalkanes did not 
affect type I substrate metabolism. The effects on 
type II substrate metabolism were inhibition (zoxazolamine 
hydroxylation) and activation (acetanilide and aniline 
4-hydroxylations).
The results are discussed in relation to the low 
toxicity of the chlorofluoroalkanes, and in comparison 
to the hepatotoxin, carbon tetrachloride.
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Materials.
Unless otherwise stated in the text, standard 
laboratory chemicals were obtained from normal sources.
Chlorofluoroalkanes were obtained from Cambrian 
Chemicals Limited, Croydon, U.K. and British Drug Houses 
Chemicals Limited, Poole, U.K.
Enzymes and cofactors were obtained from the 
following sources: Sigma Chemical Company Limited,
London, U.K. (glucose-6-phosphate, sodium salt; glucose- 
6-phosphatejdehydrogenase ; NADP sodium salt; phospho- 
lipase C from Cl. welchii; phospholipase D from cabbage), 
Boehringer Corporation Limited, London, U.K. (glucose-
6-phosphate, disodium salt; glucose-6-phosphate
+ \ dehydrogenase; NADP disodium salt), Whatman Biochemicals
Limited, Maidstone, Kent, U.K. (glucose-6-phosphate
dehydrogenase) and International Enzymes Limited, London,
U.K. (glucose-6-phosphate, disodium salt; NADP sodium
salt).
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1.1. Properties.
The chlorofluoroalkanes are hydrocarbons, 
substituted partially or completely with chlorine 
and fluorine. The discussion will be limited 
principally to the analogues of methane and ethane, 
as these are the most important commercially.
The chlorofluoroalkanes are all volatile compounds 
in comparison to the chlorinated analogues. Table
1 . 1  shows the boiling points of fully substituted 
methane and ethane series. They are also very stable 
compounds chemically.
It can be seen from Table 1.2 that the Van der 
Waal's radius of the fluorine atom is considerably 
smaller than the radii of the other halogens and that 
it closely approaches the size of the hydrogen atom. 
Fluorine is also the most electronegative element 
known. These properties allow the fluorine atom to 
approach other atoms very closely resulting in stable 
bonds and high dissociation energies. A single C-F 
bond requires about 28 kJ/mol more to break it than 
does a C-H bond. The substitution of a fluorine 
atom for a chlorine atom would therefore be expected 
to modify the compound's properties. From Table 1.3 
it will be noted that the bond energy term, which is 
derived from the compound's heat of formation, decreases 
slightly for the C-Cl bond with increasing fluorination.
This would suggest that the C-Cl bond in dichlorodifluoro 
methane would be more easily broken than in carbon
Table 1 . 1  
Boiling points (°C)
CH^ -164
CF^ -129
CCIF^ “8 l.l
cci2f2 -29.9
CCl^F 23.8
CCl^ 76.8
C2H6 -88:6
C2F6 “79
C2C1F5 ■ - 3 8
CC1F2-CC1F2 3 . 8
CC10F-CC1F 47.6
CC12F-CC12F 93
C2C1 5F 135
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tetrachloride. However, experimentally determined 
C-Cl bond dissociation energies for carbon tetrachloride 
and chlorotrifluoromethane show that this bond is 
broken less easily in the fluorinated compound. No 
other experimental values are available, but Gregory 
(1 9 6 6) calculated a dissociation energy for the C-Cl 
bond in trichlorofluoromethane. This shows that 
approximately 10% more energy is required to break 
the C-Cl bond in trichlorofluoromethane than in carbon 
tetrachloride. Table 1.4 compares some of the properties 
of selected chlorofluoroalkanes and includes, for 
comparison, carbon tetrachloride and 2-bromo-2-chloro-
1 ,1 ,1-trifluoroethane, the anaesthetic halothane. 
Substitution of a fluorine atom increases the volatility 
of the compound, and decreases the density, viscosity 
and surface tension. Water solubility is generally 
decreased, although trichlorofluoromethane is slightly 
more soluble in water at 30°C than is carbon tetrachloride 
(Table 1.4).
1.2. Uses.
The synthesis of carbon tetrafluoride was first 
achieved in 1926 by Leb eau and Damiens. Dichloro- 
difluoromethane rapidly followed (Midgley and Henne,
1 9 3 0)? having been prepared specifically for use as 
a refrigerant, to replace the inflammable ethylene 
and the corrosive and toxic ammonia and sulphur dioxide. 
This compound showed the necessary temperature-pressure
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relationships, together with the important uninflamra- 
ability and low inhalation toxicity. Chlorofluoro­
alkanes are used for both domestic and industrial 
refrigeration.
The second principal use of chlorofluoroalkanes 
is in the field of aerosol propellants. The first 
application of fluorinated hydrocarbons to this use 
was in 1 9 3 3i but it was not until 1 9 ^ 7 that the present 
type of aerosol container, or can, was marketed 
(Pickthall, 1964). The use of liquified chlorofluoro­
alkanes as aerosol propellants has advantages over 
the use of compressed gases, such as carbon dioxide, 
nitrous oxide and nitrogen. Firstly, compressed gas 
propellants must initially operate at very high pressures 
up to 90 p.s.i., and the containers must therefore be 
capable of withstanding such pressures with a consid­
erable safety margin. The vapour pressure of a 
chlorofluoroalkane propellant mixture can be varied 
by altering the composition of the mixture. The 
vapour pressure of each compound is shown in Table 1.5* 
Secondly, as the product is dispensed from a compressed 
gas container, the gas must occupy a larger volume and 
the pressure falls. It is also possible to dispense 
propellant gas alone. With liquified propellants, 
however, as product is dispensed, some of the liquid 
propellant vaporises to fill the space, thus maintaining 
the internal pressure constant. Thus the propellant 
pressure depends on the vapour pressure of the components
Table 1.5 •
Vapour pressures of some chlorofluoroalkanes used as
aerosol propellants.
b.p. (° C ) Vapour pressure 
(atm) at 21°C
c c i3f
CC12F2
CC1F„
c h c i2f
CHC1F„
CC1F -CC1Fd* d
2 3 . 8
•2 9 . 8
■8 1 . 4
8 . 9
•40.8
3.8
0 . 9 1
5.78
32.2
1.57
9.34
1.88
as noted above. In addition, as product and liquified 
propellant leave the container, the propellant vaporises 
and disperses the product into fine particles. Thus 
the extensive use of chlorofluoroalkanes as aerosol 
propellants is due to a combination of desirable 
properties: the lack of inflammability, the apparently 
low toxicity and the fact that these compounds are 
volatile liquids or easily liquifiable gases.
The development of the market for pressurised 
aerosol dispensers has risen dramatically since 1947- 
In the United States of America sales are now well 
over 2000 million containers per annum. Progress 
in the United Kingdom has been rather slower. Table
1 . 6  gives approximate sales figures up to 1 9 6l, together 
with figures of the production of chlorofluoroalkanes.
The aerosol packaging technique has been applied 
to a wide variety of products. Those for which the 
technique has some advantage are insecticides, room 
deodorants, hair lacquer and perfumes, paints and 
medicinal products. Some other applications are 
more for the novelty value and are generally more 
expensive and wasteful. These include cosmetics, 
personal deodorants (Goldberg and Netzbandt, 1 9 6 6 ), 
polish and some foods (Reed, 1 9 6 1). The medicinal 
products cover a wide spectrum. Aerosol skin sprays 
are used for applying dermatological products, for 
example in the treatment of athlete!s foot. Local 
anaesthetics are available in aerosol form; in fact
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a pain-relieving sjDray is available that is purely a
mixture of trichlorofluoromethane and dichlorodifluoro- 
methane. It is intended for spraying on the source 
of pain or irritation in such conditions as shingles, 
and gives some relief by cooling the skin and reducing 
the sensory output of pain nerve endings. This latter 
effect may be due to either the cooling or to a mild 
local anaesthetic action.. Ellis (1 9 6 1) reported 
that chlorofluoroalkane propellant mixtures were more 
effective for the relief of muscular pain than ethyl 
chloride, which was probably the first aerosol produced, 
in a glass container, in l8 9 9 -
’Spray-on bandages' are chlorofluoroalkane propelled 
plastic film forming agents, and may be used pre- and 
post-operatively. They may be used on wounds and 
burns and have the advantage of painless application 
and transparency, so that the bandage may remain in 
place even for inspection of the area. Aerosol 
antiseptics are also used oh wounds and burns.
An even more intimate contact between user and 
aerosol spray is achieved with nasal, buccal and 
vaginal medications. Finally, drugs designed for 
inhalation may also be packed in aerosol form. These 
include drugs to counter respiratory infections and 
bronchospasm.
The les£ volatile chlorofluoroalkanes may be used 
on the industrial scale as specialised solvents. They 
are lipophilic compounds; 1 ,1 ,2 -trichloro-l,2 ,2 -trifluoro-
ethane, for example, is soluble in ethanol and is 
infinitely soluble in ether and benzene.
Related to their use as industrial refrigerants, 
chlorofluoroalkanes are being used to freeze food, 
particularly fish. Norwegian legislation permits 
residues of these compounds to a maximum of 2 0 0 p.p.m.
1.3 » Human exposure.
Exposure of humans to the chlorofluoroalkanes 
may be either accidental, incidental or deliberate, 
depending on the use. Accidental exposure is most 
likely to be a result of leakage of refrigerant from 
either an industrial or domestic appliance. At the 
other end of the scale, deliberate exposure may be 
occasioned by the use of pain-relieving sprays contain­
ing only chlorofluoroalkanes (Ellis, 1 9 6 1), where the 
aerosol is directed on to the skin. Deliberate 
exposure has also occurred as an abuse (Bass, 1970); 
aerosol mixtures have been sprayed into plastic bags 
and the propellant gases inhaled. This is reported 
to give a pleasurable experience, and has been used 
as a substitute for glue solvent 1 sniffing*. Certainly, 
the compounds possess a pleasant, ether-like odour, 
but deeper subjective sensations have not been tested 
by the author. The majority of incidental exposures 
occur through the use of aerosol sprays in domestic 
and medical use. Popular use of room air fresheners, 
insecticides, paint, hair lacquers and perfumes has
greatly increased over the past few years. Medical 
uses of aerosol preparations have been described 
(1.2). There are many advantages for the presentation 
of some pharmaceutical products in this form. These 
include the obvious ease and convenience of application, 
together with speed. In addition, the product is 
kept free of contamination and remains potent for 
longer periods than usual, due ta the absence of air 
in the container. Further, by using a metered valve 
outlet, the dose can be accurately controlled. Thus 
the use of aerosols in the medical field would seem 
certain to increase.
1.4. Toxicity — animal studies.
The biological effects of fluorine-containing 
compounds have been the subject of several reviews.
Hodge and Smith (196 5 ) adequately covered the biolog­
ical properties of inorganic fluorides and the effects 
particularly on bone and teeth. Hodge et al. (1 9 6 3)
presented, chiefly in tabular form, all the existing 
information on the fluorine-containing compounds then 
known.
Chenoweth and Hake (1 9 6 2) reviewed the anaesthetic 
and toxicological aspects of halogenated hydrocarbons 
and ethers containing up to four carbon atoms. Their 
review was not as complete for this group of compounds 
as that of Hodge et al. (1 9 6 3) as it was only intended
to cover the period 1955-1961. It is worthy of note
that only two papers are cited concerning work on the 
propellant chlorofluoroallcanes within this period.
A recent and complete review by Larsen (1969) covers 
the field of clinically useful fluorinated anaesthetics.
Reviews of chlorofluoroalkane toxicity are provided 
by Clayton (1 9 6 2, 1 9 6 6 , 1 9 6 7a,b, 1 9 6 8).
As most of the chlorofluoroalkanes of interest 
are gases, exposure was most likely to occur by inhalation 
and early toxicological work was designed to evaluate 
the effects of short exposures, as might be experienced 
by householders and refrigeration engineers. The 
Underwriters Laboratories carried out simple acute 
exposures of guinea-pigs to various concentrations of 
the test compounds, and classified each compound on a 
scale running from 1-6 , where 1 indicates a highly 
toxic compound (causing death or serious injury when 
inhaled for 5  minutes at less than l%(v/v) in air) 
and 6 indicates a compound of low toxicity (causing 
no injury after a 2 hour exposure at 2 0%(v/v) in air). 
Table 1.7 shows this classification applied to three 
groups of halogenated methanes and ethanes, and also 
shows the Threshold Limit Values set by the American 
Conference of Industrial Hygienists in 1964. These 
values set the maximum permissible concentration in 
air, expressed as parts per million, on an eight hour 
average. It should be noted that several of the 
Threshold Limit Values for the chlorofluoroalkanes 
were set at 1000 p.p.m. not on the basis of toxicity,
of 
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but because adequate engineering standards should be 
capable of* adhering to this limit.
Other early work on toxicity was rather empirical 
and concerned with central nervous effects.
Sayers et al. (1930) continuously exposed dogs
and monkeys to dichlorodifluoromethane and observed 
tremors and a staggering gait at '20% (v/v). They 
also found that growth was slightly inhibited in the 
first 2-3 weeks. Nuckolls (l933)» using guinea-pigs, 
found 3 - 1 0 %  (v/v) trichlorofluoromethane for two hours 
produced loss of coordination, tremors, anaesthesia 
and convulsions; dichlorodifluoromethane was less 
effective. Cats tolerated up to 70% (v/v) dichloro­
dif luoromethane in the atmosphere (Brenner, 1937)*
Booth and Bixby (1932) investigated dichlorofluoro­
methane and chlorodifluoromethane. Convulsions in 
mice occurred at k  and l6% (v/v) respectively and 
death occurred at 20 and 49% (v/v).. Yant et al. (1932)
studied 1 ,2-dichloro-l,1 ,2 ,2-tetrafluoroethane and 
found that approximately 2 0% (v/v) in air was required 
to kill dogs; guinea-pigs survived convulsions at this 
level of exposure. Henne showed in 1937 that chloror 
fluoromethane was rapidly lethal to guinea-pigs at 
lower atmospheric concentrations than dichlorofluoro­
methane , a few per cent (v/v) compared to 10% (v/v) 
respectively.
It is apparent from Table 1.7 that the inclusion 
of one or more fluorine atoms in a molecule causes
a marked reduction in toxic effects. This trend is 
more consistent with fluorine substitution than with 
chlorine substitution; in the latter case increasing 
substitution first reduces toxicity (dichloromethane 
is less toxic than chloromethane), and then increases 
it (both carbon tetrachloride and chloroform are more 
toxic than dichloromethane).
The stabilising effect of fluorine on the toxicity 
of chloroalkanes may be due in part to the alteration 
of the physical and chemical properties of the molecule. 
Reference to Table 1.3 indicates that the substitution 
of one fluorine atom in carbon tetrachloride results 
in the fractional lengthening of the C-Cl bonds and 
a concomitant slight reduction in the bond energy 
terms. However, comparison of the bond dissociation 
energy values available for tetrafluoromethane, chloro- 
trifluoromethane and carbon tetrachloride indicates 
that for trichlorofluoromethane the energy required 
for a single dechlorination is probably a few kJ 
greater than for carbon tetrachloride.
Robbins (19^6) studied a number of fluorinated 
methanes and ethanes for their anaesthetic potency 
in mice. Many were discarded due to their provocation 
of convulsive responses, and the four compounds that 
appeared to be suitable were not investigated further.
1 ,1 ,2-trichloro-l,2 ,2-trifluoroethane was examined by 
Carpenter ejt a]L. (19^9)- They found that death 
occurred in guinea-pigs exposed to atmospheres
containing more than 3 %  o f  the compound for 0 .5 - 1  
hour.
Lester and Greenberg (1950) included three chloro- 
fluoroalkanes in their studies: trichlorofluoromethane, 
dichlorodifluoromethane and 1-chloro-l,1-difluoro- 
ethane. They found these compounds to be anaesthetic, 
and that no liver damage occurred by their inhalation. 
Acute exposures revealed trichlorofluoromethane as 
the most toxic of these compounds to rats, 10% being 
lethal within half an hour. In another publication 
they found that concentrations of 2 -3% of the two 
isomers of tetrachlorodifluoroethane were rapidly 
lethal to rats (Greenberg and Lester, 1950).
1 ,2-dichloro-l,1 ,2-trifluoroethane, 1 ,1 ,2 -trichloro
1.2.2-trifluoroethane and 1,1,2,2-tetrachloro-1,2- 
difluoroethane were studied by Burn et al. (l959)»
1 .2-dichloro-l,1 ,2-trifluoroethane was found to have 
similar pharmacological properties to halothane, but 
as it produced occasional cardiac arrhythmia, it 
could not be recommended for clinical use.
Chronic toxicological data has become more 
important since the introduction of chlorofluoroalkanes 
into fields other than mechanical refrigeration, 
particularly food propellants. Octafluorocyclobutane
was introduced as a food propellant in the United 
States in 1 9 6 1, following a 90-day inhalation study 
conducted by Clayton et al. (i9 6 0 ) using rats, rabbits,
mice and dogs. This study detected no effect of
exposure to 10% octafluorocyclobutane for six hours 
daily on general appearance and behaviour, blood and 
urine parameters, or on the histopathological 
appearance of the organs. Chloropentafluoroethane 
was similarly studied with comparable results (Clayton 
et al., 1966). The chronic oral toxicity of 
dichlorodifluoromethane has been studied by Clayton 
(1 9 6 7a), dosing 1 6 0 - 3 7 9 mg/kg to rats and 8-4-95 mg/kg 
to dogs for a 90 day period. Slight changes in serum 
alkaline phosphatase and urinary fluoride levels 
were checked by a second experiment on rats at higher 
dose levels, equivalent to approximately 3 5 0 0 and 
7000 p.p.m. of the diet. Urinary fluoride excretion 
remained within normal limits and slight changes in 
alkaline phosphatase were not directly attributable 
to dichlorodifluoromethane.
Scholz (1 9 6 2) reported acute and chronic toxicity 
studies of trichlorofluoromethane, dichlorodifluoro­
methane , 1,1,2-trichloro-l,2,2-trifluoroethane, and
1,2-dichloro-l,1,2,2-tetrafluoroethane, using rats, 
guinea-pigs, dogs and cats. No effect was found 
on blood, urine or liver. Skin and eye tolerance 
tests showed no adverse reactions.
The effects of inhalation of trichlorofluoro­
methane and dichlorodifluoromethane on lung histology 
in laboratory animals have been reported by Kubler 
(1 9 6 3 ) 1 who found no changes, and Quevauviller et al. 
(1 9 6 3 ) 1 who reported some changes in the lungs of
mice exposed for 24 hours to 1% propellant vapour.
Recently long-term continuous chronic toxicity 
studies have been carried out on rats, guinea-pigs, 
dogs and monkeys with 1 %  dichlorodifluoromethane 
(Prendergast et al., 1 9 6 7) and with 0.1% and 1% 
trichlorofluoromethane (Jenkins et al., 1970) to
assess the possible dangers to humans living in a 
confined environment, such as nuclear submarines and 
space vehicles. In the former study, Prendergast et 
al. (1 9 6 7) demonstrated that continuous exposure to
dichlorodifluoromethane was more hazardous than 
repeated exposures for 30 days to approximately the 
same concentrations. However,, no significant effects 
of toxicity were found. Liver cell vacuolation in 
guinea-pigs and focal liver cell necrosis in monkeys 
.were detected histologically. Jenkins et al. (1970)
found similar liver cell vacuolation in guinea-pigs 
after inhalation of 1000 p.p.m. trichlorofluoromethane 
for 90 days, and increased serum urea nitrogen in dogs. 
Clayton (1966) reported two experiments involving 
repeated exposures of rats to trichlorofluoromethane 
at 4000 p.p.m., 6 hours a day, for 28 days and at
12,000 p.p.m., 4 hours a day, for 10 days. He found 
some histopathological changes including vacuolation 
of liver cells and brain neuroglial cells, oedema of 
the lungs and of brain neurones, and increased haemo­
poiesis in the spleen.
The toxicology of some of the chlorofluoroalkanes
by oral and topical application has been investigated. 
Oral intubation of rats with 2 g/kg 1,2-dichloro-
1.1.2.2-tetrafluoroethane (Quevauviller, 1 9 6 5 )1 200-
4.00 mg/kg dichlorodifluoromethane (Clayton, 1 9 6 6) and
150 mg/kg chloropentafluoroethane (Clayton, 1967a)
showed lack of toxicity by this route of administration
Studies in rats have shown 1,1,2-trichloro-1,2,2-tri-
fluoroethane to be of low oral toxicity, and it is
reportedly so in dogs and man (Clayton, 1967a).
Michaelson and Huntsman (1964) showed the oral LD__50
of 1, 1, 2-tri'chloro-1, 2 , 2-trif luor oethane in rats was
43.0 + 4.8 g/kg.-
Instillations into the eye of a rabbit of 1,1,2- 
trichloro-1,2,2-trifluoroethane (Clayton, 1 9 6 7a) and 
dichlorodifluoromethane (Downing and Madinabeitia, 
i9 6 0 ) occasioned mild, transient corneal irritation.
Application to the skin, tongue, soft palate and 
auditory canal of the three pure compounds (trichloro- 
fluoromethane, dichlorodifluoromethane and 1,2-dichloro
1.1.2.2-tetrafluoroethane) and two mixtures (trichloro- 
fluoromethane/dichlorodifluoromethane and trichloro-
fluoromethane/chlorodifluoromethane) repeatedly for 
6 weeks (Quevauviller et al., 1964) showed little 
effect except on the skin, which became oedematous 
and slightly inflamed. The reaction was most marked 
with 1,2-dichloro-,1,1,2,2-tetrafluoroethane and the 
trichlorofluoromethane/chlorodifluoromethane mixture 
and was more severe in older rats. Quevauviller et
al, (1964) also showed that burn and wound healing 
was retarded compared to controls.
Chlorinated alkanes are noted for their l)Lepato- 
toxicity e.g. carbon tetrachloride (Recknagel, 1 9 6 7 ) 1  
chloroform, 1, 2-dichloroethane and 1, 1, 2 , 2-te.trachlor o- 
ethane (Irish, 1 9 6 2); the fluorine-containing halogenated 
alkanes on the other hand are not apparently hepatotoxic 
(Sayers et al., 1930; Nuckolls, 1933; Lester and 
Greenberg, 1950; Burn ert al., 1959; Clayton et al., I960; 
Clayton, 1966; Clayton, 1967a,b). Only mild liver cell 
vacuolation has been found after repeated exposures to 
chlorofluoroalkanes at levels that might be encountered by 
humans (Clayton, 1966; Prendergast et al., 1967;
Jenkins jst aJL. , 1970). It is interesting to note
that studies by Nikitenko and Tolgskaya (1 9 6 5) on the 
toxicity of 1,2-dichloro-2-fluoroethane, 1-chloro-
2,2-difluoroethane and 1,2,2-trifluoroethane to mice 
showed that the toxicity decreased with the substitution 
of fluorine for chlorine. They suggested that toxicity 
was dependent to some extent on the chlorine content.
Experiments performed by Epstein et al., (1967a,b)
show that chlorofluoroalkanes may exhibit synergistic 
toxicity with other compounds foreign to the body. 
Trichlorofluoromethane, 1,1,2,2-tetrachloro-l,2-di-
fluoroethane, 1,1,2-trichloro-l,2,2-trifluoroethane
and piperonyl butoxide (an insecticide synergist) 
were injected intraperitoneally into mice, either 
singly or in combination. After 51 weeks, the incidence
of hepatomata in male mice was found ±o be significantly 
increased in mice receiving mixtures of piperonyl 
butoxide and either ethane analogue compared to the 
single administrations or control animals. Epstein 
et al. (1 9 6 7a) indicated that unpublished data of
Fujii and Epstein suggest that the chlorofluoroalkanes 
induce microsomal enzyme synthesis.
1.5. Toxicity to man.
In 1968, Baselt and Cravey reported a fatal case 
of inhalation of a mixture of trichlorofluoromethane 
and dichlorodifluoromethane by a fifteen year old boy, 
who had sprayed the contents of an aerosol can into a 
plastic b ag. They concluded that death was due to 
anoxia.
Bass (1970) reported a survey of sudden unexplain­
able deaths in American youths, which were associated 
with inhalation of volatile hydrocarbon solvents, 
principally 1,1,1-trichloroethane and fluorinated 
refrigerants and propellants. These deaths were not 
due to suffocation by plastic bags, nor to freezing 
of the vocal chords and pulmonary oedema, but were 
associated in some way with stress or exercise. At 
post-mortem examination, eight cases showed levels of 
volatile hydrocarbons quantitatively compatible with 
light plane anaesthesia of similar anaesthetics. Bass 
did not reach any conclusion but suggested that severe 
cardiac arrhythmia, induced by the volatile compounds
and the stressful situations, may have been the cause 
of death. This report prompted Taylor and Harris 
(1970) to investigate the effect of chlorofluoroalkanes 
on asphyxia-induced cardiac arrhythmias in mice.
They found that mice inhaling chlorofluoroalkanes, 
when compared to placebo and control animals, were 
more sensitive to arrhythmias induced by asphyxia, and 
the arrhythmias (sinus bradycardia, AV block and 
ventricular T-wave depression) proved fatal. They 
also reported preliminary findings that dogs and rats 
are also sensitised. The authors speculated that 
this ’sensitisation1 of the heart might be the cause 
of sudden deaths following chlorofluoroalkane inhalation, 
either as an abuse for pleasure, or by the use of
pressurised bronchodilator aerosols in asthma,
particularly in circumstances favouring the endogenous 
release of catecholamines into the blood stream.
This study by Taylor and Harris was criticised by 
Silverglade (l97l) who reported no differences between 
control and test animals in a similar study, and 
dismissed the postulated connection between asthma 
mortality and pressurised aerosol bronchodilators.
Harris (l97l) briefly reviewed the possible causes of 
asthmatic deaths and concluded that pressurised broncho­
dilator aerosols had little effect.
Reinhardt ejb aT. (197la) reported that high 
concentrations of the chlorofluoroalkanes, like other 
halogenated and non-halogenated hydrocarbons, do indeed
sensitise the heart to adrenaline resulting in severe 
arrhythmias. They concluded that sudden deaths 
following aerosol propellant sniffing may well be due
under proper conditions of use, aerosol propellants 
presented no risk with regard to cardiac sensitisation.
Blood concentrations of trichlorofluoromethane in 
human volunteers have been measured by Dollery et al. 
(1970) and Paterson et al. (l97l). Dollery et al.
this blood level by increasing the number of exposures. 
Paterson et al. confirmed these observations and reported 
Jack’s findings (1971) on the necessary blood level of 
trichlorofluoromethane to sensitise the hearts of 
conscious dogs to adrenaline. The peak blood levels 
shown by Dollery et al. and Paterson et al. were 
approximately 10% those of Jack.
Reinhardt et al. (1971b) exposed human volunteers
to 0.1% and 0 .0 5% 1,1,2-trichloro-1,2,2-trifluoroethane 
repeatedly for a total of 30 hours. No adverse 
reactions were reported and analysis of breath samples 
indicated no significant build up of the compound in 
the body.
to cardiac sensitisation. They also noted that
showed levels of about
of this chlorofluoroalkane. They could not increase
1.6. Anaesthetics.
Halogenated hydrocarbons were first used as 
anaesthetics with the introduction of chloroform in 1847-
Ethyl chloride followed in 1888 and trichloroethylene 
in 1935• Because of the hepatotoxicity of chloroform 
and trichloroethylene (Chenoweth and Hake, 1962; Irish, 
1 9 6 2) and the explosion hazard with ethyl chloride and 
ether, fluorinated compounds were investigated for 
anaesthetic activity (Robbins, 1946). Although 
Robbins1 work was not followed up, fluroxene (2,2,2- 
trifluoroethyl vinyl ether) (Lu et al., 1953) 1 halothane 
(2-bromo-2-chloro-1 ,1 ,1-trifluoroethane) (Raventos, 1956)
and methoxyflurane (2 ,2 -dichloro-1 ,1-difluoroethyl 
methyl ether) (Larsen, 1 9 6 3) have been widely accepted 
in clinical practice.
Halothane has caused considerable controversy 
since its introduction in 1956. Various reports have 
appeared of hepatic necrosis after halothane anaesthesia 
(Burnap ejt aT. , 1958; Stephan jert all., 1958, Virtue and 
Payne, 1958; Barton, 1959; Vourch et al., i9 6 0 , Brody 
and Sweet, 1963; Lindebaum and Leifer, 1963; Tygstrup, 
1963; Keown and Bingham, 1969; Hansen, 1970; Nowill,
1970; Johnston and Mendelsohn, 1971) • In 19631 the 
Committee on Anesthesia of the National Academy of 
Sciences-National Research Council in the U.S.A. 
set up the National Halothane Study. This was a 
retrospective study, concluded in 1966, of some 8 5 6 , 5 0 0  
administrations of a general anaesthetic between 1959 
and 1962. Of these, halothane accounted for 30%.
The findings were that halothane appeared to exhibit 
a lower post-operative death rate compared to all
general anaesthetics. The subcommittee was unable 
either to confirm or to refute a causal relationship 
between halothane administration and the occasional 
massive hepatic necrosis. The incidence of hepatic 
necrosis in the study amounted to 82 cases, of which 
9 were unexplained. Of these 9 cases, which resembled 
viral hepatitis, 7 had received halothane and 5 of
these showed clinical evidence of liver failure. This 
contrasts with the explainable cases of necrosis, where 
liver failure was not clinically suspected. 2,3-Di- 
chloro-1,1,1,4,4,4-hexafluorobut-2-ene was found to 
be a contaminant of halothane (Cohen et al.-,' 1963) 
as manufactured by the high thermal process (Cohen et 
al., 1 9 6 5)- They further reported that it could 
concentrate under clinical conditions of use, that it 
was taken up by man and presumably metabolised, and 
that it was toxic to all species at levels only slightly 
above clinical concentrations. They reported that this 
contaminant was subsequently removed by the manufacturers 
Some of the more recent reports of hepatitis 
(Johnston and Mendelsohn, 1971) and liver necrosis 
(Hansen, 1970; Nowill, 1970) associated with halothane 
anaesthesia have suggested a sensitivity reaction as 
being the cause; adverse reactions appeared only after 
two or more exposures to halothane. This is in 
agreement with the observations of Belfrage et al.\ (1 9 6 6 ) 
who challenged an anaesthetist, thought to be sensitive 
to halothane, with a few minutes halothane anaesthesia.
The subject fell ill within five hours, and although not 
jaundiced, the symptoms he displayed were attributed to 
the halothane challenge. The authors suggested a 
sensitivity reaction to some product of halothane, 
rather than the compound per se, as the effect was 
delayed.
Halothane is not the only fluorinated anaesthetic 
to be linked with hepatotoxicity. Methoxyflurane has 
been reported to have caused liver cell necrosis and 
jaundice.in one patient (Klein and Jeffries, 1966). 
Methoxyflurane has also been associated with nephro­
toxicity. Panner et al. (1970) reported two deaths
following methoxyflurane anaesthesia, and gave evidence 
of crystals similar to calcium oxalate in the renal 
tubules. Taves et al. (1970) showed increases in the 
levels of inorganic fluoride and non-volatile organic 
fluoride in serum and urine following exposure to 
methoxyflurane. Fluoride excretion was prolonged,
continuing for more than 19 days in one patient.
Mazze et al. (l97l) reported several cases of nephro­
toxicity.
1.7 « Biological cleavage of the C-Cl bond.
The carbon-chlorine bond is cleaved in a number of 
ways :-
(i) Non-enzymic and enzymic reductive 
dechlorination occurs in vitro, with a requirement for 
compounds such as glutathione or cysteine.
(ii) Dechlorination followed by mercapturic acid 
formation occurs principally with mono-substituted 
alkanes and various halogenated aromatic compounds.
(iii) Some oxidative processes occur in vivo 
resulting ultimately in the formation of carbon dioxide.
(iv) Homolytic cleavage of carbon-chlorine bonds 
occurs both in vivo and in vitro, resulting in the 
formation of free radicals.
Lucas (1928) studied the degradation of chloroform, 
tribromomethane and other brominated anaesthetic agents. 
He found tribromomethane was metabolised in vivo and in 
vitro, forming bromide ions. Chloroform, in in vitro 
incubations with rabbit or dog liver homogenate, formed 
chloride ions. In 1948, Heppel and Porterfield 
demonstrated the jdehalogenation by rat liver extracts of 
several partially halogenated methanes and ethanes.
These included chloroform, bromochloromethane and 
dichloromethane and the products formed were formaldehyd 
halide ions and hydrogen ions. Sulphydryl compounds, 
such as glutathione and cysteine, activated the enzyme. 
Bray jet aJL. (1952) studied the dechlorination of 
twenty-nine aliphatic and aromatic chlorinated compounds 
including chloroform. They found that the liberation 
of chloride ions was increased in the presence of 
rodent liver extracts and cysteine, and that boiling 
the liver extract failed to reduce the activity 
markedly. They concluded that the dechlorination was
non-enzymic. Butler (l96l) found carbon tetrachloride 
and chloroform were metabolised to chloroform and 
dichloromethane respectively, by homogenates of mouse 
tissues. Heated tissue carried out this reaction more 
slowly.„ Chloroform was also converted to dichloro­
methane by high concentrations of cysteine and ascorbic 
acid; carbon tetrachloride reacted more rapidly with 
these compounds and also with reduced glutathione and 
cytochrome c.
Booth jet al. (1 9 6 1) partially purified an enzyme
which formed glutathione conjugates from a number of 
halogenated compounds. Much work has been carried out 
on the formation of mercapturic acids from brominated 
alkanes, involving dehalogenation (e.g. Bray and James, 
1 9 5 8 ; Thomson et al., 1963)* Barnsley (1 9 6 6) reported 
the formation of 2-hydroxypropylmercapturic acid from 
1-chloropropane and l-chloropropan-2-ol. Grenby and 
Young (i9 6 0 ) had previously'■ detected n-propylmercapturic 
acid from the urine of rats and rabbits dosed with 
1-chloropropane. Sims and Grover (1 9 6 5) found a close 
relationship between the production of chloride ions and 
the utilization of glutathione in the in vitro 
conjugation of 0C- 3 , 4 , 5 1 6-tetrachlorocyclohex- 1-ene and 
oc-2,3 1 4,516-pentachlorocyclohex-l-ene. Benzyl chloride 
is dehalogenated and conjugated (Boyland and Chasseaud, 
1969)i whereas chlorobenzene is not dehalogenated, but 
is conjugated with glutathione at the 4-position
(Hutson, 1970)-
Another reaction dependent on reduced glutathione
>
is the dehydrochlorination of DDT (1,1-bis(p-chlorophenyl) 
-2,2,2-trichloroethane) to.form DDE (1,1-bis(p-chloro- 
phenyl)- 2,2 -jdichloroethylene) (Hathway, 1970).
In experiments conducted by Paul and Rubinstein 
(1963)i chloroform and carbon tetrachloride were 
metabolised in vivo by the rat to 4% and 1 %  carbon 
dioxide respectively, with approximately 8 0% of each 
compound being expired unchanged within l8 hours. In 
in vitro experiments with slices of liver, kidney, 
muscle and adipose tissue, small amounts of chloroform 
were found in incubations with carbon tetrachloride, but 
no dichloromethane was detected as a metabolite of 
either chloroform or carbon tetrachloride. Reduced 
glutathione and cysteine had no effect on the metabolic- . 
conversion. From these results, Paul and Rubinstein 
suggested that the formation of carbon dioxide from 
chloroform and carbon tetrachloride was by a common 
oxidative pathway, following the reductive dechlorination 
of carbon tetrachloride to chloroform. Van Dyke et al.
Ti4 1 ------(1964b) found approx. 3 %  L Cj chloroform was excreted 
as "^CO and up to 2 %  [36ci] chloroform appeared in the 
urine, principally as ^^Cl ion.
Trichloroethylene and tetrachloroethylene 
metabolism has been studied in the rat (Daniel, 19.63)*
15% of the former and 2 %  of the latter were excreted in 
the urine, principally as trichloroacetic acid and 
trichloroethanol. Daniel proposed the following
mechanisms to account for the intramolecular 
rearrangement of the chlorine atoms:
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Jondorf et al. (1957) found hexachloroethane was
metabolised by rabbits to a variety of products: 
trichloroacetic acid (l.3%)? trichloroethanol (1.320? 
dichloroacetic acid (0.8%), chloroacetic acid (0.7%)? 
dichloroethanol (0.4%) and oxalic acid (0 .1%) appeared 
in the urine; unchanged compound, carbon dioxide, 
tetrachloroethane and te tra chioro e thylene (12%) appeared 
in the expired air. Fowler (1969a) found only penta- 
chloroethane and tetrachloroethylene as metabolites of 
hexachloroethane in sheep. Yllner has investigated the 
in vivo metabolism of various radioactively labelled 
chlorinated ethanes in the mouse. His results can be 
summarised as follows:
Substrate
CH Cl-CH Cl
CHC12-CH2C1
CC1 -CH Cl 3 2
CHC12-CHC12
Principal metabolites Reference
c h2c i-cooh
CH C1-C00H
CC1^-CH20H
CCl^-COOH
C02
CHC12-C00H
CC12=CHC1*
CC12=CC12*
Yllner (l971e) 
Yllner (l971d) 
Yllner (1971a)
Yllner (1971c)
Substrate Principal metabolites Reference
c c i3-chci2 c c i2=chci Yllner (1971b)
CC12=cc12
CC1 -CH(0H)2
The metabolites marked were formed spontaneously in 
neutral conditions (200 j x l substrate added to 100 ml 
0.14M phosphate buffer, pH 7.0, containing 30% ethanol, 
incubated at 37°C for 24 hours).
Van Dyke and Wineman (l97l) have studied the
o /T
dechlorination of Cl-labelled chlorinated ethanes 
and propanes in vitro, by measurement of the formation
O £
of inorganic Cl ion. They found the activity was 
similar to the hepatic microsomal mixed function 
oxygenase (see 1.12.) in terms of cofactor requirements 
and inducibility by phenobarbital and benzpyrene.
However, the dechlorination system appeared to be only 
slightly dependent on cytochrome P-450, as carbon 
monoxide failed to inhibit the reaction significantly. 
Glutathione was not a requirement for the dechlorination 
mechanism. Considerable differences were found in 
the amount of Cl ion formed enzymatically. 1,1-Di- 
chloroethane, 1,1,2-trichloroethane, 1,1,2,2-tetrachloro-
ethane and hexachloroethane underwent considerable 
dechlorination; chloroethane, 1,2-dichloroethane, 1,1,1-
trichloroethane and 1,1,1,2-tetrachloroethane were 
barely attacked.
Considerable attention has been focussed on the 
metabolism of carbon tetrachloride, which is now
thought to be associated with the compound's hepato- 
toxicity. McLean and McLean (196 5 , 1966) and Seawright
and McLean (1 9 6 7) showed that maintenance of rats on 
a protein-free diet, which depresses microsomal drug- 
metabolising activity, increased the oral LD-^ of 
carbon tetrachloride, decreased its metabolism to 
carbon dioxide by 7 0%, and ameliorated its effects on 
various parameters of liver damage. Pulmonary 
excretion of the compound was unchanged. They found 
that a single dose of DDT or three doses of sodium 
phenobarbital increased microsomal enzyme activity 
and carbon tetrachloride toxicity. They thus associated 
carbon tetrachloride toxicity with its metabolism, 
which seemed to occur in the endoplasmic reticulum.
McCollister et al. showed that monkeys absorbed 
about 30% of* an inhaled dose of [_ CJ carbon tetrachloride 
half of which was eliminated by the lungs over a 75 
day period. A small quantity of C0Q was expired, 
and some non-volatile radioactivity was detected in the 
urine. Paul and Rubinstein (196 3 ) also showed 
metabolism to carbon dioxide in vivo, and these workers 
and Butler (1 9 6 1) showed the in vitro production of 
chloroform.
Reynolds (1 9 6 3) found that after a dose of [^cj- 
carbon tetrachloride, some of the activity was bound 
chemically to liver tissue constituents. Subcellular 
localisation of the radioactivity showed a 3•1 ratio 
between microsomes and mitochondria. This suggested
the formation of a reactive metabolite. Cessi et al. 
(1 9 6 6) in a similar experiment found radioactivity 
bound to peptides, possibly through lysine, and they 
believed that carbonyl chloride was the reactive 
metabolite of carbon tetrachloride.
Slater (1 9 6 6) speculated that carbon tetrachloride 
was metabolised to a free radical, perhaps *CC1 ,^ by 
homolytic fission of a carbon-chlorine bond. However, 
Gregory (1 9 6 6) suggested metabolism of carbon tetra­
chloride and chloroform may occur by electron transfer 
resulting in a free radical and a chloride ion. 
Wirtschafter and Cronyn (1964) had previously postulated 
a free radical mechanism as an explanation of halogen­
ated and non-halogenated solvent toxicity. Both 
Slater; and Wirtschafter and Cronyn suggested the 
-participation of naturally occurring endogenous free
14 16radicals. Gordis (.1969) showed that when C- or Cl- 
labelled carbon tetrachloride was injected into rats, 
radioactivity was rapidly bound to a mixture of branched 
long-chain fatty acids; liver slices formed similar 
metabolites. Gordis also showed that chemically 
produced trichloromethyl radicals combined with methyl 
oleate, yielding esters with similar characteristics 
to the metabolites formed in vivo and in vitro.
Experiments by Fowler (1969b) on the metabolism 
of carbon tetrachloride by the rabbit showed chloroform 
(approximately 1%), hexachloroethane (less than 0 .0 0 1%) 
and two other unidentified metabolites. Dimerisation
of trichloromethyl radicals might have occurred to 
form hexachloroethane. Slater and Sawyer (1971a,b,c) 
have studied the increased lipid peroxidation due to 
carbon tetrachloride and conclude that it is dependent 
on the initial formation of trichloromethyl radicals.
Scholler (1970) suggests a similar metabolite 
in chloroform metabolism. Chemically, chloroform in 
the presence of free radical sources, e.g. benzoyl 
peroxide, yields the trichloromethyl radical (Walling, 
1957)? and not the dichloromethyl radical as might be 
expected from comparison of the C-Cl and C-H bond 
energies in chloroform (Table 1.2). Chloroform and, 
to a lesser extent, carbon tetrachloride.form carbanions 
in the presence of a strongly basic nucleophile (Hine, 
1950), but Slater (1972) discounted this as a possible 
mechanism of biological degradation, in view of the 
highly non-polar environment of the endoplasmic reticulum.
1.8. Stability of the C-F bond in biological systems.
Because of the high bond energy of the C-F bond, 
it is rarely broken biologically or chemically. The 
C-F bond in fluoroacetate withstands boiling concentrated 
sulphuric acid (Saunders and Stacey, 1948) and is only 
broken by sodium fusion at 500°C or by refluxing with 
30% sodium hydroxide (Mirosevic-Sorgo and Saunders,
1959). This property, together with the stabilising 
effect on other carbon-halogen bonds to the same carbon 
atom, has been put to use in the elucidation of some
biological phenomena. For example, cerebral blood
1*131 1flow may be traced using [_ Al iodotrifluoromethane 
(Solokoff, 1957; Kety, I960), whereas its analogue, 
iodomethane, is unstable in biological systems.
From the discovery that fluoroacetate was an 
inhibitor of the Krebs cycle by virtue of the formation 
of fluorocitrate (the classical example of 'lethal 
synthesis1.(Liebecq and Peters, 1949)) many fluorinated 
compounds have been assessed as selective inhibitors 
of various enzymes. 5-Flu.oro-2 *-deoxyur idine-5 1 -
monophoshate, formed from 5“Pluorouracil, is a potent 
inhibitor of thymidylate synthetase (Hartmann and 
Heidelberger, 1 9 6 1) and thus blocks DNA synthesis.
Substitution of fluorine for hydrogen in molecules 
such as steroids has been used to stabilise the compounds 
and thus to decrease the metabolic degradation and consequent 
loss, of activity. Florini and Buyske (1959) showed that 
the metabolism of cortisol was decreased by 3 0% by the 
insertion of a fluorine atom in the 9C<- -position.
1.9. Biological cleavage of the C-F bond.
Despite the great chemical stability of the C-F 
bond, examples exist of its cleavage by biological 
systems. Goldman (1 9 6 9) reviewed the compounds 
containing the C-F bond which are of biological interest.
Two principal examples exist of C-F bond cleavage:
(i) Peroxidase enzyme, derived from either 
horseradish or turnip, was shown by Hughes and Saunders
(1954) to rupture the C-F bond of 4-fluoroaniline, 
yielding a fluoride ion. Similar reactions occurred 
with 4-chloro- and 4-iodo-aniline.
(ii) Phenylalanine hydroxylase obtained from 
rat or sheep liver was studied by Kaufman (l96l). 
4-Fluorophenylalanine was found to be hydroxylated at 
approximately 1 5 %  of the rate of phenylalanine 
hydroxylation. The reaction yielded L-tyrosine and 
fluoride ion in approximately equal amounts, utilising 
excess NADPH. 4-Chlorophenylalanine, however, forms
3-chlorotyrosine by migration of the chlorine atom 
during hydroxylation (Guroff et al. , 1966).
Additional examples of C-F bond cleavage have been 
found by growing bacteria on^media enriched with various 
fluorinated carbon sources. Pseudomonads have been 
•found to defluorinate fluoroacetate, but not 2 - and 3 - 
fluor opr op1onat e (Goldman, 1965)? and 2-fluorobenzoic 
acid (Goldman et al., 1967) .
Barnett et al. (1967) described the defluorination
of oc-D-glucosyl fluoride by rat intestinal mucosa, and 
associated this activity with oi-D-glucosidase.
Daly et al. (1 9 6 8) reported the formation of
4-hydroxyaniline from 4-fluoro- and 4-chloro-anilines, 
and the formation of the corresponding 4-hydroxy 
derivative from the 3~ and 4- position halogen 
substituted acetanilides, in a rat liver microsomal 
system.
Gottlieb et al. (1965) showed that 4-fluoro-L-
proline was incorporated into protein and collagen 
precursor in guinea-pig granuloma tissue, and was 
subsequently defluorinated to yield bound 4-hydroxy-L-
4-fluoro-L-proline.
Recently, Ward and Huskisson (1972) showed the 
defluorination of fluoroacetate by lettuce. The 
reaction was enzymic and required cysteine or reduced 
glutathione.
1.10. Metabolism of the fluorinated anaesthetics.
Brown and Vandam (l97l) and Cohen (l97l) have 
reviewed the metabolism of volatile anaesthetics, 
including the chlorinated and the non-halogenated 
compounds.
Until comparatively recently the inhalation 
anaesthetics were thought to be metabolically inert, 
with the principal exception of trichloroethylene. 
Vandam (1 9 6 3) suggested that halothane was 'inert1 
because the carbon-chlorine and carbon-bromine bonds 
were stabilised by the adjacent trifluoromethyl,group. 
However, Stier (1964a) showed the prolonged urinary 
excretion of inorganic bromide by rats injected intra­
muscularly with halothane in propylene glycol. The 
quantity recovered in the first three days represented 
0 . 3 %  of the dose of halothane administered. Using
average of 1 .5 6% of the injected dose in the 24-hour
proline. E. coli was also able to incorporate
Van Dyke et al. (1964a) found an
urine of* rats, which they assumed to be dechlorinated 
or debrominated residues, perhaps conjugated. They 
also found 0.84% of the radioactivity appeared as 
carbon dioxide within 24 hours. Stier (1964b) 
identified trifluoroacetic acid as a metabolite of 
halothane in rabbits. Van Dyke et al. (1964b), using
• o/:
Cl-labelled halothane, found inorganic chloride in 
rat urine for over l4 days following the dose. The 
amount totalled 2.9% of the dose given. 83- 90%  of the 
radioactive material was recovered in the expired air 
within 30 hours. Van Dyke and Chenoweth (1 9 6 5b) found 
that the dechlorination of halothane also occurred in 
vitro with liver slices and liver microsomal preparations 
This dehalogenation showed requirements for oxygen 
and NADPH, but no requirement for sulphydryl compounds. 
Metabolism of halothane was also demonstrated in thymus 
and kidney slices. Van Dyke (1 9 6 6) extended this work 
to show that phenobarbital pretreatment of rats! increased 
metabolism of! [ * « ]  halothane both in vivo and in vitro, 
by approximately 130% and 6 5% respectively.
Cohen and Hood (l9 69) and Cohen (1 9 6 9) have used 
low-temperature autoradiography to study the metabolism
T 14 1of [2- CJ halothane in the mouse. They found the 
highest concentrations of radioactivity immediately 
following inhalation to be in the liver and brown fat. 
Within ten minutes significant concentrations of non­
volatile metabolites had built up in all tissues except 
the general body fat and brown fat. These metabolites
persisted in the body for at least 12 days and became 
concentrated in the liver and large intestine compared 
to the total body radioactivity. Cohen (1 9 6 9) showed 
that weekly injections of halothane caused a 400% 
increase in the_ non-volatile radioactivity of the 
liver over five weeks, and suggested halothane induced 
its own metabolism. The non-volatile metabolites in 
the mouse and squirrel monkey are mainly polypeptide 
and amino acid in nature, two-thirds having molecular - 
weights over 700 (Cohen, 1971 )• The liver metabolites 
appear to be closely associated with the mitochondrial 
and microsomal fractions. Sawyer et al. (1970), using
miniature swine, measured the extraction of halothane 
from the blood by the liver. Above 0.5% (v/v) halothane 
in the alveolar gas, extraction by the liver decreased 
•towards zero. They suggested therefore that the 
results of radioactive tracer studies of metabolism 
and uptake cannot necessarily be extrapolated to the 
situation of clinical anaesthesia and, conversely, 
that studies of metabolism under anaesthesia must 
grossly underestimate the degree of biotransformation 
at subanaesthetic levels. They found that the liver 
extracted nearly all the halothane from the blood, 
when the alveolar concentration was less than 0 .0 0 2 6% 
(v/v).
Sawyer et al. (1970) also reported blood levels
of halothane in clinical anaesthesiologists of between 
0.6 and 3.5 yag/ml. Linde and Bruce (1 9 6 9) had reported
previously observations made of ten anaesthetists 
routinely exposed to 10 p.p.m. halothane in the 
operating room air. Halothane was found in the 
expired air of these subjects and the fluorine content 
of the urine was significantly increased.
Several studies have been made of the excretion of 
metabolites by patients following halothane anaesthesia 
(Stier et al., 1964; Rehder et al., 1967; Stier, 1968) 
and by volunteers following intravenous infusion of 
radioactive halothane (Cascorbi et al., 1971a,b) or
trifluoroethanol (Cascorbi and Blake, 1971)• Stier 
et al. (1964) found that patients anaesthetised with
halothane excreted bromide into the urine over a long 
period and that the bromideihalide ratio was increased. 
Rehder et al. (1967) found inorganic bromide and
trifluoroacetic acid in the urine of two patients,
and calculated that between 12 and 20% of the halothane 
absorbed was metabolised. Stier (1 9 6 8) showed tri­
fluoroacetic acid was excreted biphasically and that 
~the time course was identical whether trifluoroacetic 
acid was given directly or was formed metabolically 
from halothane. He postulated the following mechanism 
for metabolism:
H F F
I I I _
C — B r  ^F— C —  C— Br  fr-F—  C—  C00H + Br + Cl
I I I  I
Cl F Cl F
as an alternative, or parallel, route to that proposed 
by Van Dyke and Chenoweth '(1 9 6 5a):
F
I
F —  C 
I
F .
F H F
I I  _ I
j> F C —  C —  OH + Br + Cl --->F— C— COOH
I I I
F H F
Trifluoroethanol has not been found as a urinary
metabolite, but Blake and Cascorbi (1970) using 
volunteers have shown up to 80%  transformation of 
trifluoroethanol to trifluoroacetic acid. Cascorbi 
et al. (l971a,b) report large individual variations
in halothane metabolism. Comparison of a group of 
pharmacists and a group of anaesthetists showed that 
occupational exposure to halothane vapour can increase 
its metabolism. Comparison of identical and fraternal 
twins showed an overlying genetic influence on halothane 
metabolism.
It would seem from this evidence that halothane is 
debrominated and dechlorinated to form trifluoroacetic 
acid fairly readily, up to 25%  of an anaesthetic dose 
being metabolised by man, and that defluorination 
accounts for a very small proportion of the metabolism 
(less than 1%). It seems possible that the route 
of metabolism might involve free radical formation, 
analogous to the metabolism of carbon tetrachloride 
(see 1 .7 ). The evidence of Cohen (l97l) for the 
formation of bound metabolites would seem to support 
this. Both Cascorbi et al. (1971b) and Cohen (1971) 
suggest that the combination of a free radical metabolite 
with a large protein might form an antigenic molecule. 
This could result in the 'sensitisation1 to halothane
F H 
I I 
F —  C —  C —  Br 
I I 
F Cl
previously noted (1.6). Thus, the rare and unexpected 
cases of hepatotoxicity following halothane anaesthesia 
could be dependent on a number of factors, including 
the individual’s rate of halothane metabolism, the 
degree of enzyme induction produced by previous anaes­
thesia or by other drugs, and the formation of antigens.
The metabolism of other fluorinated anaesthetics 
has not been as fully investigated. Fluroxene (2,2,2- 
trifluoroethyl vinyl ether) is not dehalogenated to 
any extent, but undergoes ether cleavage (Blake and 
Cascorbi, 1970; Cohen, 197l)s
CF<5CHq-0-CH=CH  >CF CH_0H + H0CH=CH
CF^OOH C 0 2
Methoxyflurane is metabolised principally by dechlorination 
and ether cleavage (Van Dyke et al., 1964b; Van Dyke 
and Chenoweth, 1965a).
c h3-o-cf2chc i2 -— ^ c h3-o-cf2-c h2oh’ I
HCHO + H0-CF - C H C 1  > H0CHoCHCl
2 2 2 2
and induces its own dechlorination (Van Dyke, 1966). 
Defluorination also occurs (Holaday et al., 1970;
Cohen, 1971) as indicated by the increased excretion 
of fluoride ion.
1 .1 1 . Metabolism of the chlorofluoroalkanes.
Little, if any, study has been made of the possible 
metabolism of the chlorofluoroalkanes. It would
appear that the increased stability of the fluorine- 
containing compounds compared to the chlorinated 
analogues is assumed to confer metabolic inertness 
on the chlorofluoroalkanes. Saunders et al. (19^9)
found l-chloro-2-fluoroethane non-toxic at a level 
of 0.184 mg/l of air, which was the for 2-fluoro-
ethanol. l-Chloro-2-fluoroethane is unreactive to 
a variety of chemical reagents and the authors suggested 
that the animals were unable to metabolise the compound 
to form the toxic 2-fluoroethanol. Slater (1 9 6 5) 
compared the effects of trichlorofluoromethane (2.5 
ml/kg) and carbon tetrachloride (l. 2 5 ml/kg) on serum 
^.-glucuronidase activity and on liver levels of 
nucleotides in the rat. Whilst carbon tetrachloride 
produced a pronounced increase in the level of p- 
glucuronidase in the serum, trichlorofluoromethane 
caused a fall in the serum level of the enzyme, which 
was ’not appreciable’. Both carbon tetrachloride and 
trichlorofluoromethane caused a reduction in the ratio 
of NADPH to NADP in the liver compared to control 
levels in animals administered the liquid paraffin 
vehicle only. However, in the case of carbon tetra­
chloride this was due to a decrease in the level of 
NADPH, whereas the level of NADP was increased by 
trichlorofluoromethane. From this evidence, Slater
concluded that metabolism of trichlorofluoromethane was 
probably insignificant.
1.12. Biochemical aspects of foreign compound metabolism.
It is widely accepted that the vast majority of 
compounds foreign to the mammalian system are metabolised 
usually to form less toxic metabolites, but occasionally 
to form an active, toxic metabolite (Parke, 1 9 6 8).
The liver endoplasmic reticulum is a major site of this 
activity. Estabrook et al. (1963) showed that NADPH- 
dependent drug and steroid hydroxylations required the 
b type cytochrome, cytochrome P-450, as an oxygen 
activating system. The role of cytochrome P-450 in 
drug metabolism has been reviewed recently by Gillette 
et al. (1972). There have been numerous review
articles on other aspects of drug metabolism such as 
enzyme induction (Kuntzman, 1969; Gillette, 1971a), 
enzyme inhibition and activation (Anders, 1971) and the 
influence of other factors such as species and sex ' . .
(Gillette, 1971b).
Cytochrome P-450 is found principally in liver 
microsomal and adrenal mitochondrial, preparations, 
although many other organs contain smaller concentrations 
Cytochrome P-450 is thought to be the terminal electron 
acceptor of the microsomal electron transport chain.
A recent scheme, suggested by Estabrook et al. (l97l) 
for the microsomal electron transport reactions 
associated with cytochrome P-450 is shown in Figure 1.1.
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Of particular interest are the spectral properties 
of the cytochrome. In chemically reduced (Na2*^ 2^ 4^  
conditions, CO ligands to the porphyrin prosthetic 
groups and causes a spectral change around 450 nin. By 
difference spectrophotometry this is shown as a sharp 
peak with a maximum at a wavelength of 450 nm and this 
is the basis of the assay of cytochrome P-450 (Omura 
and Sato, I964a,b).
\J
i--- 1--- 1--- » nm
390 510
The second type of spectral interaction of particular
importance in drug metabolism is that produced by
v
foreign compounds in aerobic microsomal preparations. 
Remmer et al. (1966, 1968) showed that addition of 
substrates such as hexobarbital, phenobarbital and 
aminopyrine to microsomal preparations gave a small 
difference spectrum (absorbance difference approx. 0 . 0 5  
units) with a peak at approx 385 nm and a trough at 
approx. 420 nm. Substrates such as aniline and 
2,4— dichloro-6-phenylphenoxyethylamine-HCl gave a 
difference spectrum with the peak at 430 nm and the
trough at 390 nm. These spectra are termed types I 
and II respectively:
II
350 390 430 470 350 390 . 430 470
Similar substrate-induced difference spectra have been 
obtained with human liver microsomal preparations 
(Kamataki et al., 1971)•
Microsomes contain relatively large amounts of 
lipid (approx. 370 ^g phospholipid/mg protein; Victoria 
and Barber, 1969)- It is now generally accepted that 
type I substrates are interacting with the phospholipid 
fraction of microsomes, as modification or extraction 
of the phospholipid by isooctane treatment (Leibman and 
Estabrook, 1971)? phospholipase C (Chaplin and Mannering,
1970) and phospholipases C and D (Eling and DiAugustine,
1971) destroys the type I spectral interaction. It has 
been suggested that type II substrates ligand to the 
haem of the cytochrome (Schenkman et al., 1967;
Schenkman and Sato, 1 9 6 8).
The affinity of binding of substrates to microsomal, 
preparations can be estimated by measurement of the so-
called spectral constant (K ). Degkwitz et al. (1 9 6 9)
S  1
associated K with K in the metabolism of hexobarbital, s m ’
but spectrally observable interaction (binding) does 
not appear to be an absolute requirement for metabolism 
as alteration of the type I site by isooctane or 
phospholipase treatment does not prevent metabolism of 
type I compounds (Chaplin and Mannering, 1970; Leibman 
and Estabrook, 1971)• .
1.13» Effects of chlorofluoroalkanes and related compounds 
on drug metabolism and cytochrome P-450.
Epstein et al. (1967a) referred to unpublished
observations that chlorofluoroalkanes (trichlorofluoro­
methane , 1 ,1 ,2 ,2-tetrachloro-l,2 7difluoroethane and
1 ,1 ,2-trichloro-l,2 ,2-trifluoroethane) might be enzyme 
inducers, but this work appears not to have been 
followed up.
Van Dyke and Rikans (1970) showed that both
 —4
halothane (8 x 10 M) and methoxyflurane (6 x 10 M) 
enhanced the metabolism of aniline (a type II substrate) 
i-n vitro, but did not affect the metabolism of amino- 
pyrine (a type I substrate). Brown (1971) also 
studied the in vitro effects of halothane and found that 
type I substrate metabolism was depressed but that 
aniline 4-hydroxylation was enhanced. They also 
demonstrated that acetanilide 4-hydroxylation was 
actually depressed and zoxazolamine hydroxylation was 
unaffected. The lack of enhancement of the metabolism
of* these type II substrates is not in accord with the 
author1s suggestion that depression of.type I substrate 
metabolism causes increased metabolism of type II 
substrates by greater availability of electrons from 
the microsomal electron transport chain.
Davis et al. (l97l) found depression of type I
substrate metabolism and cytochrome P-450 levels after 
injection of rats with halothane (lml/kg i.p.) for 2 days, 
but no effect on aniline 4-hydroxylation. However, the 
effects were smaller than those produced by carbon 
tetrachloride (0.4 ml/kg). Phenobarbital pretreatment 
increased the metabolic effects of carbon tetrachloride 
but not those of halothane. Berman and Bochantin (1970) 
showed that repeated exposure of rats to subanaesthetic 
concentrations (approx. 0 . 1 %  (v/v) in air) of methoxy- 
flurane resulted in a non-specific stimulation of drug 
metabolism. Hexobarbital sleeping times were reduced 
markedly, aminopyrine demethylase activity increased
and the LD__ of methoxyflurane was increased.50
Microsomal enzyme inhibitors reversed these effects.
The effects of chlorinated hydrocarbons, and 
particularly carbon tetrachloride, on drug metabolism 
have been widely studied. Dingell and Heimberg (1968) 
showed that carbon tetrachloride prolonged hexobarbital 
sleeping times in rats as early as 30 min after feeding 
orally 2.5 ml CCl^/kg body weight. Microsomal 
metabolism of hexobarbital, aminopyrine and 4 -nitrobenzoic 
acid was depressed by carbon tetrachloride administration.
In comparison, chloroform and dichloromethane caused 
only slight impairment of drug metabolism. Vorne and 
Alavaikko (l97l) showed increasing prolongation of 
hexobarbital sleeping times over a period of weeks by 
repeated doses of carbon tetrachloride. Lai et al.
(1 9 7 0) showed similar effects due to inhalation of 
relatively low levels (about 3 00 p.p.m.) of carbon 
tetrachloride. Barker et al. (1969)? Feuer and
Granda (1970) and Vorne and Arvela (l97l) have all 
reported depression of various drug-metabolising 
activities in rats by dosing the animals with carbon 
tetrachloride.
Glende (1972) has suggested that this depression of
I
drug metabolism is a direct result of lipid peroxidation 
damage of the endoplasmic reticulum. Wills (l97l) 
showed the inhibition of drug metabolism in vitro by 
enhancement of lipid peroxidation and believed that 
peroxidation controlled the integrity of the microsomal 
membrane and could thus exert a regulatory influence on 
drug metabolism.
Sasame et al. (1968) showed that carbon tetrachloride 
caused significant impairment of cytochrome P-450 in 
vivo in less than 3 hours. In in vitro incubations 
with microsomal preparations and NADPH, carbon tetra­
chloride has been reported to convert cytochrome P-450 
to cytochrome P-420 in a stoichiometric manner (Heni,
1 9 7 1), with over 30%  conversion occurring within 30 min.
Carbon tetrachloride has been shown to be a type I
compound (Reiner and Uehleke, 1971)* - However, of 
particular interest was their finding that Na^S^O^ 
abolished the type I spectrum and caused the formation 
of a difference spectrum very similar to the cytochrome 
P-450-C0 complex, with a peak at 454 nm. With microsomal 
preparations from phenobarbital pretreated rabbits, an 
absorbance change at 454 nm of approximately 50%  that 
produced by CO at 450 nm was achieved. Reiner and 
Uehleke believed that this interaction was a liganding 
of the carbon tetrachloride directly to the haem of 
cytochrome P-450 and that this interaction was of 
fundamental importance in carbon tetrachloride toxicity.
1 .l4. Introduction to the present work.
It has been shown that although there is a 
considerable body of literature on the metabolism of 
chlorinated hydrocarbons and their effects on cytochrome 
P-450 and drug metabolism, little work has been 
reported on their analogues, the chlorofluoroalkanes.
This has been due presumably to the low acute and 
chronic toxicity demonstrated for the chlorofluoroalkanes.
However, the existence of a few,reports of adverse 
effects, quoted in 1.4 and 1.5? indicates that chloro- 
fluoroalkanes are not biochemically inert. The 
fluorinated anaesthetics, although not all strictly 
chlorofluoroalkanes, have profound physiological effects. 
Evidence has been reviewed showing that they affect 
drug metabolism both in vitro and in vivo, the latter
effects being a possible factor in the occasional 
cases of toxicity to humans following anaesthesia 
with these agents.
The increasing use of chlorofluoroalkanes in 
applications that may result in the exposure of the 
general population implies that any toxic risk, if it 
exists, is becoming greater. In view of the profound 
toxic effects of the chlorinated hydrocarbons, which 
are thought to be due to more active, toxic metabolites 
formed by the mixed-function oxidase of the hepatic 
endoplasmic reticulum, it is desirable to assess 
whether metabolism of the chlorofluoroalkanes occurs, 
and to what extent under what conditions.
In our society at present, the use of sophisticated 
drug preparations and the ingestion or inhalation of a 
wide variety of other foreign compounds, such as food 
additives and dry-cleaning solvents, presents the 
danger of interactions between these compounds.
Alteration in the normal biological fates of some 
foreign compounds can have unfortunate consequences, 
e.g. warfarin and phenylbutazone, ethanol and barbiturates. 
The effects of chlorofluoroalkanes on drug metabolism 
are therefore of importance as humans are frequently 
exposed to mixtures of these compounds with other 
foreign compounds.
The two basic areas covered by this thesis are the 
distribution and metabolism of chlorofluoroalkanes and 
the effects of these compounds in vivo and in vitro on 
cytochrome P-450 and drug metabolism.
CHAPTER 2 
GAS-LIQUID CHROMATOGRAPHIC ASSAY.
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2.1. Introduction.
Several techniques have been used to detect and 
quantitate volatile chlorofluoroalkanes. Burns and
Snow (1961), for example, estimated halogenated 
anaesthetics in body fluids by measuring the halide 
liberated by sodium reduction of the sample. Chenoweth 
et al. (1 9 6 2) used infra-red analysis for chloroform
and methoxyflurane and X-ray fluorescence for halothane 
in monkey tissue samples. Silverman et al. (1 9 6 6)
described infra-red spectrophotometric and gas chromato­
graphic techniques for analysing aerosol propellants, 
but gave no data on quantitation. In the majority of 
investigations, however, gas-liquid chromatography has 
been the method of choice.
Quantitative determination of chlorofluoroalkanes 
•by gas-liquid chromatography has been applied principally 
to the quality control of aerosol products (Brook and 
Joyner, 1966; De Becker et al., 196?; Esposito and Swann, 
1967; Konig, 1967; Bourne and Murphy, 1 9 6 9) and to the 
estimation of halothane in blood (Purchase, 1 9 6 3 ; Brachet- 
Liermain et al., 1971; Allott et al., 1971)- The 
measurement of chlorinated hydrocarbons in the expired 
air of humans has been carried out by Stewart et al.
(1 9 6 3; 1 9 7 0a,b), using electron-capture detection gas-
liquid chromatography. Boethner and Muranko (1969) 
used flame ionisation and thermoconductivity detectors 
for their work on halogenated hydrocarbons in the 
expired air of rats.
Extraction of chlorinated hydrocarbons from 
tissue samples into iso-octane was reported by Ehrner- 
Aamuel (1 9 6 3)- Butler and Hill had used n-heptane 
extraction (1 9 6 1). Carbon tetrachloride was used by 
Allott et al. (l97l) to extract halothane from tissues.
Direct transfer of living tissue to the gas chromatograph 
using a special biopsy needle has been used by Cohen and 
Brewer (1964) for the analysis of halothane and 2,3“di- 
chloro-1,1 ,1 ,4,4,4-hexafluorobut-2-ene. The compounds
measured were all liquid at room temperature. The 
fluorinated analogues of interest in this study, however, 
are mostly gaseous (Table 1.4), which gives rise to 
additional problems.
The gas chromatographic conditions described in 
the literature for the separation of halogenated 
hydrocarbons are very diverse. The liquid phases 
range from silicone oils (Butler and Hill, 1961; Curry 
et al., 1962; Brook and Joyner, 1966; Ratcliffe and 
Targett, 1969; Allott et al., 1971) and Carbowax (Bourne 
and Murphy, 1 9 6 9) to more unusual mixtures, for example 
3 %  dibutyl phthalate and 'aluminosilicate1 catalyst 
(Petrova et al., 1968). Gadsen and McCord (1964) and 
Paulet et al. (1969) used 10% bis(2-ethylhexyl)sebacate 
and 2 %  dioctyl sebacate respectively. Separations have 
also been achieved on porous polymer beads (Konig, 1 9 6 7 ; 
Foris and Lehman, 1969; Gvosdovich and Jashin, 1970) and 
grains of magnesium fluoride (Chichugova et_ al., 1964).
The detergent fTide' has been used in the estimation of
halothane (Brachet-Liermain et al., 1971)• Other
operating conditions varied as widely.
None of the methods reported seemed ideally suited 
to the present problem. As a result, an accurate 
quantitative assay by gas-liquid chromatography was 
developed which was applicable to solvent extracts of 
expired air, body fluids and tissues, containing 
trichlorofluoromethane or 1 ,2-dichloro-l,1 ,2 ,2 -tetra- 
fluoroethane. The electron-capture detector is
particularly sensitive to halogenated compounds (Clemons 
and Altshuller, 1966) and this detector was chosen for 
the assay.
2.2. Apparatus and materials.
A Pye model 104 gas chromatograph, equipped with 
6 ?a heated, 10 mC Ni electron-capture detector was used. 
Output was recorded, after amplification, on a Honeywell 
recorder. A Pye soap-bubble flow meter was used to 
measure the gas flow through the column.
Columns were made from 6 mm o.d. 3 mm i.d. annealed 
copper tubing, cleaned internally with several washes 
of acetone. Connectors supplied for use with glass 
columns were used to attach the metal columns to the 
detector inlet.
Samples were injected with a glass and stainless 
steel Terumo microlitre syringe.
Celite and analytical reagent grade solvents were 
obtained from BDH Chemicals, Poole, England. Squalane
and Apiezon L were obtained from Pye-Unicam, Cambridge, 
England. Trichlorofluoromethane, dichlorodifluoro­
methane, dichlorof luoromethane and 1 ,2-dichloro-1 ,1 ,2 ,2- 
tetrafluoroethane were obtained from Cambrian Chemicals 
Ltd., Croydon, England.
2.3» Column preparation.
A preliminary run with an existing column (l.5 m 
3% oronite polybutene 128 and 0 .3% epikote 1001 on 
80-100 mesh Diaport-S) showed that a packing ratio of 
stationary phase greater than 3%> together with a 
longer column, was required to separate trichloro- 
fluoromethane from diethyl ether. As a result, two 
different columns were prepared which proved suitable:
4.66 m 15% squalane on 80-120 mesh Celite
2.0 m 15% Apiezon L grease on 80-120 mesh Celite.
An appropriate quantity (5 g per metre column length)
was stirred with excess benzene in a 250 ml beaker and
allowed to settle. The finer particles remaining in 
suspension were decanted off. This procedure was 
repeated three times. The stationary phase, squalane 
or Apiezon L grease (0.75g)? dissolved in benzene (15ml), 
was added to the Celite and the resulting slurry was well 
mixed. The benzene was evaporated off over a water 
bath, the beaker being shaken gently to ensure an even 
coating of stationary phase on the support material.
The flocculent coated support was then dried, first in
A
B
air and then under a vacuum over anhydrous silica gel.
One end of the column tubing was plugged with 
silica wool and the coated support poured into a funnel 
attached to the other end. Even packing was achieved 
by rapidly tapping the tubing on the floor. When the 
packing was a few centimetres from the top, a second 
silica wool plug was inserted. The tubing was then 
wound into a coil of 17-6 cm diameter. Columns were 
also packed with the tubing coiled. This required 
somewhat greater cafe in packing, but avoided to some 
extent Channelling1 of the packing material while 
coiling the tubing.
The columns were conditioned for 24 hours by 
passing oxygen-free nitrogen through the column with the 
oven temperature at the maximum level for the stationary 
phase (250°C for Apiezon L grease and 100°C for squalane). 
Table 2.1 shows the retention times of various volatile 
solvents on the two columns, under the conditions set 
out.
2.4. Column efficiency.
The efficiency of a g.l.c. column, expressed as 
theoretical plates, is given by the formula:
No. of plates = l6
retention distance (cm)
peak width at half height (cm)
a good value lying between 300 and 3 0 0 0 theoretical 
plates/m.
Table 2.1.
Separations obtained on column A.
Retention time (s) at 
column temperature of
Compound
air (injection artefact) 
CCl^F
C H o C 1 9
(C2H5 )2°
CHC1„
n-hexane
CC1.
4o °c
92
4 4 l
447
489
1173
1515
229 8
6 0 C 
92
3 26
326
4 n
756
Conditions - 40°C or 6 o °ccolumn temperature 
detector temperature 120°C 
carrier gas , flow rate
electron capture detector 
* checked with katharometer detector
40 ml/min
Separations obtained on column B .
Compound Retention time (s)
34 
101 
110 
153 
259 
2 8 0  
484
Conditions - column temperature 6 l°C
detector temperature 130°C 
other conditions as above
air
CC13F
(C2Ii5)2°
CH2C12
n-hexane
c c i 4
cyclohexane
Under the conditions given in Table 2.1, column A 
had an efficiency of 4l5 plates/m for diethyl ether, 
and column B 715 plates/m. The efficiency of column 
A measured with n-hexane was 1360 plates/m.
2.3« Extraction solvent.
The solvent chosen for the extraction of blood 
and tissue samples had to be lipophilic and of as low 
a volatility as possible, commensurate with a short 
retention time on the column. Diethyl ether was un­
suitable because of its volatility. n-Hexane was 
used initially but was subsequently found to contain 
impurities. n-Heptane eluted immediately after carbon 
tetrachloride and was suitable in other respects.
It was essential that the solvent was stored 
away from possible exposure to chlorofluoroalkanes, as 
the use of an aerosol spray, in a fume cupboard some 
distance away, caused an appreciable contamination of 
some n-heptane left open to the atmosphere.
Considerable difficulty was encountered in the 
early part of this work in making up accurate standard 
solutions. This difficulty was eventually traced to 
the use of polypropylene stoppers, which dissolved 
appreciable amounts of the chlorofluoroalkanes, and on 
subsequent use, some of the compound was extracted.
This problem was overcome by using glass apparatus 
throughout and by rinsing all apparatus before use 
with n-heptane.
2.6. Preparation of standard plots.
With compounds as volatile as the selected chloro 
fluoroalkanes, it was necessary to use an internal 
standard in the quantitative assay. The ratio of 
peak heights or peak areas of sample to standard are 
plotted against the mass ratio of sample to standard. 
Very accurate sample injection volumes are thus 
unnecessary.
Diehloromethane was too volatile and tailed badly 
on the column. Chloroform contained an impurity 
with a retention time very close to that of trichloro- 
fluoromethane, and was thus unsuitable. Carbon tetra 
chloride was chosen as the internal standard, although 
its retention time on the column was considerably 
greater than those of the chlorofluoroalkanes.
Because of the volatility of the chlorofluoro­
alkanes and the low viscosity of these compounds and 
the solvent, all dilutions of standards or test sample 
were made by weight.
Figure 2.1 shows a plot of peak height against 
concentration of carbon tetrachloride. Initially,
carbon tetrachloride was used at a concentration of
—6approximately 10 g/g solvent; as the sensitivity of
the assay was increased, the concentration was reduced
—8to about 2 x 10 g/g solvent.
It was found that the peaks for the chlorofluoro­
alkanes and for carbon tetrachloride were nearly 
symmetrical and that peak height and peak area ratios
Figure 2.1.
peak height
(units)
100 4-
80
60
40 ••
20
io“V 10“6 10-5
concentration of CCl^ (g/g solvent)
were directly related (Figure 2 .2 ). Consequently 
peak height ratios were used to estimate the 
concentration of chlorofluoroalkanes.
Figure 2.3 shows the effect of different sample 
volumes on the plot of peak height ratio against mass 
ratio for trichlorofluoromethane and the carbon tetra­
chloride standard. 0 . 3  and 1 jx,1 samples produced 
almost identical lines, whereas 2 p i  samples produced 
a line of shallower gradient. A sample volume of 
approximately 1 l^1 was used in all subsequent determin­
ations .
Figure 2.4 shows the loss of linearity in the 
standard plot for 1 ,2-dichloro-1 ,1 ,2 ,2-tetrafluoro- 
ethane, following storage of the standard solutions. 
Because of this, standard solutions were made on the 
•day of use.
In addition, the sensitivity of the electron- 
capture detector varied slightly from day to day.
Over thirteen standard plots for trichlorofluoromethane, 
the mean gradient and standard deviation was 2 . 3 6  +
0 . 3 0  peak height ratio units/mass ratio unit.
The electron-capture detector showed a large 
difference in response to trichlorofluoromethane and
1 .2-dichloro-l,1,2,2-tetrafluoroethane. The lower 
limits of quantitation were approximately 1 pg for 
trichlorofluoromethane and 100 pg for 1 ,2 -dichloro-
1 .1 .2.2-tetrafluoroethane. The linearity of standard 
plots for the compounds was from 0 . 1  to 5 * 0 mass ratio
Peak height 
ratio 
(CCl3F/CClZt)
Figure 2.2.
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units for the former and from 10 to 200 mass ratio 
units for the latter (Figure 2.5). In practice, 
samples were diluted to give peak height ratios close 
to unity and standard plots were prepared over much 
smaller ranges. Gas chromatographic conditions 
finally used for quantitative assays were as follows:
2 m 1 5 %  Apiezon L column (column B) 
column temperature 100°C 
detector temperature 150°C
carrier gas O^-free , flow rate 60 ml/min
electron-capture detector pulse space 150 yjusec
2amplifier attenuation 2 x 10 
chart speed 40 in/hour.
Under these conditions, retention times in seconds 
were as follows:
air 25
o o H to to 30
c c i3f 4 9 . 5
c h c i3 ■: 96
CC14 138
n-heptane 161
Total analysis time was about four minutes (Figure .2.6) 
It was found possible to overlap two determinations 
without affecting peak height ratios and without 
obscuring any peaks (Figure 2.7). This cut the time 
required for a duplicate determination from 8 minutes

Figure 2.6.
D
E
B
A injection point 
B air
c ccif2 -ccif2
D CCl^F 
E CHCl^
F CCl^
G n-heptane
V/
Figure 2.7-
A injection 
point
B air 
C CCl^F 
D CCl^
E n-heptane
D
D
B
* indicates 
second run
B
E
V J \ J
E
to minutes.
2.7» Separation of mixtures of chlorofluoroalkanes.
The conditions used for the quantitation of 
individual chlorofluoroalkanes were not suitable for 
the analysis of mixtures. It proved impossible to 
separate dichlorodifluoromethane.and 1,2-dichloro-
1,1,2,2-tetrafluoroethane on the 2 m column B (2.3)• 
However, separation was achieved on column A (2.3) 
of mixtures of dichlorodifluoromethane, dichlorofluoro- 
methane, trichlorofluoromethane and 1,2-dichloro-1,1,2,2- 
tetrafluoroethane. This is shown in Figure 2.8.
For metabolism studies, it was necessary to be 
able to detect dichlorofluoromethane in the presence 
of a large excess of trichlorofluoromethane (see 4.1) 
but in a short analysis time. Under the conditions 
given in Figure 2.9i using column A, it was possible 
to detect 0.21 j p g  dichlorofluoromethane in the presence 
of 100 j x g  trichlorofluoromethane per g solvent, in a 
total analysis time of 10 minutes. This time could 
not be reduced by heating the column to elute the 
trichlorofluoromethane more rapidly, as this destroyed 
the baseline stability.
2.8. Summary.
A quantitative gas-liquid chromatographic assay 
for solutions of trichlorofluoromethane and 1,2-di- 
chloro-1,1,2,2-tetrafluoroethane in n-heptane was
Figure 2.8.
C
A injection point 
B air
C CC12F2 
D CC1F2-CC1F2
E CHC1 F
F CC13F
D
E
Column A at 43°C and 
N2 flow rate 80 ml/min
Retention times (s)
B 48 
C 73 
D 87 
E 139 
F 230
B A
Figure 2 .9.
Separation of 0.2%  CHC1 ,^F from CCl^F (100 p»g/ml)•
A injection 
point
B
C CHC1 F£-k
D CC10F
E n-heptane
D C B
%r
Conditions - column A at 110°C, detector temperature 
250°C, carrier gas flow rate 60 ml/min
developed, utilising internal standardisation with 
carbon tetrachloride. The difference found in the 
response of the electron-capture detector to these 
compounds agreed quantitatively with the findings of 
Clemons and Altshuller (1966). Qualitatively, the 
detector response to the chlorofluoroalkanes was 
CC13F> CCl^ » CF2C12 > CC1F2-CC1F2 » CHFC12, which again 
was in agreement with Clemons and Altshuller1s work.
Two principal points emerged that required rigid . 
adherence. Firstly, glass apparatus had to be used 
throughout the handling of samples, and secondly, 
standards had to be made up by weight on the day of 
use.
A qualitative, and potentially quantitative, 
separation of mixtures of chlorofluoroalkanes was 
developed.
CHAPTER 3 
TISSUE DISTRIBUTION AND EXCRETION.
Contents.
Introduction.
Experimental methods.
Animals; extraction and assay of 
chlorofluoroalkanes in tissues;; 
extraction of chlorofluoroalkanes 
from the expired air.
Results.
Recovery of chlorofluoroalkanes 
from tissues; accuracy of analysis 
tissue distribution pattern of 1,2 
dichloro-1,1,2,2-tetrafluoroethane 
tissue distribution pattern of 
trichlorofluoromethane; trichloro- 
fluoromethane in the expired air.
Summary.
3.1. Introduction.
Little study has been made of the uptake, 
distribution and excretion of chlorofluoroalkanes.
Paulet et al. (1 9 6 9) studied the retention of chloro-
fluoroalkanes in the lungs of humans and dogs. They 
found that the concentration of these compounds in 
expired air fell exponentially, and that in the case of 
humans the chlorofluoroalkanes were expired within a few 
minutes. After the commencement of the work reported 
in this chapter, Dollery et al. (1970) showed trichloro- 
fluoromethane was absorbed into the blood after in­
halation. Paterson et al. (l97l) extended Dollery1s
observations and estimated the blood half-life of 
trichlorofluoromethane in humans to be between 0.3 
and 1.5 minutes.
3.2. Experimental methods.
The animals used were male and female Wistar 
albino rats (Porton strain, random bred in closed 
colony) weighing between l60 and 200 g.
Chlorofluoroalkanes were administered by stomach 
tube as solutions in ethyl oleate, at levels of 50 mS 
trichlorofluoromethane/kg body weight and 560 mg
1,2-dichloro-1,1,2,2-tetrafluoroethane/kg body weight. 
Oral feeding was chosen for the following reasons:
(i) Large scale facilities for inhalation 
exposure were not available.
(ii) The dose given by stomach tube was
accurately known, as rats do not exhibit 
reverse peristalsis.
(iii) Oral feeding avoided the direct surface
contact with organs that would have occurred 
if intra-peritoneal injection had been 
chosen.
Extraction and assay of chlorofluoroalkanes from tissues
Experiments to check the recovery of chlorofluoro­
alkanes in n-heptane in the presence of blood and 
tissues were carried out. Small weighed pieces of 
tissue from untreated animals were placed into known
I
weights of n-heptane, containing varying concentrations 
of chlorofluoroalkane. The tissue was homogenised
and the extract was assayed as described below.
Standard solutions for these experiments were made up 
from dilutions of the n-heptane containing chlorofluoro­
alkane . Recovery was calculated from the mass ratio 
of compound to standard found by assay compared to the 
mass ratio calculated for the original solution.
Extraction of chlorofluoroalkanes from rat tissues 
with n-heptane was effected as outlined in Figure 3«1«
At known time intervals after dosing, the rats were 
killed by cervical dislocation or, if blood was required 
by guillotining. In the case of all tissues except 
blood, a piece weighing approximately 0.2g was rapidly 
removed and placed into a known weight of n-heptane 
(lOg). Samples of six tissues could be removed
Figure 3 .1.
Extraction procedure for tissues.
Animal dosed orally
Killed after known time 
and tissue rapidly excised
Approx. 0.2g placed into weighed tube 
containing lOg n-heptane
Reweighed and homogenised 
with a'Polytron’
Approx. 0.05g extract into 
weighed volumetric flask 
containing 6 .8 3g n-heptane 
(10ml)
Reweighed and CC1. internal 
standard added
Reweighed and mixed
10ml extract into 
volumetric flask
V
Weighed and CCl^ added
V
Reweighed and mixed
Assayed by g.l.c.
within 60 seconds following death. The weight of 
tissue was determined by difference. The tissue was 
rapidly homogenised for 10-30 seconds with a Polytron 
PT10 ultrasonic homogeniser (obtained from Northern 
Media Supplies, Hull, England) and the tube re-stoppered. 
When the tissue debris had settled, 10 ml of the n-heptane 
was transferred to a glass-stoppered 10 ml volumetric 
flask. Carbon tetrachloride was added by weight on 
a balance accurate to four decimal places. In the case 
of.1,2-dichloro-l,1,2,2-tetrafluoroethane, this could 
be assayed directly by g.l.c. With trichlorofluoro­
methane , however, a further 1:200 dilution of the n- 
heptane extract was required. In order to minimise 
possible variations in the concentration of the chloro- 
fluoroalkanes within each tissue, due to differences 
-in blood flow and lipid distribution, the pieces of 
tissue taken from different animals were removed from 
approximately the same areas:
liver - lower edge of right lobe
lung - part of inferior lobe of right
lung
brain - mid- and hind-brain
cardiac muscle - tip of ventricles
adipose tissue - epididymal fat pad in male, fat
posterior to right kidney in 
female.
Blood was treated differently. The rats were guillot­
ined and whole blood was collected directly into a 
beaker containing 15 ml n-heptane. Blood and solvent 
were rapidly poured into a 25 ml graduated glass tube 
and the volume of blood collected was noted. Extraction 
of the chlorofluoroalkanes was accomplished by shaking 
with the solvent, as sonication with the Polytron 
produced a highly viscous colloidal mass. The n- 
heptane extract was then assayed as described above.
Repeated blood samples from individual animals 
were taken from the tail vein. Samples taken by this 
method took between 45 seconds and 2 minutes to obtain.
If the volume required (50 or 100 r1) was not collected 
within 2 minutes, clotting usually occurred within the 
pipette. The volume taken was then estimated by 
measuring the column of blood and subsequently weighing 
~the same amount of water from that pipette. Blood 
samples were immediately blown out into 2 ml water, 
which was overlaid by 15 ml n-heptane, in a glass- 
stoppered tube. The pipette was rinsed out by sucking 
the water up and down it, followed by the n-heptane.
The chlorofluoroalkane was extracted into the solvent 
by shaking the two phases together for about 60 seconds. 
The extract was then assayed without further dilution, 
as described above.
Extraction of chlorofluoroalkanes from the expired air.
Trapping very volatile compounds in expired air, 
particularly for kinetic studies, is difficult. Gage
(1 9 6 3) devised a complicated apparatus for extracting 
trichloroethylene from expired air with toluene.
However, it was decided that a simpler system 
would prove adequate.
The apparatus used is shown diagramatically in 
Figure 3*2. A fMetabowl! (Jencons Ltd., Hemel 
Hempstead, Herts, England) was connected to an extraction 
system containing n-heptane. Both sintered-disc 
bubblers and coil bubblers (Jencons Ltd.) were used.
The former were simply glass tubes with sintered discs 
at the ends immersed in about 40 ml solvent. The 
principal disadvantage of this type was that the 
solvent was continuously bubbled through with air. 
Although chlorofluoroalkanes are very soluble in 
n-heptane, it was feared that the continual stream 
of air might remove the compounds from solution.
In addition, over a period of hours, a considerable 
percentage of the solvent was lost by evaporation into 
the air stream. Loss of solvent by evaporation was 
small with the coil bubblers as the solvent (2 0 0 - 3 5 0 ml) 
was not continuously bubbled with air. Figure 3-2 
only shows one of each type - in practice, six coil 
bubblers were used and five sintered-disc bubblers.
All connecting pieces were glass and were blown to 
form butt joints, polyvinyl tubing merely being used 
to hold the joints close together. The only contact 
between the n-heptane and the polyvinyl tubing was at 
the bottom outlet; the tubing was clamped with a screw-
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clip as closely as possible to the glass.
The flow rate of air through the metabolism cage 
was measured with a ’MeTeRate1 flowmeter (Glass Precision 
Engineering Ltd., Hemel Hempstead, Herts, England).
The obvious position for this was on the air inlet of 
the fMetabowlf. However, when so placed, a resonant 
oscillation was set up in the meter. The manufacturers 
were unable to explain this and could not suggest a 
remedy. It was subsequently discovered that the 
oscillation was prevented by placing a buffer volume 
(an empty bubbler) between the meter and the VMetabowl1. 
This suggested that the volume of the metabolism cage 
was such as to permit the establishment of a standing 
wave pattern in the air flow. By placing the meter 
between the fMetabowlf and the first coil bubbler a 
slightly greater air flow was registered and the meter 
was thus placed in this position.
Air was drawn through the system by a filter pump 
at a rate of 200 ml/min.
Sampling the n-heptane in the coil bubblers was 
accomplished by removing the top caps, commencing at 
the farthest from the filter pump to prevent the 
solvent sucking back. At the end of each experiment, 
the volume of solvent in each bubbler was measured.
Loss of solvent by evaporation was assumed to be linear 
and thus the solvent volume present at each sampling 
could be calculated.
Recovery of a known weight of chlorofluoroalkane
by the extraction system was tested by adding trichloro- 
fluoromethane to the first bubbler, drawing air through 
the system for 4 hours and assaying the amount of 
trichlorofluoromethane present in the entire system.
3.3. Results.
Where appropriate, results have been expressed 
as the mean + S.E.M. (standard error of the mean).
* Student1s’ t-distribution was used to test significance 
Values of P of less than 0.05 were regarded as 
significant, and values between 0 . 0 5  and 0 . 1 0  as 
possibly significant.
Recovery of chlorofluoroalkanes from tissues.
Table 3»1 shows the percentage of 1 ,2-dichloro-
1 ,1 ,2 ,2-tetrafluoroethane (concentration range 2 . 1  x 10 
—6- 2 . 5  x 10 g/g n-heptane) recovered at different 
ratios of n-heptane to tissue (w/w). For lung,
kidney, brain and cardiac muscle, a minimum ratio of 
approximately 1 5il was necessary for 1 0 0% recovery.
For fat the ratio was in excess of 20:1 and for liver 
it was about 40:1. Brief studies with trichloro- 
fluoromethane showed similar results. It was decided 
to use a ratio of approximately 5 0 : 1  for tissue 
distrubution studies, i.e. 0 . 2  g tissue in 10 g 
n-heptane.
Recovery of chlorofluoroalkane from whole blood 
was lower. For example, using 15 ml n-heptane for 
the extraction of 4.5 ml blood, giving a n-heptane/
Table 3.1
Recovery of* 1 , 2-dichloro-1, 1, 2 , 2-tetraf luoroethane from
tissue extracts.
Tissue n-heptane/tissue %  recovery
ratio (w/w)
Liver 2 88
k  9 k
6 9 k
18 89
k 2  100
Lung 6 62
7 87 
1 2 . 5 9 8 - 1 0 0
Kidney 9 92-95
11 98
Brain 13 9 k
17 102
21 93
Cardiac muscle 8 6 k
15 100
28 101
3 k  9 k
Adipose tissue 7 73
9 71
12 80
21 97
50 101
blood ratio of 3 - 3 (v/v) , recovery was '5 l%i 5while 
6 ml blood reduced the ratio to 2 . 3  (v/v) and the 
recovery to 3 6%. In view of the very low levels of 
chlorofluoroalkane subsequently found in the blood, 
and the inaccuracies inherent in the extraction of 
the blood, recovery was assumed to be 50% .
Accuracy of analysis.
Duplicate g.l.c. analyses were made of each 
sample. Peak height ratios for these duplicates were 
in good agreement (see Appendix Table A.l).
Dilution of the initial n-heptane extract and the 
addition of carbon tetrachloride as the g.l.c. internal 
standard were shown to be accurate to within about 5 % i  
by two parallel analyses of single tissue samples.
For example, the following results for parallel analyses 
of liver extracts for trichlorofluoromethane showed 
good agreement:
(i) 1 2 . 0  and 1 2 . 5  j i - g / g  liver
(ii) 3 3 . 0  and 3 ^ . 0  j x g / g  liver
(iii) 5 3 - 0  and 5 6 . 0  j i g / g  liver
However, analysis of two samples from a single 
tissue showed greater variation. In four separate 
experiments, the following concentrations of trichloro- 
fluoromethane were found in two samples of each liver:
(i) l6 . 0  and 6 . 0  j i g / g
(ii) 8.5 and 10.0 p g / g
(iii) l4.0 and 11.5 f i g / g
( iv) 11.0 and 7-0 j X g /  g .
Tissue distribution pattern of 1,2-dichloro-1,1,2,2- 
tetrafluoroethane.
Tissue levels of this compound were measured at 
various time intervals after an oral dose to male rats 
of 5 6 0 mg/kg body weight. Table 3 . 2  shows the mean 
concentration + S.E.M. of 1, 2-dichloroi-l, 1, 2 , 2-tetra- 
fluoroethane in various tissues at 0.5 ? 1 , 4, 6 and 
19 hours. Figures 3-3 and 3-4 show the concentration 
of chlorofluoroalkane plotted against time for liver 
and adipose tissue and for lung respectively. Complete 
figures are given in the Appendix (Table A.2).
Maximum concentrations were reached at 0.5 hours 
in the lungs, at 1 hour in the blood and liver, and at
4 hours in adipose tissue. Table 3-3 shows the ratio 
of the concentration of 1,2-dichloro-l,1,2,2-tetra- 
fluoroethane in the tissues to its concentration in
the blood. The liver maintained a concentration 
about 70 times that in the blood from 20 minutes to
6 hours after dosing. Adipose tissue, however, 
showed a ratio rising to a maximum of 1100 at 4 hours. 
The ratio of concentration in the brain compared to 
blood reached only 1.5 and the value of 0.09 at 2 hours 
may have been primarily due to the chlorofluoroalkane in 
the blood flowing through the brain.
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Tissue distribution pattern of trichlorofluoromethane.
Initially, very wide variations in tissue levels 
were found, which were far greater than those experienced 
with 1 ,2 -dichloro-1 ,1 ,2 ,2-tetrafluoroethane (see 
Appendix Table A.3). Variations in the stomach 
content, affecting the rate of absorption of the 
compound, might have been a contributory factor and 
all subsequent experiments were carried out with 
animals starved for l8 hours.
Figure shows the blood levels of trichloro­
fluoromethane found in male and female rats following 
an oral dose of 50 mg/kg body weight. At 15 minutes, 
the level was still rising in male animals. Females 
showed a blood level curve with two peaks. The 
concentration of trichlorofluoromethane at 7 minutes was 
higher than at 15 minutes (P<0.10) and significantly 
higher than at 30 minutes (P<0.05)« In addition, 
the concentration at 90 minutes was higher (P<0.10) 
than at 15 minutes. Differences between other time 
points were not significant.
Figure 3-6 shows the liver levels of trichloro­
fluoromethane over a 90-minute period. In both male 
and female rats there was a sharp rise in the level 
within the first few minutes. In males, the liver 
concentration was not significantly decreased over the 
period from 5~30 minutes. However, in females, the 
initial rise was transient and a second peak occurred 
at about 40 minutes after dosing. The concentration
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of trichlorofluoromethane at both 7 and 45 minutes was 
significantly greater than at 20 minutes (P<0.05)«
Figure 3-7 shows the results for adipose tissue. 
The two-fold difference in concentration between male 
and female rats was almost certainly due to differences 
in blood supply between the epididymal fat pad and the 
supra-renal fat respectively. In the male, the 
maximum concentration of chlorofluoroalkane occurred 
at approximately 2 hours after dosing.
Complete results for blood,liver and adipose 
tissue levels of trichlorofluoromethane are given in 
the Appendix (Table A.4).
The double peak in the blood level curve (Figure 
3 -5 ) was further investigated by analysis of serial 
blood samples taken from 6 female Wistar albino rats 
(starved for l8 hours). The individual blood level 
curves obtained are shown in Figure 3*8. It will be 
noted that five of the six curves showed two peaks and 
that, in two of the curves, the second peak was the 
larger. Figure 3-9 shows the result of averaging 
the curves over three minute intervals. Trichloro­
fluoromethane reached a peak blood level within about 
30 minutes and this level was not significantly lowered 
for a further 70-90 minutes (Appendix Table A.5)«
Trichlorofluoromethane in the expired air.
In three experiments, after an oral dose of 50 
mg trichlorofluoromethane/kg body weight, 9 2 . 1  + 2 .6 . %
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of the dose was recovered unchanged from the expired 
air within 6 hours. Table 3*4 and Figure 3*10 show 
the results of these experiments.
Recovery of trichlorofluoromethane added to the 
first coil bubbler of the extraction system was 99 • 2% 
after 4 hours. The distribution of trichlorofluoro­
methane between the six coil bubblers at this time was 
very similar to the distribution at 6 hours in the 
animal experiments (Table 3«5>).
3.4. Summary.
A solvent to tissue ratio of 50:1 was required for 
100% extraction of chlorofluoroalkanes from rat tissues 
with n-heptane.
Tissue distribution patterns were obtained for 
trichlorofluoromethane and 1,2-dichloro-1,1,2,2-tetra- 
fluoromethane after gastric intubation of rats with 
these compounds dissolved in ethyl oleate. Maximum 
tissue levels were reached at the times (min) shown 
below:
Dose Sex Blood Liver Lung Brain Cardiac
muscle
Adipose
tissue
c c i3f M 15 + 5 - - - -
(5 0 mg/kg) F 7 & 60 7 & 45 - - - 90 +
cc i f2-cc i f2 M 60 60 30 60 30 + 240
(5 6 0 mg/kg)
Assuming 4g liver, 1.4g lung and lg brain per lOOg body
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Figure 3 • 10.
Unchanged trichlorofluoromethane in the expired air.
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weight (see Tables 3-3 and 3-5) and that approximately 
1 0 %  of the body weight of* rats (2 0 0g) was fat (Wardlaw 
et al., 1 9 6 9)? the following table shows the approximate
total percentages of the dose of chlorofluoroalkanes that 
could be accounted for by these tissues at various times:
Time in minutes.
Compound Sex 3 7 30 60 90 120 2 k 0
CCl^F M to • 00 1 1 - - .4-5 -
CCl^F F 1 to • VJ1 1 2.9 .3-5 — -
CC1F -CC1F
tL &
M 1 . 0 1.5
Recovery of trichlorofluoromethane added to the 
extraction system was 9 9 •2 %  after 4 hours operation.
In the female Wistar albino rat, 92.1 + 2 . 6 %  of 
a dose of trichlorofluoromethane (3 0 mg/kg body weight) 
was expired unchanged within 6 hours.
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4.1. Introduction.
It was possible that metabolism of trichloro­
fluoromethane might occur in a manner analogous to that 
proposed for carbon tetrachloride and chloroform. The 
following scheme was suggested:
method described earlier (2 .7 ) to detect 0 .2% dichloro- 
fluoromethane (I) in the presence of large concentrations
to detect the percentage of 1 ,1 ,2 ,2-tetrachloro-1 ,2-di- 
fluoroethane (II) that might- be expected to be formed 
(less than 0 .0 0 1%) under the g.l.c. conditions described.
The indirect method was to look for evidence of 
the formation of dichlorofluoromethyl radicals.
Slater and Sawyer (1971a,b,c) showed that lipid per­
oxidation was increased by carbon tetrachloride and, 
from a complicated series of experiments, concluded 
that this was due to the formation of trichloromethyl 
radicals. The production of a coloured complex by 
reaction of the malonaldehyde formed from peroxidised
X ? CHC12F (I)
* CC12F-CC12F (II)
Two approaches were used to test this scheme, one
direct and one indirect. The direct approach was to
look for the possible metabolites in an in vitro
microsomal system. It was possible using the g.l.c.
of trichlorofluoromethane. It was i'easible, therefore,
to investigate the production of (i) in vitro as a
possible metabolite. However, it was not practicable
lipids with thiobarbituric acid (TBA) has been used to 
quantitate in vitro peroxidation (Ghoshal and Recknagel, 
1965; Slater and Sawyer, 1971a). Thus lipid per­
oxidation was used as a tool in attempts to detect 
radical formation from trichlorofluoromethane.
4.2. Methods.
Animals.
The following species were supplied by the - 
University of Surrey Animal Unit:
Wistar albino rats (Porton strain, random bred in 
closed colony), male and female in three weight 
ranges (6 0 - 7 0 g, 1 3 0 -1 5 0 g and 140-155 g)-
C^H/Mg strain mice (l8-22 g).
Syrian hamsters (golden - pure line strain) in 
two weight ranges (7 5 - 9 0  g and 140-155 g)*
Guinea-pigs (approx. 400 g).
Female chickens (5 months old) were obtained from a 
local farm.
Rats, mice, hamsters and guinea-pigs were housed 
in polypropylene cages on Sterilit bedding (W.P. Usher 
& Co. Ltd., London, England) and were fed on Spillers 
No. 1 Diet (autoclaved) (Spillers Ltd., Barking, Essex, 
England). The temperature and relative, humidity of 
the experimental rooms were maintained at 22°C and 50%
respectively. The lighting cycle was O6 3O-1 8 3O h 
(lights on).
Preparation of microsomal suspensions.
Animals were killed by cervical dislocation and 
the livers rapidly removed and cooled in ice-cold 1 .15% 
KC1. All subsequent manipulations were accomplished
I 0
at 4 C. The liver was washed clear of blood, blotted 
dry, weighed and homogenised in 3 volumes of 1.15% KC1 
.with a Potter-Elvehjem glass and teflon homogeniser, 
driven at 2950 rev./min. The suspension was centri­
fuged at 10,000 g for 20 minutes at 4°C (High Speedav.
l8 centrifuge with an 8 x 50 ml rotor, MSE Ltd., Crawley, 
Sussex, England). The supernatant was decanted and
■ O
recentrifuged at 4 C in a Superspeed 50 centrifuge
(MSE Ltd.) either at 104,000 g for 1 hour (8 x 25 mlav.
rotor) or at 1 5 7 ,0 0 0 g for 40 minutes (1 0 x 10 mlav.
rotor). The supernatant (cell supernatant) was 
retained and for the lipid peroxidation assay the 
microsomal pellet was resuspended in sufficient 1 .15%
KC1 to make 1 ml suspension equivalent to 1 g wet 
weight of liver. For the dechlorination system, the 
microsomal pellet was resuspended in 0.05M tris-HCl 
buffer pH 7-4 at a microsomal protein concentration of 
5 mg/ml, measured by the method of Lowry et al.« (l95l)«
In vitro incubation system.
A modification of the incubation conditions used
by Van Dyke and Wineman (l97l) in their radioactive 
assay of the dechlorination of ethanes and propanes 
was adopted. The incubation was carried out in 10 ml 
glass-stoppered tubes and the composition of the medium 
was as follows:
10 mg microsomal protein in 2 ml 0.05M tris-HCl 
buffer pH 7-4 
1 ml cell supernatant 
0.3mM NADP+
' 1 .5-mM glueose-6 -phosphate
1 unit glucose-6-phosphate dehydrogenase.
Final volume 3*0 ml.
1 ^  and 10 jxl samples of trichlorofluoromethane were 
added to the incubation medium by microlitre syringe, 
immediately after flushing the tubes with oxygen. 
Incubations were for 1 hour at 37°C and at a shaking 
rate of 100 cycles/min. The reaction was not stopped 
by protein precipitation, but was stopped and extracted 
with 5 ml n-heptane. The n-heptane extract was 
assayed by g.l.c. (2 .7 ).
The system was later modified to ensure that no 
dichlorofluoromethane formed would be lost. The 
incubation was carried out in a 50 ml Quickfit round- 
bottomed flask, fitted with a separating funnel as a 
stopper. At the end of the incubation period, the 
flask was cooled rapidly in ice and 5 ml n-heptane 
placed in the separating funnel. When the tap was
opened, the solvent was drawn into the incubation flask.
The apparatus was shaken for a few minutes to extract 
the chlorofluoroalkane from the incubation medium, and 
the extract assayed by g.l.c.
Lipid peroxidation assay.
Lipid peroxidation is expressed in terms of the 
formation of malonaldehyde J (malonyldialdehyde, malonic 
dialdehyde). However, the thiobarbituric acid reaction 
is not highly specific (Franz and Cole, 1 9 6 2) and Saslaw 
et al. (1 9 6 6) have shown that the oxidation products of 
linolenic and arachidonic acids do not include malonaldehyd 
but other carbonyl compounds. The production of malon­
aldehyde only represents a fraction of the destruction of 
fatty acids (May and McCay, 1 9 6 8) and is proportional to 
the amount of polyunsaturated fatty acids present (Bloom 
and Westerfeld, 1971)• Thus, the term 'malonaldehyde* 
is used here as a synonym for 'thiobarbituric acid-positive 
material'
The assay methods used by Ghoshal and Recknagel (19.65) 
and Slater and Sawyer (197la) are outlined in Figure 4.1 
together with the modifications adopted.
Tetraethoxypropane (TEP), which hydrolyses to malon­
aldehyde in acid solution, was used for the preparation of 
standard plots. Ghoshal and Recknagel claimed linearity 
of their standard plot from 0.44-4.4 jjig TEP/ml, but Scheig 
and Klatskin (1 9 6 9) only showed linearity from 0.l8 to 0.88 
j Kg TEP/ml by the same method. Using Ghoshal and Recknagel1
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method, linearity of the standard plot extended to approx. 
1 /«g/ml, and the extinction coefficient was calculated 
to be 9•9-x 10^ l.mol ^.cm  ^ (Figure 4.2). However, 
a fine white precipate formed within three hours, 
causing turbidity and falsely high extinction values.
Using Slater and Sawyer’s method, the standard plot 
was linear up to 2.2 jxg TEP/ml (Figure 4.3), which 
was in good agreement with the findings of these
authors. The extinction coefficient was (1.10 + 0.05)
5 - 1 - 1x 10 l.mol .cm and the colour was stable for
several days.
Preliminary experiments using procedure I (Figure 
4.1) failed to show an appreciable rise in malonaldehyde 
production in the presence of carbon tetrachloride.
-4<*-Tocopheryl acetate (2.5 x 10 M) also failed to delay 
the onset of spontaneous endogenous peroxidation.
All subsequent experiments were carried out by procedure 
III (Figure 4.1'). The incubation, conditions were as 
follows:
5 mg of microsomal protein 
8 3 .5mM KC1
37.2mM tris-HCl buffer pH 8.0 
5 .5mM glucose-6-phosphate 
0.245mM NADP+ 
lOmM acetamide
0 . 6  units glucose-6 -phosphate dehydrogenase 
Final volume 2.5 ml.
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Trichlorofluoromethane and carbon tetrachloride were 
added by microlitre syringe directly to the incubation 
medium in 50 ml stoppered conical flasks. Incubations 
were for 45 minutes at 3 7 °C, unless otherwise stated. 
Incubations were stopped by the addition of 5 nil 10% 
trichloroacetic acid (TCA), giving a final concentration 
of 6.67% TCA, and standing the flasks in ice. The 
precipitate was spun down in a Mistral 6L centrifuge 
(MSE Ltd., Crawley, Sussex, England) at 2,000 rev./min 
for 10 minutes, and 2 ml aliquots of the supernatant 
were mixed with 2 ml portions of 0 .6 7% thiobarbituric 
acid (TBA), heated at 100°C for 10 minutes, and when 
cool the absorbance was measured at 535 nm. Incubations 
were carried out in triplicate or quadruplicate, and 
each incubation was assayed in duplicate.
4.3. Results.
In vitro incubations.
The purity of the trichlorofluoromethane used was 
checked by g.l.c. using the conditions described in 
Figure 2.8. Prior to elution of trichlorofluoromethane 
from the column, there were only minor disturbances in 
the baseline trace that at the retention time of 
dichlorofluoromethane accounted for something less than 
0.1%.
Addition of a 1 to 500 mixture of dichlorofluoro­
methane and trichlorofluoromethane to the 3 ml incubation
medium, followed by extraction of the medium with 5 ml 
n-heptane, resulted in a qualitative recovery of a 
detectable amount of dichlorofluoromethane.
However, no dichlorofluoromethane was detectable 
by the methods described in incubations of trichloro- 
fluoromethane with microsomal preparations from the 
following control and phenobarbital-induced animals:
male Wistar albino rat
male Wistar albino,rat (0.1% sodium phenobarbital 
in the drinking water for 7 days) . 
male C^H/Mg mouse (0.1% sodium phenobarbital) 
female C^H/Mg mouse (0.1% sodium phenobarbital) 
male golden hamster (0 .1% sodium phenobarbital) 
male guinea-pig (0 .1% sodium phenobarbital) 
female chicken.
Lipid peroxidation.
Use of ethyl oleate as a solvent for the addition 
of trichlorofluoromethane and carbon tetrachloride to 
incubations resulted in falsely high absorbance values 
at 5 3 5 nm» A range of solvents were tested in 
incubations, and ethanol, propanol, butanol and di- 
m e t h y l f ormamide did not form coloured products in the 
thiobarbituric acid reaction. Butyl acetate and 
liquid paraffin showed some formation of a coloured 
complex, but not to the same extent as ethyl oleate. 
Ethanol was used as solvent in subsequent experiments.
Incubation of microsomal suspensions under nitrogen 
prevented peroxidation for at least 60 minutes, as did 
storage of the suspensions at 0°C, which is shown below:
nmol malonaldehyde produced
per ml incubation in G O  min at
O o 0
37 C 37 C 0 C
(under N^)
No addition 2.55 0 0.23
+ 100 nl CCl^ 3 . 1 0 0
A requirement for NADPH was demonstrated by the 
omission of the NADPH generating system from incubations. 
Without NADPH, endogenous peroxidation in a 15 minute 
incubation was decreased from 4.37 nmol/ml to 1 . 1 7  
nmol/ml suspension, and the stimulation due to the 
addition of 2 CCl^/ml was decreased from 26%  to 
1 3 % .
The extent of peroxidation during incubation at
O37 C increased with the ageing of the microsomal 
suspension. Using a microsomal preparation from a 
2 0 0 g female rat, incubations were commenced 3 0 , 60  
and 90 minutes after resuspension of the microsomal 
pellet. With no additions, 2.50, 2.77 and 4.l8 nmol 
malonaldehyde were produced per ml suspension.
However, the percentage stimulation due to the addition 
of 1 jjJ L. CCl^/ml was 3 0 %  in each case.
Tables 4.1 and 4.2 show the effects of trichloro- 
fluoromethane and carbon tetrachloride on lipid per-
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oxidation in vitro, in microsomal preparations from the 
rat and from the mouse and hamster. Carbon tetra­
chloride produced highly significant increases in all 
cases, the percentage increase in mouse microsomal 
preparations being particularly striking. It will be 
noticed that the control level of in vitro peroxidation 
(no addition) was considerably lower in the mouse than 
in the rat or hamster.
The effect of trichlorofluoromethane was rather 
erratic. In the rat, small but significant increases 
were found in the experiment shown in Table 4.1 . In 
preparations aged for only 40 minutes, an addition of 
2 j x l  trichlorofluoromethane/ml suspension caused a 
significant 8% rise (P<0.05). 40 and 80 yfL/ml
additions caused slightly greater rises. However, in 
the mouse and hamster microsomal preparations, addition 
of up to 40 j x . 1 trichlorof luorome thane/ml either had no 
effect or depressed the level of the endogenous per­
oxidation. The only exception was found on the 
addition of 80 j j J L trichlorof luoromethane/ml to micro­
somal preparations from the male mouse. However, 
the increase in malonaldehyde produced (3 8%) must be 
compared to the 1 3 5% increase produced by the addition 
of carbon tetrachloride (0.4 ^ .l/ml).
Table 4.3 shows the effect of trichlorofluoromethane 
and carbon tetrachloride on microsomal preparations 
from male and female rats in three weight ranges, both 
untreated and phenobarbital-induced (0 .1% sodium
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phenobarbital in the drinking water for 7 days).
The results are expressed as a percentage of control 
values because endogenous peroxidation decreased as 
the age (and weight) of the rat increased. It can 
be seen that In most cases addition of trichlorofluoro­
methane to the incubation medium depressed lipid 
peroxidation, whereas carbon tetrachloride caused 
increased peroxidation. Phenobarbital pretreatment of 
the animals caused increases in endogenous peroxidation 
of between 10% and 40%. However, only phenobarbital- 
induced rats of 1 3 0 - 1 5 0 g showed larger increases in 
peroxidation due to carbon tetrachloride compared to 
controls.
4.4. Summary.
No dichlorofluoromethane was detected as a 
metabolite of trichlorofluoromethane in incubations of 
microsomal preparations from the rat, mouse, hamster, 
guinea-pig or chicken. The limit of detection of 
dichlorofluoromethane in the presence of a large 
concentration of trichlorofluoromethane was approximately 
0.2%.
The effect of trichlorofluoromethane on 
microsomal lipid peroxidation in vitro was variable, 
in some experiments (e.g. Table 4.l), lipid peroxidation 
was significantly increased by addition of trichloro- 
fluoromethane (1 - 80 to the incubation. In other
experiments (Tables 4.2 and 4.3) peroxidation was
unaffected or even depressed by the addition of 
trichlorofluoromethane. Carbon tetrachloride was used 
as a positive control; in all experiments, carbon 
tetrachloride produced significant increases in the in 
vitro lipid peroxidation when added to the incubation 
medium at a concentration of 1 yjCL/ml. In the mouse, 
carbon tetrachloride produced greater percentage 
increases in microsomal lipid peroxidation than in other 
species, but trichlorofluoromethane caused decreased 
levels of peroxidation.
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PRELIMINARY TOXICITY EXPERIMENTS.
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5.1. Introduction.
Chlorofluoroalkanes have been reported to be of 
low toxicity, judged by both acute and chronic exposures.
To confirm these reports, preliminary toxicity experiments 
were designed-to investigate the effects of high dose 
levels of trichlorofluoromethane and 1 ,2 -dichloro-1 ,1 ,2 ,2- 
tetrafluoroethane on body and tissue weights over a 
period of days or weeks. In addition tissue lipids 
were measured, as 1 fatty liver1, caused by the accumulation 
of triglycerides, is a clear toxic effect in carbon 
tetrachloride poisoning.
5.2. Methods.
Preliminary toxicity experiments.
Four experiments were carried out:
(i) 2 male and 2 female Wistar albino rats 
(Porton strain) were dosed with trichlorofluoromethane 
(400 mg/kg body weight) i.p. daily for 35 days.
Control rats (2 male and 2 female) were dosed an 
equivalent amount of ethyl oleate. Body weight was 
measured daily and liver, kidney and lung weights at 
the end of the experiment. Protein and lipid were 
assayed in these tissues.
(ii) 2 male Wistar albino rats were dosed with 
trichlorofluoromethane (1 . 9 g/kg and 2 . 5  g/kg body 
weight) i.p. for 5 days. 2 control rats received
ethyl oleate. Body and organ weights were measured on 
the sixth day, as were tissue lipids. Serum, liver 
and adipose tissue were assayed qualitatively for 
, trichlorofluoromethane by g.l.c.
(iii) 4 groups (randomly selected) of 6 male 
Wistar albino rats were treated as follows for 37 days:
(a) ethyl oleate alone, i.p.
(b) trichlorofluoromethane in ethyl oleate 
(400 mg/kg), i.p. •
(c) trichlorofluoromethane in ethyl oleate + 
sodium phenobarbital in 0 .9% saline ( 3 0 mg/kg) 
i.p.
(d) sodium phenobarbital in 0 .9% saline ( 3 0 mg/kg) 
i.p.
Body and tissue weights and liver protein and lipid 
were measured.
(iv) 2 male Wistar albino rats were dosed
1 ,2 -dichloro-l,1 ,2 ,2-tetrafluoroethane ( 1 5 0 mg/kg) 
i.p. daily for 17 days. Body and tissue weights 
were measured.
Tissue preparation and protein estimation.
Tissues were homogenised in 3 volumes of ice-cold 
0.25M sucrose, as described before (4.2) and the 
homogenate was fractionated following the general 
principals of de Duve et al. (1955).
Protein was measured by the method of Lowry et al. 
(l9 5l). 5 nil freshly prepared copper reagent (2%
Na^CO^, 0 .02.% sodium potassium tartrate, 0 .0 1% CuSO^.^H^O 
was added to 1 ml of a suitable dilution (in 0.5M NaOH) 
of each fraction and mixed well. After 10 minutes,
0.5 nil of Folin-Ciocalteu reagent (l:2 (v/v) Folin 
reagent : distilled water) was added and immediately 
mixed. The absorbance was measured after 30 minutes 
at 720 nm. Standards were prepared with crystalline 
bovine serum albumin and the standard plot was linear 
up to 200 yug/ml.
Lipid extraction.
Lipid was extracted by the method of Folch et al.
(1937). Tissue was homogenised in 2:1 chloroform- 
methanol mixture and the final volume adjusted to 20 
times the volume of the tissue used. This was filtered 
through glass-fibre filter discs and mixed well with 
0.2 times its volume of 0.29% NaCl. This was centri­
fuged at 2,000 rev./min for 10 minutes (MSE Mistral 6L) 
to separate the phases. The upper phase was carefully 
sucked off and the interface was washed three times 
with a chloroform-methanol-water mixture (3 i ^ S : k 7  by 
volume). The lower phase and remaining traces of 
upper phase were made into one by the addition of a 
small volume of methanol. Chloroform-methanol mixture
(2 : 1  v/v) was added to the washed extract to make it up 
to any desired volume.
Quantitation of total lipid.
Total lipid was measured gravimetrically.
Initially, 1 ml and 2 ml aliquots of the washed 
chloroform-methanol extracts were evaporated down in 
weighed test tubes and the residue weight obtained by 
difference, after drying the residue for 2 hours at 
105°C. «
The accuracy of pipetting 1 ml aliquots was 
approximately + 0.4%, as estimated by the weights of 
six aliquots (1.2457 + 0.0055 g)» The accuracy of 
weighing empty tubes was also good (l8 . 8 9 5 3  + 0 . 0 0 0 1  g). 
However, from results obtained for residue weights, it 
was apparent that the accuracy of weighing a difference 
of approximately 2 mg was insufficient to obtain 
reasonable triplicates.
The final modification used was a major simplif­
ication of the method of Sperry and Brand (1955)• A 
15 ml glass-stoppered tube was heated at 90°C for 2 
hours, and weighed when cool. Two 5 ml aliquots of 
the chloroform-methanol extract were evaporated down 
in this tube at 55“60°C under a stream of oxygen-free 
nitrogen. The tubes were desiccated for 3 days over 
cone. H^SO^, reweighed, heated at 9 0°C for 2 hours and 
finally reweighed when cool. The weight of the residue
Oafter drying at 90 C was decreased by an average of 
0.15 + 0.06 mg. Control tubes run through the full 
procedure showed an overall increase in weight of 
1.13 + 0.09 mg. Test values were of the order of
50-75 mg.
A second method was used to quantitate lipids. 
Frings and Dunn (1970) reported a colorimetric method 
for the determination of total lipids in 0 . 1  ml serum, 
which was based on the formation of a sulpho-phospho- 
vanillin complex involving a carbon-carbon double bond 
in some way. These workers used olive oil dissolved 
in ethanol as a standard, and stated that the colour 
was "stable for at least 10 minutes". They also 
stated that "triolein, oleic acid, linoleic acid, 
linolenic acid and cholesterol reacted quantitatively 
in the method", but did not explain this in any way.
The method was open to criticism on several points. 
Firstly, the assay required the transfer of an aliquot 
(0 . 1  ml), containing 9 5 %  cone. H^SO^. 0 . 1  ml conc. 
HgSO^can only be pipetted with great difficulty, yet 
no details were given of the procedure. Secondly, 
olive oil is not homogeneous and the composition of 
different batches may alter, thus affecting the standard 
curve. Thirdly, without further information on the ' 
nature of the chromophores formed with different 
compounds, it seems unjustified to equate mg olive oil 
equivalents with mg lipid.
The method was adapted for use on chloroform- 
methanol tissue extracts. Oleic acid was used as a
standard, dissolved in chloroform-methanol (2 : 1  v/v) 
and stored at 4°C. Phosphovanillin reagent was 
prepared by adding conc. phosphoric acid ( 8 0 0 ml) with
constant stirring to 0 .6% (w/v) vanillin solution
( 2 0 0 ml) and was stored in the dark at room temperature.
2 ml conc. H^SO^ was pipetted into a tube 
containing 0 . 1  ml of a chloroform-methanol extract or 
standard. This was mixed on a Whirlimixer (Fisons 
Scientific Apparatus Ltd., Loughborough, Leics., 
England). The resulting emulsion was heated for 
exactly 10 minutes on a boiling water bath, and then 
cooled for 5 minutes in ice-cold water. A 0.1 ml 
aliquot was transferred to a second tube, using a 
fixed-volume microlitre pipetter, with a disposable 
tip. 0 . 1  ml chloroform-methanol mixture was used as 
a blank. Phosphovanillin reagent (2.5 ml) was added 
and well mixed. The samples were incubated at 37°C 
for exactly 15 minutes and were allowed to cool for 
10 minutes at room temperature. The absorbance was 
measured at 540 nm in 1 cm path length cells using a 
Unicam SP500 spectrophotometer. Triplicate analyses 
were made of each sample. Results have been expressed 
as mg oleic acid equivalents.
The stoichiometry of the colour reaction was 
investigated by comparison of oleic, linoleic and 
linolenic acids and cholesterol as standards.
5.3. Results.
Estimation of lipid by the colorimetric method.
Figure 5«1 shows a comparison of oleic acid
Figure 5 .1.
Standard plot for colorimetric lipid assay.
Absorbance 
(units)
0.6
0.5
0.2
Dissolved in
ethanol
a chloroform-methanol 
(2 : 1  v/v)
1 2 3 4 / 5  6
mg oleic acid/ml
standards prepared in ethanol and in chloroform - 
methanol (2:1 v/v). It is apparent that the standards 
prepared in ethanol show a greater degree of variation 
within triplicates than those prepared in chloroform- 
methanol and they also show poorer linearity.
Figure 5»2 shows standard plots prepared with 
oleic, linoleic and linolenic acids and with cholesterol.
These compounds contain 1, 2, 3 and 1 double bonds
respectively. It can be seen that the standard plots 
lay close together and that cholesterol and linolenic 
acid shared exactly the same plot. If, however, the 
extinction coefficients are compared, cholesterol and 
linoleic acid then show the same value. This is 
shown below:
No. of Absorbance at Extinction
double bonds lmg/ml (units) coefficient
(l.mol.*cm ^)
oleic acid 1  . 0 . 8 1 0 2 . 2 8 X 1 0 5
linoleic acid 2 0.875 2 . 5 6 X 10 5
linolenic acid 3 0 . 6 5 0 1 . 6 5 X 1 0 5
cholesterol 1 0 . 6 5 0 2 . 3 6 X 1 0 5
Storage of lipid extracts.
Two portions of a crude extract of liver lipid
/  O  \were stored, one at room temperature (22 C) and one at
4 C. On day 1 , day 4 and day 8 , aliquots were taken 
and washed as described above (5*2). The washed extracts
Figure 5 - 2.
Comparison of unsaturated Fatty acids as standards in
the colorimetric lipid assay.
Absorbance 
(units)
3
0.2
oleic acid1
linoleic acid
linolenic acid
cholesterol
k
mg/ml
were assayed by the colorimetric method. The washed 
extracts prepared on days 1 and 4 were retained and 
assayed again on days 4 and 8 and day 8 respectively. 
The results are expressed as mg oleic acid equivalents/ 
g liver + S.E-.M. No significant decrease was found.
sample stored
at
Day 1 Day 4 Day 8
A1 4°C 2 4 . 7 2  + 0 . 5 7 2 3 . 6 0  + 0 . 7 0 2 6 . 4 3  + 1 . 0 0
A4 4 ° c - 2 3 . 8 3  + 0 . 6 7 2 3 . 5 3  + 1 . 1 5
A8 4 ° c - - 2 6 . 6 2  + 1 . 0 0
B1 22 °C 2 3 . 7 5  + 0 . 3 1 2 3 . 8 7  + 0 . 8 7 2 5 . 3 2  + 1 . 5 2
b 4 to to 0 O - 2 3 . 7 0  + 1 . 8 6 2 5 . 4 8  + 0 . 8 6
b 8 to to
0
O - - 2 2 . 5 3  + 0 . 9 3
Preliminary toxicity experiments.
(i) Table 5.1 shows the results of this experiment. 
No differences in protein content of the various sub- 
cellular fractions were found. Slight alterations
were indicated in liver and lung total lipid, but the 
values were not significantly different. No change was 
found in kidney protein or lipid.
(ii) Table 5-2 shows the results of this 
experiment. There was a significant increase in 
liver weight in the test animals. Total lipid levels 
were not altered in liver, kidney, lung, serum or 
adipose tissue.
Traces of trichlorofluoromethane were found in
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the serum and liver and greater concentrations were 
found in adipose tissue.
(iii) The results of body and tissue weights in 
this experiment are shown in Table The only
significant difference found (in liver weight expressed 
per 100 g body weight) was not attributable to tri- 
chlorofluoromethane, but to the phenobarbital treatment. 
The liver lipid values are given in Table 5-^- Total 
lipid measured gravimetrically and lipid measured 
colorimetrically showed no significant differences 
between the three groups receiving ethyl oleate.
However, the group of animals receiving on3.y pheno­
barbital (d) showed significantly lower lipid levels 
measured by both methods compared to those in the ethyl 
oleate control group (a).
Subtraction of mg oleic acid equivalents from mg 
total lipid showed a significantly lower difference 
(P < 0.05) in animals receiving trichlorofluoromethane 
compared to animals receiving solvent alone. It 
should be noted that the difference between total lipid 
and oleic acid equivalents for group (d), which did 
not receive ethyl oleate, was the same as for the control 
group (a).
(iv) In the rats dosed with 1 ,2 -dichloro-1 ,1 ,2 ,2- 
tetrafluoroethane ( 1 5 0 mg/kg) for 17 days, body weight 
gain was slightly depressed. However, one test 
animal contracted peritonitis toward the end of the
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experiment and the results (Table 5-5) must therefore 
be interpreted with caution.
5*^ :. Summary.
Lipid assays.
The gravimetric procedure for assay of total lipid 
that was finally adopted proved to be reproducible, and 
was a great simplification of the method of Sperry and 
Brand (1955)•
The colorimetric procedure, used by Frings and 
Dunn (1970) for the assay of total serum lipids, appeared 
to involve the reaction of the sulpho-phospho-vanillin 
complex with compounds containing double bonds.
However, the formation of the coloured complex was not 
dependent on the degree of unsaturation in individual 
molecules. The slight differences in extinction 
coefficients for the unsaturated compounds tested was 
probably due to differences in the chromophores formed.
The colorimetric assay appeared to be a measure of the 
molecules containing at least one C=C bond. Results 
could thus be interpreted either as a measure of 
unsaturated lipids or as a reflection of the content of 
unsaturated residues in a particular population of lipids.
Oleic acid was chosen as the standard in the assay 
for two reasons: it is a pure compound and its standard 
plot lay betwen those of the other compounds tested, 
whether expressed as mg/ml or umol/ml. Use of
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chloroform-methanol (2 : 1  v/v) as the solvent instead of 
ethanol improved the reproducibility and linearity of 
the standard plot up to 6 mg oleic acid/ml. The 
linearity reported by Frings and Dunn (up to 10 mg olive 
oil/ml) could not be reproduced.
Storage of lipid extracts was possible, even at 
room temperature, for several days. No decrease was 
found in the stored lipid extracts when the lipid was 
measured colorimetrically, which suggested that 
autoxidation (Dodge and Phillips, 1966) did not occur.
The slight increase at 8 days was probably due to small 
losses of solvent.
Preliminary toxicity experiments.
Intraperitoneal injection of large doses of 
trichlorofluoromethane or 1 ,2-dichloro-1 ,1 ,2 ,2 -tetra- 
fluoroethane produced little effect over several weeks. 
Tissue proteins and total lipids were unaffected. 
’Unsaturated lipid’ in the liver was not significantly 
affected. However, the difference between total and 
’unsaturated1 liver lipid ('saturated’ lipid) was 
significantly lower (P<Q.05) in animals receiving 
trichlorofluoromethane in ethyl oleate compared to 
ethyl oleate controls.
The qualitative analysis of tissues in experiment
(ii)!indicated that trichlorofluoromethane was still 
present in the tissue 24 hours after the final dose,of 
a series of 5 repeated doses (1 . 9  g/kg).
CHAPTER 6
INTERACTIONS WITH CYTOCHROME P-450 
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6.1. Introduction.
The effect of chlorofluoroalkanes on the metabolism 
of foreign compounds is of importance as considerable 
use is made of them in aerosol sprays containing drugs, 
pesticides and food additives. These compounds, most 
of which are foreign to the mammalian system, are 
metabolised principally by the hepatic microsomal 
mixed-function oxygenase system, the terminal electron 
acceptor being cytochrome P-450.
In addition, as already suggested . (.1.12), the 
hepatic microsomal electron transport chain would be a 
probable site for metabolism of the chlorofluoroalkanes, 
if this occurs. Interaction of chlorofluoroalkanes 
with this system, and particularly with cytochrome P-450, 
might indicate the possibility of metabolism.
Two aspects of the interaction of the chlorofluoro­
alkanes with drug metabolism were considered:
(a) The interactions of several chlorofluoro­
alkanes and chlorinated hydrocarbons with hepatic 
cytochrome P-450 were investigated spectrophotometrically 
to determine the class of spectrum produced with 
oxidised preparations, the apparent spectral
constant (K^) and the nature of any binding in chemically 
reduced (Na^S^O^) microsomal suspensions. The spectral 
interactions of several of these compounds and some 
chlorinated hydrocarbons were studied in several species.
(b) The influence of trichlorofluoromethane, in
particular, on in vivo and in vitro hepatic drug 
metabolism was studied, and compared with the effects of 
carbon tetrachloride. In vivo studies were of hexo­
barbital sleeping times and zoxazolamine paralysis 
times. To determine the effects of chlorofluoroalkanes 
in vitro on drug metabolising activity, four compounds 
showing type I spectral interactions and four showing 
type II interactions were used as substrates. The 
reactions tested were:
Type I
(i) biphenyl 2- and 4-hydroxylation
(ii) ethylmorphine N-demethylation
(iii) hexobarbital oxidation
(iv) p-nitroanisole O-demethylation
Type II
(v) acetanilide 4-hydroxylation
(vi) aniline 4-hydroxylation
(vii) thiabendazole hydroxylation
(viii) zoxazolamine hydroxylation.
The effect of carbon tetrachloride on these activities 
was used as a positive control.
6.2. Methods.
Animals.
The animals used in these experiments were as 
described before (4.2) and were maintained under the 
same conditions.
When required, animals were pretreated as follows:
(i) Sodium phenobarbital (0.1%) in the drinking 
water supply for 7-l4 days, or by i.p. injection.
( 1 0 0 mg/kg body weight) daily for 3 days.
(ii) 3-Methylcholanthrene ( 3 0 mg/kg body weight) 
in ground nut oil daily for 3 days by i.p. injection.
(iii) Carbon tetrachloride (0.2 ml/kg body 
weight) in ethyl oleate daily for 7 days by stomach 
tube.
(iv) Trichlorofluoromethane (l g/kg body weight) 
in ethyl oleate daily for 7 days by stomach tube.
Controls were given 0.9% saline i.p. or ethyl oleate 
by stomach tube as appropriate.
Tissue preparation.
Whole liver homogenates were prepared as described 
previously (4.2).
For enzyme assays, the homogenate was centrifuged 
as before (4.2) and either the 11 0 , 0 0 0 g supernatant1 or
the microsomal pellet, resuspended in buffer appropriate
to the assay, was used.
For binding studies, the liver homogenate was
centrifuged at 12,000 g for 20 minutes at 4°Ca v •
(High Speed l8 centrifuge, 8 x 50 ml rotor, MSE Ltd.)
to ensure that the supernatant was free from contamination
by the mitochondrial or lysosomal fractions. The
supernatant was very carefully decanted and was
recentrifuged at 4°C in a Superspeed 50 centrifuge
(MSE Ltd.) either at 104,000 g for 1 hour (8 x .25 mlav •
rotor) or at 1 5 7 , 0 0 0 g for 40 minutes ( 1 0 x 10 mlav •
rotor). The supernatant was discarded and the 
microsomal pellet was resuspended with a motor-driven 
Potter homogeniser in fresh 1.15% KC1 and recentrifuged 
under the same conditions. The supernatant was 
discarded again. This procedure reduced contamination 
of the microsomal pellet due to haemoglobin and reduced 
the concentration of soluble enzymes and cofactors 
trapped in the pellet. The 'washed1 microsomal 
pellet was either resuspended in approx. 1 ml O.IM 
Na^HPO^.NaH^PO^ (O.IM phosphate buffer) pH 7 •6 per g 
wet weight of original tissue and used immediately or' 
was stored for up to 24 hours at 4°C, overlaid with the 
phosphate buffer.
The microsomal suspension (approx. 20 mg protein/ 
ml) was, diluted with buffer as required, to between 
1 . 0 and 4.0 mg protein/ml, measured by the method of 
Lowry et al. (1951) (see 5*2).
Recovery of microsomal protein in the 'washed' 
pellet was 64.0 + 0.5% (3 experiments).
Extraction of microsomal preparations with isooctane.
The 'washed* microsomal pellet was extracted by 
a modification of the method of Leibman and Estabrook 
(l97l). The pellet was resuspended in 0.25M sucrose, 
containing 50mM Tris-HCl, pH 7*^, to give a protein 
concentration of approx. 30 mg/ml. The suspension was 
stirred at 4°C with 0 . 6 7 volumes isooctane (2,2,4-tri- 
methylpentane, spectroscopic grade) for 25 minutes.
The resulting emulsion was centrifuged at 104,000 g 
for 1 hour. The isooctane and aqueous layers were 
removed and the microsomal pellet resuspended in 0.1M 
phosphate buffer, pH 7*6.
The recovery of microsomal protein and cytochrome 
P-450 reported by Leibman and Estabrook (l97l) was 19%, 
using different centrifugation conditions. The modified 
procedure described above gave 7 6% and 103% recovery of 
protein in two experiments.
Digestion of microsomal preparations with phospholipase C .
Microsomal preparations were treated with phospho­
lipase C (from Cl. welchii; supplied by Sigma Chemical 
Co. Ltd., London, England) by the methods of Chaplin 
and Mannering (1970) and Eling and DiAugustine (1971K 
Microsomes (5 mg protein/ml) were incubated with stirring 
at 22°C with phospholipase C (l.O mg/ml) in 0.02M Tris-
HC1 buffer pH 6.5, lmM CaCl for 40 minutes. The 
reaction was stopped by adding EGTA (ethyleneglycol- 
bis-(j3-aininoethylether )N, N*-t etraacetic acid) (final 
concn. 5mM). The digested suspension was centrifuged 
at 1 5 7 , 0 0 0 g for 40 minutes, and the pellet resuspended 
in O.IM phosphate buffer, pH 7-6.
Digestion of microsomal suspensions with phospholipase D.
The method of Eling and DiAugustine (l97l) was 
used, except that pH 6.5 Tris-HCl buffer was used for 
the incubation. Conditions were exactly as described 
for phospholipase C. Phospholipase D (from cabbage) 
was supplied by Sigma Chemical Co. Ltd.
Measurement of cytochromes.
Cytochrome P-450 was measured by the method of 
Omura and Sato (1964a), using a Unicam SP 1800 dual 
beam recording spectrophotometer with 1 cm path length 
cuvettes.
Microsomal suspensions (protein concentration 
1-4 mg/ml) were placed in both sample and reference 
cells. The contents of the sample cell were bubbled 
through with CO for 20-30 seconds and then the contents 
of both cells were reduced by the addition of a few mg 
of solid N a S  Or. After mixing, the difference spectrum2L Ca fr
was recorded between 390 nm and 500nm. Cytochrome 
P-450 was estimated in terms of units of absorbance 
difference between 450 nm and 490 nm.
Cytochrome P-420 was estimated in a similar 
fashion, by the difference in absorbance between 420 nm 
and 490 nm.
Extinction coefficients for these cytochromes in
rabbit microsomal preparations (Omura and Sato, 1964b)
were used to calculate concentrations. For cytochrome
1 — 1P-450 and cytochrome P-420 they were 91 l.mmol .cm 
-1 -1and 111 l.mmol .cm respectively.
Cytochrome b^ was estimated by reducing the sample
cell contents with NADH and recording the spectrum
between 390 and 500 nm. The extinction coefficient
- 1  - 1between 424 and 409 nm was taken to be 185 l.mmol .cm 
(Omura and Sato, 1964a).
Binding spectra.
Five ml of a microsomal suspension (1-4 mg protein/ 
ml) in O.IM phosphate buffer pH 7-6 was divided between 
two 2 . 5  nil stoppered cuvettes, and the cuvettes placed 
in the forward sample position of a Unicam SP l800 
recording spectrophotometer. A baseline of the 
optical difference between the two cuvettes was recorded 
between 350 nm and 460 nm. Substrate (in ethanol) was 
added to the sample cuvette by microlitre syringe and 
an equal amount of pure ethanol was added to the 
reference cuvette. After mixing, the optical difference 
between sample and reference was recorded over the base­
line. For measurement of absorbance changes, the 
spectrum was scanned at 4 nm/sec at a slit width of 3 nm.
Scan speed and slit width were reduced to 1 nm/sec and 
0.5 nm respectively for the determination of the 
wavelengths of spectral maxima and minima.
The spectral, binding constant (Kg) was 
determined by measuring the absorbance change in the 
difference spectrum at a range of substrate concentrations. 
The total absorbance change produced at each substrate 
concentration was taken to be the sum of the absorbance 
differences between the peak and baseline and the 
baseline and trough.
Sequential additions of substrate were usually 
made to the same microsomal suspension in the sample 
cuvette. The volume in the reference cuvette was 
adjusted with solvent (ethanol). In a few cases, 
fresh microsomal suspension was used to determine the 
absorbance change at each substrate concentration.
The maximum volume added to the cuvette was 5 0  J J ^ L i.e.
2%. The range of substrate concentrations used was 
usually 1/3 to 3 times the Kg value.
The results were plotted in one of two ways. A 
plot of the reciprocal absorbance change (l/AE) on the 
y axis versus reciprocal substrate concentration (l/S) 
on the x axis yielded a normal Lineweaver-Burk plot 
(Lineweaver and Burk, 1934). The intercept on the 
x axis was -l/K . An alternative plot (Hanes, 1932)
S
was also applied to the determination of Kg. The 
substrate concentration divided by the absorbance 
change (S/AE) (y axis) was plotted against substrate
concentration (S) (x axis). K was determined directlys
from the intercept on the x axis. Plots were fitted 
to the experimental points by the method of least 
squares. In the case of plots with a break in the 
straight line, the two lines were initially fitted 
by eye.
Spectra were also recorded between 390 nm and 500 
nm after chemical reduction of the contents of both 
cuvettes with a few mg solid Na^S^O^. The baseline 
Obtained with reduced microsomal suspensions was 
level between 430 and 500 nm. These spectra will be 
referred to as reduced spectra.
In one experiment, an NADPH generating system was 
substituted for Na^S^O^.
Conversion of cytochrome P-450 to P-420 during incubation 
with trichlorofluoromethane.
The in vitro system reported by Heni (l97l) was 
used. Composition of the incubation medium (final 
volume 5 nil) was as follows:
10 mg microsomal protein in 0.05M Tris-HCl buffer, 
pH 7.5.
0.3mM NADP+.
1.5 units glucose-6-phosphate dehydrogenase.
1.5mM glucose-6-phosphate.
ImM MgClg.
In some incubations the buffer contained 20% (v/v)
glycerol.
The incubation tube was flushed with oxygen, 
stoppered and pre-incubated at 37°C for 5 minutes. 
Trichlorofluoromethane or carbon tetrachloride was then 
added with a microlitre syringe. Incubations were 
stopped at different time intervals up to 30 minutes by 
plunging the tubes into ice. When cold, the incubation 
medium was poured into two cuvettes and the content of 
cytochrome P-450 determined as described above.
Hexobarbital sleeping times.
Sodium hexobarbital (in 0.9% saline) was injected
i.p. into female rats at a dose level of 100 mg/kg 
body weight at specific time intervals after dosing 
the animals orally with chlorofluoroalkanes. The 
time interval chosen was designed to allow the blood 
level of chlorofluoroalkane to reach its maximum and 
was 10 minutes for trichlorofluoromethane and 30 minutes 
for 1,1,2-trichloro-1,2,2-trifluoroethane and dichloro- 
fluoromethane.
The sleeping time was taken to be the interval 
between loss and regain of righting reflexes.
Zoxazolamine paralysis times.
Zoxazolamine (2-amino-5-chlorobenzoxazole), 
purchased from K & K Laboratories Ltd., Plainview,
N.Y., U.S.A., was injected i.p. into female rats at a 
dose level of 7 0 mg/kg body weight, as described for
hexobarbital sleeping times.
Paralysis time was taken to be the time interval 
between loss and regain of reflexes.
In. vitro hepatic enzyme assays.
All incubations were carried out in duplicate in 
stoppered tubes at 37 °C, and were shaken at 100 cycles/min.
All centrifugations were carried out using a 
Mistral 6L (MSE Ltd.) at 2,000 rev./min for 10 min.
The following abbreviations are used: G-6-P 
(glucose-6-phosphate), G-6-P dehydrogenase (glucose-6- 
phosphate dehydrogenase), Tween 80 (polyoxyethylene 
sorbitan mono-oleate).
(i) Biphenyl 2- and 4-hydroxylation.
A modification of the method of Creaven et al. (19&5)
was used to determine the formation of 2- and 4-hydroxy- 
biphenyl .
Incubations were set up as follows:
Test Blank 4-0H 2-OH
standard standard 
(volumes in ml)
Microsomes O • to
CMt
o
o • to o • to
Buffer 0.7 0.7 o • to o • to
Cofactor solution o t to o • to O • to 0 . 2
lOOmM MgSO^ 0 . 1 0 . 1 0 . 1
*
0 . 1
4-0H standard - - 0.5 -
2-OH standard — — ■ — 0.5
* *
Substrate 0.5 0.5 0.5 0.5
Final volume 1.7 nil. * added after incubation.
Microsomes were suspended at 10 mg protein/ml.
Buffer was O.IM Na^iPO^. Nal^PO^ , pH 7.6.
Substrate was 15mM biphenyl in 3% Tween 80.
Standards (dissolved in 5% ethanol) were 4-hydroxy-
biphenyl (30 yug/ml) and 2-hydroxybiphenyl (12 yu.g/ml) .
Cofactor solution (0.2 ml) contained 1.25 yjunol
NADP+, 13 j x m o l  G-6-P and 1.5 units G-6-P dehydrogenas
o10 minute incubation at 37 C.
Incubations were stopped by the addition of 0.5 nil 
2 0 %  trichloroacetic acid. The incubation was extracted 
for 15 min with 7 nil n-heptane (containing 1 %  (v/v) 
isoamyl alcohol) on a rotary shaker. A 2 ml aliquot 
of the n-heptane extract was extracted for 15 min with 
7 ml 0.1M NaOH on a rotary shaker. The two phases 
were separated by centrifugation (2,000 rev./min, 10 min) 
and the n-heptane was sucked off. 2 ml of the NaOH 
extract was pipetted into a spectrofluorimeter cuvette 
and mixed with 0.5 ml 0.25M sodium succinate, and the 
fluorescence measured on a Perkin-Elmer spectrofluorimeter 
The excitation/emission wavelengths for 4-hydroxybi- 
phenyl and 2-hydroxybiphenyl were 2 7 5 / 3 3 8 nm and 295/415 
nm respectively.
(ii) Ethylmorphine N-demethylation.
A modification of the method of Holtzman et al.
(1968) was used. Ethylmorphine was supplied us a gift 
by May and Baker Ltd., Dagenham, England. Incubations
were set up as follows:
Test Blank Standard
(volumes in ml)
Microsomes 0.2
Buffer 0.5
Cofactor solution 0.2
lOOmM MgSO^ 0.1
Standard -
Substrate 0.3
Final volume 1.3 ml. * added after the incubation.
Microsomes were suspended at 10 mg protein/ml.
Buffer was 0.3M Tris-HCl, pH 7-4.
Substrate was 50mM ethylmorphine in distilled water.
Standard was formaldehyde in the range 1-1.5 j x mol/ml
—  1 —  1(standardised by €• = 8,000 l.mol .cm for the 
HCHO-Nash reagent complex)
Cofactor solution (0.2 ml) contained 1.25 ^ Lunol
NADP+, 15 j x m o l  G-6-P and 1.5 units G-6-P dehydrogenase.
O
10 minute incubation at 37 C.
The reaction was stopped by the addition of 1 ml 
15% ZnSO^ and 1 ml 2:1 freshly mixed saturated BatOH)^: 
saturated sodium tetraborate. After mixing, the precip­
itated protein was centrifuged down. A 2 ml aliquot 
of the protein-free supernatant was mixed for 40 min at 
37°C with 2 ml freshly prepared 4M ammonium acetate 
containing 0.4% (v/v) acetylacetone. The absorbance 
was measured at 412 nm.
0.2 0.2
0.5 0.2
0.2 0.2
0.1 0.1
0.3*
0.3* 0.3*
(iii) Hexobarbital oxidation.
An adaptation of the method of Gilbert and 
Goldberg (1 9 6 5) was employed in this assay. The 
reaction was followed by measuring the disappearance 
of substrate. Incubations were as follows:
Test Blank Zero time (not
incubated) 
(volumes in ml)
Homogenate 2.0 2.0 2.0
Buffer 0.2 0.7 0.2
Cofactor solution 0.2 0.2 0.2
lOOmM MgCl2 0.1 0.1 0.1
Substrate 0.5 - 0.5
Final volume 3 ml.
Liver whole homogenate (33%) in 0.25M sucrose,
0.1M phosphate, pH 7*4, 0.001M EDTA.
Buffer 0.1M Na2HP0^..NaH2P0^ , pH 7-4.
Substrate 20mM sodium hexobarbital.
Cofactor solution (0.2 ml) contained 1 ^ unol NADP+,
3-75 jjunol G-6-P and 0.2 units G-6-P dehydrogenase.
15 minute incubation at 37°C.
The reaction was stopped by saturating the medium 
with NaCl and extracting with 10 ml n-heptane (containing 
1.5% isoamyl alcohol) and 1 ml M NaH^PO^ for 20 minutes.
A 2 ml aliquot of the n-heptane was extracted by
shaking with 6 ml 0.8M Na^PO^ (brought to pH 11 with
10M NaOH) for a further 10 minutes. The absorbance of 
the aqueous phase was measured at 245 nm.
(iv) Nitroanisole O-demethylation.
A modification of the method developed by Netter 
and Seidel (1964) was used to determine this activity. 
Incubations were set up as follows:
Test Blank Standard
(volumes in ml)
Microsomes 0.2 0.2 0.2
Cofactor solution 0.2 0.2 0.2
lOOmM MgSO^ 0.1 0.1 0.1
Standard - - 0.2*
Substrate 1.2 1.2* 1.0*
Final volume 1.7 ml. * added after the incubation.
Microsomes (10 mg protein/ml) were suspended in
0.1M Na^HPO^.NaH^PO^, pH 7.8.
Standard was 0.3mM p-nitrophenol.
Substrate was 4mM nitroanisole dissolved in 0.1M 
phosphate buffer, pH 7 , 8 .
“f*Cofactor solution (0.2 ml) contained 1.25 yjunol NADP , 
15 yuimol G—6 —P and 1.5 units G-6 -P dehydrogenase.
15 minute incubation at 37°C.
The reaction was stopped with 0.5 ml 2 0 %  TCA.
The protein precipitate was centrifuged down and 1.4 ml 
of the supernatant was mixed with 1.5 ml 4M NaOH. The 
absorbance was measured at 4l0 nm.
(v) Acetanilide 4-hydroxylation.
The method developed by Krisch and Staudinger 
(l96l) for assay of this activity was modified. The
incubation was not stopped with acid as Krisch et al. 
(1964) found this lead to artefactual results. 
Incubations were as follows:
Test Blank Standard
(volume in ml)
Microsomes
Buffer
0.3
0.9
0.3 
0.9 
0.2 
0 . 1
0.3
0.4
0.2
0.1
0.5*
0.5*
Cofactor solution 0.2
lOOmM MgSO^ 0.1
Standard
Substrate 0.5 0.5*
Final volume 2.0 ml. * added after incubation.
Microsomes were suspended at 10 mg protein/ml.
Buffer 0.3M Tris-HCl, pH 7.4.
Standard 0.4mM 4-hydroxyacetanilide.
Substrate l6mM acetanilide.
+Cofactor solution (0.2 ml) contained 2 ^mol NADP ,
15 yumol G-6-P and 1.5 units G-6-P dehydrogenase.
30 minute incubation at 37°C.
The incubation medium was saturated with solid 
NaCl and shaken with 10 ml diethyl ether (containing 
1.5% isoamyl alcohol) for 5 minutes. 8 ml of the ether 
phase was sucked off and 1.5 ml of the aqueous phase was 
added to 1 ml Folin-Ciocalteu reagent (diluted 1:6 (v/v)
with water). This was mixed, incubated at 37°C for 
30 minutes and the absorbance measured at 691 nm.
(vi) Aniline 4-hydroxylation.
The method of Nakanishi et al. (l97l) formed the
basis of this assay, the 4-aminophenol formed being 
measured by a method similar to that of Brodie and 
Axelrod (1948). Incubations were set up as follows:
Test Blank Standard
(volume in ml)
Microsomes 0.3 0.3 0.3
Buffer 0.7 0.7 0.6
Cofactor solution 0.2 0.2 0.2
lOOmM MgSO^ 0.1 0.1 0.1-
Standard - - 0.1*
Substrate 0.5 0.5* 0.5*
Final volume 1.8 ml. * added after the incubation.
Microsomes 10 mg protein/ml.
Buffer 0.3M Tris-HCl, pH 7*4.
Standard 0.5mM p-aminophenol in 0.01M HC1.
Substrate 20mM aniline hydrochloride.
Cofactor solution (0.2 ml) contained 2 j^imol NADP ,
15 yuumol G-6-P and 1.5 units G-6-P dehydrogenase.
' o
15 minute incubation at 37 C.
The reaction was stopped by saturating the 
incubation with NaCl. This was extracted with 10 ml 
diethyl ether (peroxide-free) containing 1.5% (v/v) 
isoamyl alcohol, for 30 minutes on a rotary shaker. A 
7 ml aliquot of the ether extract was shaken with 4 ml 
1% phenol in 0.5M K^PO^ for 30 minutes, and was then 
left to stand for at least 60 minutes. The ether was
sucked off and the absorbance of the aqueous phase 
measured at 630 nm.
(vii) Thiabendazole 5-hydroxylation.
The method used was developed by Wilson, Parke and 
Cawthorne (unpublished work). The incubations were 
set up as follows:
Test Blank Standard
(volume in ml)
*1 0 , 0 0 0 g* supernatant 0..5 0 . 5  0 . 5
Buffer 0.7 0.7 0.6
Cofactor solution 0.2 0.2 0.2
lOOmM MgCl2 0.1 0.1 0.1
Standard - - 0.1*
Substrate 0.5 0.5* 0.5*
Final volume 2 ml. * added after incubation.
Buffer 0.3M Tris-HCl, pH 7-4.
Standard 5 -hydroxythiabendazole (l^imol/ml in 0.1M
HC1) .
Substrate lOmM thiabendazole (2-(41-thiazolyl)
benzimidazole) in 1 %  Tween 80.
Cofactor solution (0.2 ml) contained 2 j j a n o l  NADP+,
10 yjjnol G-6-P and 2 units G-6 -P dehydrogenase.
20 minute incubation at 37°C.
The reaction was stopped by the addition of 10 ml 
ethyl acetate and 3 ml 0.3M sodium phosphate, pH 6.0 and 
shaken for 15 minutes. A 5 ml aliquot of the ethyl 
acetate extract was shaken with 5 ml 0.1M HC1 for 15
minutes, and the HC1 extract (diluted 1 in 10 with 0.1M 
HCl) was assayed fluorimetrically at an excitation 
wavelength of 336 nm and an emission wavelength of 
5 3 0 nm.
(viii) Zoxazolamine hydroxylation.
The methods of Conney et al. (i9 6 0 ) and Juchau et
al. (1 9 6 5) were considerably modified to give the
following procedure for measuring the disappearance of 
zoxazolamine. The incubations were as follows:
Test Blank Zero time (not 
incubated)
(volume in ml)
*10,000 g' supernatant 
Buffer
Cofactor solution 0.5
0.1
0.5
0.4
0.5
0.9
0.5
0.1
0.5
0.4
0 . 5
0.1
0 . 5
lOOmM MgSO^ 
Substrate 0.5
Final volume 2 ml
Buffer 0.1M Na^PO^ .Nat^PO^, pH 7-4.
Substrate 300^ xM zoxazolamine (dissolved in a very 
 small amount of M HCl and diluted with water.
+Cofactor solution (0.5 ml) contained 1.25 Jtimol NADP 
15 f t mol G-6-P and 1.5 units G-6-P dehydogenase.
40 minute incubation at 37 °C.
The incubation was stopped with 0.5 ml M NaOH, and 
extracted by shaking with 10 ml n-heptane (containing 
1.5% isoamyl alcohol) for 30 minutes. A 7 ml aliquot
of the organic phase was shaken with 2 ml 0.1M acetate 
buffer, pH 5*6, for 5 minutes. 5 ml of the n-heptane 
was then extracted with 3 ml 0.1M HCl, by shaking for 
5 minutes, and the absorbance of the acid phase was 
measured at 278 nm against 0.1M HCl.
6 .3 « Results.
Spectral interactions.
The binding spectra of five chlorofluoroalkanes:
CC13F
CHC1 F
CC12F2
CC1 F-CC1F 
CC1F -CC1F
with microsomal preparations were examined. They 
were all of the type I class, exhibiting peaks at 
about 3 8 3 - 3 8 8 nm and troughs at about 420 nm. The 
spectra produced by a number of chlorinated methanes, 
ethanes and propanes were also type I. Of the 
compounds tested:
CC14
CHCl^
CH2C12
CHClg-CH , CH2C1-CH2C1
cciq-ch„, chci0-ch0ciJ  J  eL cL
CHC12-CHC12 
CC1„-CHC10 
■ -CC1 -CC1
CC1 -CC10-CC1
only 1 ,2 -dichloroethane failed to give any sort of 
spectrally observable interaction.
Figure 6.1 shows a comparison of the spectra 
obtained with trichlorofluoromethane and carbon tetra­
chloride. The spectra have been redrawn, for this 
figure, on a straight baseline. Such an ideal baseline 
was not obtainable directly on the spectrophotometer 
used, as provision for balancing the two light beams 
was made only every 40 nm.
Determination of K values.------------------ s-------
Considerable problems were involved in the accurate
determination of K values for the chlorofluoroalkanes.s
All the compounds have vapour pressures close to or 
greater than 1 atm. Sequential additions to the 
sample cuvette, made by removing the stopper, involved 
the risk of loss of vapour and consequent repartitioning 
of substrate between the microsomal suspension and the' 
vapour phase. The use of a ‘Subaseal* septum in place 
of stoppers allowed repeated additions of substrate 
by injection through the septum. However, Figure 6.2
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compares the plots obtained for carbon tetrachloride 
using glass stoppers and 'Subaseal* septa. It is 
apparent that the Kg values obtained with the ‘Subaseal1 
septum method are greater than those obtained by using 
glass-stoppered cuvettes. The explanation for this 
is that the septum, which is made of silicone rubber 
must have absorbed approx. 200 i^g carbon tetrachloride 
before becoming saturated. The actual concentration in 
the cuvette was thus smaller than the calculated 
concentration, giving a smaller absorbance change than 
expected and resulting in the shift of the S/AE versus 
S plot upwards. A similar result was found with 
1,2-dichloro-l,1,2,2-tetrafluoroethane. Even making 
single additions of substrate to fresh microsomal 
suspensions for each substrate concentration was not 
entirely satisfactory. Kg values for the more 
volatile compounds are therefore only to be regarded 
as approximate.
Using microsomal preparations from the rat, the 
following approximate IC^  values were determined in an 
initial series of experiments:
mM
CC13F 3 - 2
C C 1 2F 2 6 -°
CHC12F kO
CC1F2-CC1F2 30
CCl^ 2 . 0
chci3 6 . 6
CH2C12 1-7
Figure 6.2.
Determination of the K for carbon tetrachloride in ---------------------- s-----------------------------
microsomal preparations from the plienobarbital-pr etr eat ed 
mouse, using glass and 'Subaseal1 stoppers.
+ 'Subaseal* 
stopperAE
Glass
stopper
20
-1
substrate
concentration
(mM)
The determination of K was not affected by thes J
protein concentration of the microsomal suspension 
(Figure 6.3) • Spectral constants were thus measured at 
microsomal protein concentrations in the range 1 - 3 mg/ml 
suspension.
The K plots frequently showed a break, thus 
yielding two intercepts on the x and y axes (Figures 
6.2 and 6.4). The break was not reproducible, changing 
position with respect to substrate concentration. In 
cases not showing the break, the derived from the plot 
was generally the higher of the two possible values,
i.e. the lower affinity.
Tables 6.1, 6.2 and 6.3 show the K valuess
determined for various polyhalogenated alkanes with rat 
microsomal preparations, the effect of various pre­
treatments of the animals on K values for trichloro-s
fluoromethane and carbon tetrachloride, and the 
comparison of Kg values in various species.
Pretreatment of rats with phenobarbital and 
3-methylcholanthrene altered the magnitude of the 
difference spectrum produced by 2mM trichlorofluoro­
methane , measured at identical cytochrome V - k ^ O  
concentrations. The spectrum was greatly enhanced 
(1 0 0%) in microsomes from phenobarbital pretreated rats, 
but preparations from 3-niethylcholanth.r ene treated rats 
showed a'reduction ( k 0 % )  in the spectral interaction 
(see Figure 6 .l6 ). The values for trichlorofluoro­
methane in control and phenobarbital pretreated rats
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F i gure 6.4
K_ plots for halogenated methanes with microsomal
preparations from the guinea-pig.
A E
150
CHC1
100
CC1
10
Substrate concentration 
S (mM)
Table 6.1
K_ values in rat microsomal preparations.
mM
CH2C1 2 10.25 + 3-75 (2 )
CHC1 3 2.94 (2 )
CCl^ 1.54 + 0 . 1 8  (2 )
CC-1 F 3-19+0.15 (2)
CH2C1 -CH2C1 no spectrum
CHC1 2 -CH3 11 + 2 (2 )
CHC12 -CH2C1 3-7 (l)
CC1 3-CH3 4.6 (1 )
CHC12-CHC12 2.78 + 0.12 (2)
CC1 -CHC1 1.1^ (l)
3 2
CC1 -CC1 0.75 (1 )
CC1 -CC1 -CC1 „ 0 . 3 8  (2 )J  2 j
CC1 2F-CC1F2 5.1 (1 )
CC1F2 -CC1F2 8 . 1  (1 )
Figures in parentheses show the number of estimations.
Table 6.2
Effect of pretreatment of male rats on the spectral 
constants for trichlorofluoromethane and carbon
tetrachloride.
(the number of animals used is given by the figures in
parenthesis)
Pretreatment Kg (mM)
cci3f CC14
Phenobarbital
Control 2.25 (2 ) 1.15 (3)
Test 1.45 (2 ) 0.4l (3)
Control 1 . 3 8 (3)
Test 0.49 (3)
Control 1 . 8 3 (3)
Test 0 . 6 5 (3)
Trichlorofluoromethanei
Control 2 . 2 0  + 0 . 0 2  (3 ) 1 . 8 7 + 0 . 0 1  (3 )
Test 1.58 (3) 1.40 (3)
Carbon tetrachloride
Control 1.85 + 0.25 (2 ) 1 . 6 6 (3)
Test 2 . 8 0  + 0 . 1 0  (2 ) 1 . 9 0 (3)
Control 1.34 (2 )
Test 1 .44 (3)
Table 6.3
Species differences in spectral constants.
K (mM)s
CC13F c c i 4 chci3
rat 2.7^ +0.49 (1 1) 1.39 + 0 . 0 7  (l8 ) -
mouse
-HoCO 
. 
•o 0 . 8 0  (l) 2.7 (1)
hamster 4.20 + 0 . 1 5  (3) 1 . 2 0 (3 ) -
guinea-pig 2.42 + 0.42 (2 ) 1 . 7 2  + 0.37 (2 ) 3.7 (1)
chicken 3.33 (l) - -
Figures in parentheses indicate the number of estimations.
were only slightly different (3-04 and 2.71 mM
respectively), but in 3-methylcholanthrene pretreated
animals the K was increased (9.65 mM) . s
Effect of isooctane extraction.
Extraction of microsomal preparations with 
isooctane abolished the aerobic difference spectrum 
produced by trichlorofluoromethane, even at high 
concentrations. Some slight spectral change was 
observed but this was independent of the concentration 
of substrate added (Figure 6.5). At very high 
concentrations, a modified type II spectrum was 
observed with carbon tetrachloride. This is shown in 
Figure 6 .6 , compared with the spectrum produced by 
aniline, a type II substrate. The Kg value for aniline 
in microsomal preparations from male rats (2.6 x 10 mM) 
was not altered after isooctane extraction (2 . 5  x 10 ^mM).
Effect of phospholipase digestion.
Digestion of the microsomal preparation with 
phospholipase C also resulted in some loss of type I 
spectral interactions due to chlorofluoroalkanes and 
chlorinated hydrocarbons. • The spectra produced by 4mM 
trichlorofluoromethane with untreated, isooctane 
extracted and phospholipase C digested microsomal 
preparations are shown in Figure 6.17- In. the case of 
phospholipase C, the spectrum was altered, the peak 
increasing and broadening and the trough disappearing.
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Figure 6.6
Interactions of* CCl;^ ("". “) with control and isooctane
extracted microsomal preparations compared to the aniline
(------ ) spectrum.
(Both preparations 2 mg protein/ml)
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Treatment with phospholipase D by the method 
described (6.2) did not affect type I spectral binding. 
Treatment of microsomal preparations with phospholipase 
D at pH 5*6, as. described by Eling and DiAugustine 
(1 9 7 1)» was found to result in approx. 9 5 %  destruction 
of 'cytochrome P-450 (Burke M.D., unpublished observations).
Interference by chlorofluoroalkanes with type II spectra.
Schenkman (1970) showed that the presence of low 
concentrations (2 .5mM) of a type I substrate (hexobarbital) 
enhanced the type II difference spectrum of aniline.
Trichlorofluoromethane, however, interfered with 
the spectrum due to aniline. Figure 6.7 shows the 
effect of addition of 2mM trichlorofluoromethane on the 
spectra produced with 1, 2 and 4mM aniline.
Reduced spectra.
The findings of Reiner and Uehleke (l97l) using carbon 
tetrachloride and rabbit hepatic microsomal suspensions 
were confirmed using microsomal, suspensions from the 
untreated rat. Figure 6 . 8  shows the spectrum produced 
by carbon tetrachloride and Na^S^O^ compared to the 
aerobic difference spectrum. It was noted
that the spectrum altered with time and this is also 
shown in Figure 6 . 8  superimposed on the cytochrome 
P-450-C0 spectrum. Upon reduction of the microsomal 
suspension with Na^^O^ the type I difference spectrum 
was abolished and (a) was recorded after 15 seconds.
Figure 6.7
The interference between trichlorofluoromethane and
aniline difference spectra in microsomal preparations
from the rat.
Baseline is the 
heavier line. .
2mM CC10F
t I j nm
350 430 510
aniline aniline + 2 mM CCl^F
2 mM
k  mM
Figure 6.8
Formation of the carbon tetrachloride reduced spectrum 
with microsomal preparations from the rat.
E = 0.05
baseline
oxidised spectrum 
reduced spectrum
(a) (b) (c) (d)
E =
cytochrome P-450 CCl^ reduced spectrum
This showed a peak at about 420 nm. The peak at 420 nm 
decreased over the next 5 minutes and a peak at 4^4 nm 
appeared (b-d).
Trichlorofluoromethane was found to interact in a 
very similar fashion, giving peaks at 422 nm and 452 nm. 
The magnitude of the spectrum was greater than that 
caused by carbon tetrachloride. Figure 6.9 shows 
reduced spectra of trichlorofluoromethane and carbon 
tetrachloride compared to the cytochrome P-450-C0 
spectrum. The formation of the reduced spectrum of 
trichlorofluoromethane in rat microsomal suspensions was 
also time dependent. With trichlorofluoromethane and 
carbon tetrachloride (final concentration 2mM) the time 
required to achieve maximal spectral interaction was 
found to be 17-18 min and 5-5-6 min respectively (Figure 
6.10). No difference was found in the rate of formation 
of these spectra due to the prder of addition of the 
substrate and the Na^S^O^ to the microsomal suspension. 
Incubation of trichlorofluoromethane with the microsomal 
preparation for 20 min prior to the addition of Na^S^O^ 
made no significant difference in.the rate of spectral 
interaction. The spectrum due to carbon tetrachloride, 
however, reached a maximum within about 3 min.
Three halogenated compounds were found to give 
reduced spectra with peaks at about 450 nm:
c c i3f
ccik
CC1 F-CC1F
A t-i
452 nm 
454 nm 
452 nm
F i gure 6.9
Reduced spectra due to trichlorofluoromethane and
carbon tetrachloride compared to the cytochrome P-450-C0
spectrum.
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These are shown in Figure 6.11 together with the spectrum 
produced by pentachloroethane (peak at approx. 420 nm). 
This latter spectrum was typical of the spectra produced 
by the other chlorofluoroalkanes and chlorinated 
hydrocarbons tested. Table 6.4 gives the maxima of the 
reduced spectra obtained with these compounds and micro­
somal preparations from the male rat. Similar results 
were found with microsomal preparations from rat, mouse, 
hamster, guinea-pig and chicken.
Halothane (2-bromo-2-chloro-l,1,1-trifluoroethane) 
also yielded a reduced spectrum in chemically reduced 
microsomal preparations. The peak was smaller than 
that produced by carbon tetrachloride, with its 
maximum at 471 nm, and was formed within 10 minutes 
(Figure 6.12).
The rate of formation of these reduced spectra was
further investigated with a range of concentrations of
trichlorofluoromethane (Figure 6.13)• It was found that
the initial rate of formation was dependent on the
concentration of added substrate. The curves obtained
were reproducible (Figure 6.l4). A plot of the
reciprocal of the initial rate of formation against
reciprocal substrate concentration yielded a Lineweaver-
Burk type plot (Figure 6.13)- The reciprocal of the
intercept on the substrate (x) axis gave a value of 1 . 3 3
mM for the "spectral K ".
m
In vivo pretreatment of the rats and in vitro 
treatment of the microsomal preparations affected the

Table 6.4
Maxima of spectral interactions in Na^S^O^-reduced 
microsomal suspensions of the male rat.
Compound Final concentration Wavelength of
(mM ) spectral maxima (nm)
c c i3f 0.5 422 and 452
CC1 2 F 2 3-5 -
CHC1 F 2 . -
CC14 1 4l8 and 454
CHC1 10 420 small
1 
O 
i 
W to o H to 10 420 v. small
CH2C1-CH2C1 20 422 v. small
CHC12 -CH3 20 -
cci3-ch3 10 422
CHC12-CH2C1 10 420
CHC12-CHC12 10 420
CC1 -CHC10
J  2 2.5
4l8-420 small
CC13-CC13 3 420 small
CC12F-CC1F2 5 approx. 420 and 452
CC1F2-CC1F2 1 -
CF^CHBrCl 5 approx. 426 and 471
Figure 6.12
The reduced spectrum of halothane in rat microsomal
preparations.
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Figure 6 .15
trichlorofluoromethane reduced spectra only to a small 
extent.
The small peak at about 420 nm was abolished in 
preparations from phenobarbital pretreated animals, but 
the rate of formation of the 4.52 nm peak and the maximal 
absorbance change were not altered. 3-Methylcholanthrene
pretreatment of the animals resulted in the formation 
of smaller reduced spectra (Figure 6 .l6 ) at a slower 
rate (0.0085 units E/min compared to O.O182 units E/min 
in phenobarbital treated and control animals at a final 
substrate concentration of 2mM with 2.5 nmoles cytochrome 
P-450/ml).
Isooctane extraction and phospholipase C digestion 
of microsomal preparations did not abolish the reduced 
spectra. Both treatments caused increases in the 
magnitude of the 422 nm peak, although only isooctane 
extraction increased the magnitude of the 452 nm peak 
of the trichlorofluoromethane spectrum (Figure 6.17)*
The rate of formation of the reduced spectrum was 
only affected byjphospholipase! C. digestion of the
microsomal preparation (Figure 6 .l8 ) , which approximately 
halved the initial rate. Phospholipase D treatment 
failed to have any effect.
Aniline interfered with the reduced spectral 
interactions to a small extent:
F i gure 6 . 16
Effects of pretreatment of rats on the oxidised and 
reduced spectra of trichlorofluoromethane
Oxidised
spectrum
Control
P-450
nmol/ml
Phenobarbital 
pretreated
P-450 
1 .7 nmol/ml
Reduced
3-Methyl- 
cholanthrene 
pretreated
P-450 
1.7 nmol/ml
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Control 0.0184 0.111
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+ 2mM aniline O.Ol49 0.095
+ 4mM aniline 0.0108 0.094
Effect on measurement of cytochromes b _^ and P-450«
Neither trichlorofluoromethane nor carbon tetra­
chloride had any effect on the measurement of cytochrome 
. Both compounds, however, reduced the magnitude of 
the cytochrome P-450 spectrum, e.g. by 20% at a final 
concentration of 2mM. At a final concentration of lOmM, 
.carbon tetrachloride caused a 40% reduction in the 
cytochrome P-450 spectrum. Even bubbling the microsomal 
suspension for several minutes with CO did not restore 
the cytochrome P-450 spectrum to the amplitude of control 
measurements.
Destruction of cytochrome P-450 by incubation at 37°C.
Microsomal suspensions were stored at 0°C for at 
least 30 minutes without destruction of the cytochrome 
P-450. Incubation at 37°C, either static or shaken 
(lOO cycles/min), caused destruction of cytochrome P-450. 
Without NADPH, 10-15% was destroyed in 30 minutes, 
whereas inclusion of an NADPH generating system in the 
incubation increased the loss of cytochrome P-450 to
40-50%, cts shown below:
Generating Cytochrome %,
system P-450 remaining
(nmol/ml)
Zero time - 2.26 (2)
30 min in ice - 2 . 2 0  (2 ) 98
30 min in ice + 2 . 3 1  (2 ) 102
30 min at 3 7 °C static 1 .90 (3 ) 84
30 min at 3 7°C static + 1 . 1 5  (2 ) 51
30 min at 3 7 °C shaken - 2 . 0 0  (3 ) 89
30 min at 3 7°C shaken + I . 3 8 (2 ) 6 l
(figures in parentheses show number of incubations)-
The reported conversion of cytochrome P-450 to P-420 
by incubation with carbon tetrachloride (Heni, 1971) 
could not be repeated. Both carbon tetrachloride and 
trichlorofluoromethane caused approx. 10% conversion of 
cytochrome P-450 to a spectrally unobservable product.
The presence of a substrate (zoxazolamine) 
protected the cytochrome P-450 during a 30 min incubation, 
but did not affect the interference by trichlorofluoro­
methane or carbon tetrachloride:
cytochrome P-450 
AE (450 - 500nm)
expressed as %  of 
zero time value.
Blank (no substrate)
+ substrate (zoxazolamine)
+ substrate + 10 j f L CCl^
+ substrate + 10 j x 1 CCl^F 
+ substrate + 10 j x l  C^Cl^F^
100%
79%
5 2%
2 k %
7 9 %
It can be seen that 1 ,1 ,2-trichloro-1 ,2,2 -trifluoroethane 
prevented the protection of cytochrome P-450 by substrate, 
but did not further decrease the concentration of the 
cytochrome.
Effects on hexobarbital sleeping times and zoxazolamine 
paralysis times.
\
Tables 6 . 5  and 6 . 6  show the effects of chloro- 
fluoroalkanes on the. hexobarbital sleeping time of 
female rats. Trichlorofluoromethane (lg/kg) significantly 
increased the sleeping time in two experiments.
Diehlorofluoromethane (lg/kg) showed no significant 
effect, whereas 1 ,1 ,2-trichloro-1 ,2 ,2-trifluoroethane 
(lml/kg) decreased the sleeping time significantly.
Zoxazolamine paralysis times were not affected by 
trichlorofluoromethane (lg/kg)(Table 6 . 7 ) •
In vitro enzyme assays.
The in vitro metabolism of the four type I binding 
substrates (biphenyl, ethylmorphine, hexobarbital and 
nitroanisole) was not affected to any significant extent
LT\
VO
<D
H
42
d
H
d
+>
•rl
42
U
d
42 O
X0
43
0
43
-P
PiO
ft
43faO
•rl
0
£
in
T3O
42
b O
X\bO
in
O
*3
s
d
bO
43 
\
bO
0
ft
d
43
-P
0
B.
o
u
o
3
rH
ft
O
u
o
rH
43
o
•H
Pift
ft
O
ft
o
0
ftft0
0
43
H:
to
ft
(3
Pi
o
S3
•rl
42
H
d
Pi
dft
to
•H
ts
0
iH
d
B
0
ft
ftO
0
£•H
ft
bO
Pi
•rl
ft0
0
rH
to
rs
0 rH in
u 0 rH rH
d U • CM o H
f t ft f t O i o d
£ P3 i • • • U
0 0 JZi o o 0
o o
v_^ n
0 0
ft f t to
o •
to
0
cn 0 K/—\ CM • CO IN. 0
bO s3 • CM • • • d ‘ H
S3 •H cn ft n- cn CM 43 • f t
•rl £ f t  • 0 0
ft + 1 + 1 + i + 1 + 1 0 ft Pi
0 £ d
0 0 ft n - in o O 0 0 bO
H £ • • • • • u H Pi
t/3 •rl n- VO ON cn in 0 0 •H
ft VO in CO CM cn 2 ft
rH rH 43
ft in bO
TD X—s 0 43 •H •
0 rH P ft u to
Sh 0 0 0 0
d u rH ft X
ft ft • ft ft 43 TJ 0 0
£ Pi . ft o o o 0- rH
0 0 1 • o I o •H > to ft
o o £ • Pi . •H ■ to 0
o o ft 0 0 u
0 O rH
ft ft 0 bO
Pi T5 Pi• Pi •H
ft to d ft
✓-\ in • H 43
Pi 53 CM rH in CM •H 0 rH bO
0 •H • • •' • • d •H
•rl £ O O o o o ft ft Pi
ft 0 Pi •H
O + 1 + 1 + 1 + i + 1 f t 0 42 ft
3 0 O o Pi O
TJ £ ON VO VO ON o 0 d
P3 •H t • t • •n> 42 53
H ft CM CM rH in Pi 0 •H
•H • X d
rH 0 bO
/—s d 43 0
ft ft Pi
43 •H ft
bO 42 0 TJ
/—s n- cn •H U S3
bO • • 0 d Pi d
ON VO -a* VO CM % 42 O
• • • • 0 •H to
+> cn CM rH + 1 + 1 in X ft to>(«■* T3 0 O o
+ i + 1 + i m O . o 43 0 rH
in • • 42 •rj
X3 in cn ft cn ON 0 Pi Pi
0 VO in. n- cn CM bO ft •H 0
ft ft ft X 0
\ Pi S3 £
bO o 0 4J
£ •H 0 0
Pi £ 42
ft to O ft ft
O rH O 0 rH
d VO ON VO is. O ft 53 42 d• S ft >—' •H >
0 •H £ 0 U
£ Pi rH £ 0
d d O •H ft
ft ft ft Pi
•H •H
42 0 • •
bO bO bO Pi ft 0 • •
43 X X d d £ 0
\ \ \ 42 0 •H E
ft fa fa fa 0 H ft •H
a cn cn cn X 0 ft
0 rH rH rH 0 S3
£ O O o 43 H 0 bO
ft H o o rH o •H Pi
d 0 0 £ 43 ft •H
0 U bO bO u bO '3 f t O ft
Pi ft f t •H 0 3 0ft Pi in O P3 O T3 TJ 0
0 • * 0 • 0 53 Pi rH
o o rH o rH 1/3 •H H C/3
1
•
CO
0 -p
u cd
0 Pi
pi
rH 0
ft Pi
•H •H
Pi 42
ft H
1 cd
OJ
Pi
CM cd
r- ft
rH CO
1 •H
0 £
u0 0
H H
43 CCS
O £
■H 0
u ft
ft
1 ft
CM 0
rH 0
■ £
rH •rl
X
Pi
-P
to
<d P3
f— V •Hft
-p 0
A 0
to ip
VD -H CO
• CD
VD £ H
<D
Cd
-p
H X •rl
& 0 42
cd 42 Pi
Eh Ctf
to 42
A 0
\ X
to 0
tH
43
0
CD
43
ft
Pi
<d Pi
43 0
-P
CD f—s
s -p
0 43
u to
0 •rl
Pi 0
i—I >
ft
0
Pi *0
0 0
H 42
43
o to
•rl M
TJ \
ft
H
£
0
-P
rH 
v_<
O
CD 0
ft Pi
ft cd
CD 43
0
-p
0
43
H
X
0 H
Pi 0
Pi • ft
ft -P to o
£ Pi I • o rH
0 0 £ • cd
o O o ft •
•H CO
0 rO 0
ft ft U K
cd 0
rQ rH-•— s 0 ft
Pi n- V D K 0.
to •rl • • • 0 Pi
P3 £ CM w CM 41
•rl v_ ' to
ft +  1 +  i +  1 ft Pi
0 0 0 •H
0 £ CM cn CO ft
H •H • • • P3 41
C/2 ft V D r- CO 0 to
cn cn CM •rl •H
ft Pi
o
0 ft
■r~5 0 •
'd Pi CO
0 H •rH CO 0
Pi 0 CO K
ccS Pi O • 0 0 0
ft ft ft to Pi H rH
' £ Pi 1 • • • 0 ft
0 0 o •23 • ft t TS 0o o • 0 0 Pi PiN-/ 42 ft cd
o cd to
ft ft Pi 0 rH PI­
•H rH cd TH
£ 0 ft ft✓-N •rl 43
P3 Pi rH V D m o rH 4! to
0 •rl • • • c n Pi •rl
•H £ ft O o 43 cd Pi
-P v_ ' 0 ft 42
0 +  1 + 1 +  i ft <12 O ft
pi 0 cd K 0
X £ Cn Os o 0 •d 0
Pi •rl • • t rH 0 43 Pi
H ft I'- i n r- O > •rl
•rl ft cd
H 0 0 to
O 0
41 0 P3 Pi
■ ft Ph 0
0 •rl X
-P CO ft P3
43 cn co cn Pi rH O cd
to • • • •rl 0 0
•rl . in n- CM Pi *r-3 CO
0 ft Pi CO£ rs + i + i + 1 H Pi •rl 0
to .rH 0 rH—' o r- ft Cd o Pi
X • • • Pi 0 P3
0 CO f t O 0 0 0
PQ cn £ 0ft ft f t X • ft £
0 ft 0 ft
tfi o 0fiu
0 •rl 42
X rH
m /— s cC H
ft rH U1 ft > cd
0 cd cd 43 u >
£ ft r- O N £ to 0 U• *H ft •rl ft 0
0 p3 0 0 Pi ft
a cd Pi £ •rl P3
cd •rl
X >> • •
H X 0 • •
cd 0 £ 0
0 42 •rl £
CM Pi ft •Hft 0 to ft
-p H pi A Pi
Pi O H \ 0 to
0 H O ft to •H Pi
£ 0 ft 1 0 £ ft •rl
-p Pi CM ft Pi O Pi
cd ft H CM 0 o Pi 0
0 Pi O H rH o X 0
Pi 0 HI O 43 rH Pi rH
Eh o o O O >_/ H to
0
a
•rl
-P
0
•rl
0
|A
H
0
d
0
.ft
0
d
•rl
£
0
HOSI
0
«o
SI
0
A
-p
do
+>
dbQ
•HI'- 0
£
VD
0  73
H 0
,Q ,Q
• £-1 b€
d 
\
bO
0
d0
d
-P
0
ao
uo
dH
ft
0
do
H
do
•rl
d
•P
ft0
■Po
0
ft
ft
0
0
A
ft
73 r \
0 H
d 0
0 d'
f t ■P m
£ d • t rH
0 0 m in 0
0 o i « 1 • d
V -/ 53 53 •P
0 d
ft -p 0o
•
0 •
d 0
•H 0
/*—s rH CO £ K
0 d • • 0 0
•rl •rl VD co rH pH
0 £ CO 03 0 • ft
>■> + 1 + 1 rH rH SI ft 0
H 0 • u
0 0 rH CO + 1 + 1 K •rl
d £ • « o ft
0 •H 03 o VD LA SI 73 0
ft •P VD a- VD • 0
rH LA 0 •P 0
VO -p O m
rH 0 o
u rH0 d
•rl •rH 73 ■
u d •ft /—\ 0 0
-p 0
d d 0 X
•rl bO d 0
d d rH rH rH rH £ •rl •rl rH
0 •rl • • • • 0 £ ft
•rl £ o o o o O £ 0 0
-P rH rH d
O + 1 + 1 +  1 + 1 !A 0
d 0 0 73 SI f t
73 £ A - VD CO CO -P 0 0 0
d •rl • • • • 0 A
H •P rH rH 03 03 0 0 d
rH bO SI •H
0 A 0\ f t bO
rH bO o 0
£ d
d
-p o 0 73
0 A - •rl d
-P 0
d O
• 03 03 a - VD •rl 0 0 to­
+> • • • • d *T> co
£ 03 rH CO LA {A •H d 0
/—\ rH £ •rl rH
5a bO + 1 +  i + i + 1 H 0
73 w 0 rH d d
0 - f t o to -A - d 0 0 0
PQ VD 0 - CO 03 o SI 0 0
rH rH 0 £ £
Ti K -p -p
0 0 0 0
0 N A A
o
73 rH rH
0 0
0 0 • 5> >
f t H d 0 u d
0 cd 0 ■P 0 0
£ d 0 •p •P
• •rl Os a - LA LA -p 0 d d
0 d 0 rH •rl •rl
53 cd £ 0
o • • • •
d H 0 0
0 5a £ £3 £ •H •rl
H •p -P -P
ft 0
-P 0 d 0
d u 73 0 •rl
0 rH H 0 0 •rl 0
. £ 0 0 rH 5> -P rO
•P d ft d f t rd •rH O r—1
0 -P CO •P co O 0 d 0
0 d H d H •H 0 73 d
d 0 O 0 O d 0 d 0ft o O o O ft u H ft
by the addition of trichlorofluoromethane (1 0 j x l ) to 
the incubation medium (Table 6 .8 ). Addition of carbon 
tetrachloride inhibited metabolism, except in the case 
of hexobarbital. However, the assay for measuring the 
disappearance of hexobarbital from the incubation 
medium was found to be rather poor and no significance 
can thus be read into the results.
The metabolism of the four type II binding substrate 
(acetanilide, aniline, thiabendazole and zoxazolamine) 
was significantly inhibited by carbon tetrachloride. 
Trichlorofluoromethane and 1,1,2-trichloro-1,2,2- 
trifluoroethane also inhibited the hydroxylation of 
zoxazolamine to a significant extent (Table 6.12). 
Thiabendazole 5-hydroxylation was not affected by either 
of these compounds (Table 6.11). Aniline and acetanilid 
4-hydroxylations were however increased by the addition 
of trichlorofluoromethane to the incubation media (Tables 
6.9 and 6.10). This did not appear to be a solvent 
effect as chloroform and 1 ,1 ,1-trichloroethane had no 
effect on aniline 4-hydroxylation (Table 6.10).
6.4. Summary. ,
The chlorofluoroalkanes were found to interact
with microsomal preparations, yielding type I binding
spectra, and spectral constants (Kg) "the order of 
- 2  -35 x 10 . to 10 M. Modification of the microsomal 
phospholipid by extraction or enzyme digestion 
abolished these aerobic difference spectra.
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Table 6.10
Aniline 4— hydroxylation in the male rat.
Control levels are expressed as nmol 4— aminophenol 
formed/mg protein/min. Other levels are given as a 
percentage of the control levels.
Control 0.432 0 . 6 0 2 0 . 4 2 6 0 . 6 0 8
+ 240 nl CCl^ 72 81 80 -
+ 10 j x l  CCl^ - - - 85
+ 1 yjO. CC13F - 155, - -
+ 2 j j J l CCl^F - 104 - -
+ 5 yxl CC13F 111 154 -
+ 10 j j J l CC13F 164 132 - 116
+ 50 ytxl CC13F - 204 - -
+ 10 yul CC12F-CC1F2 - - 126 107
+ io j x i  chci3 - - 100 -
+ 10 yjO. CC1 3 -CH3 - - 104 -
+ 10 ^ a1 cci^-chci2 - - 119 -
Th
ia
be
nd
az
ol
e 
5
-
h
y
d
r
o
x
y
l
a
t
i
o
n
.
too
to
d
0
d
0
*
bO
IA 
•
CA 
+ 1 
ON 
rH
to
-p
cd
d
o
d
•rl
rOrH
cd
d
cd
P
to
•H
£
0
H
cd
s
/—s
iHnO 0
0 d p P
d P o • O •cd d 1 o to o to
PM ft 0 • • * •
B o o d o do
o 0>_■< p
iH0 0
<H d d0 P H 1 CM VD A- CA
d cd VD ON LA ON0 >o
•
d•H
0 £
K rH ’
O O d P VD a- O VD1 SI 0 • • • • •
LA cd > (M CM CM CA CMno •Hto d iH + 1 + 1 + 1 + ! + 1
0 0
rH & to CO ON ON ON LA0 cd \ • • • •
s •H *0 o o CO CO A-
d ,3 0 LA CA CMP £
d0
<H
0
<H H0 cd
S VO VD VD VD VD• •H
0 d
d cd
-
t—\
O
P
\X
rH
o
p
H O
C ft Po CA
O P rH
P O CA
O ftH ft\ CA0 cF CA H
d H H H O
P O O o CM
d O O o O0
o + + + +
TO
Pi
Cd
0
•a
•H
do
H
rdo
Cd
dp
0
p
do
rQ
d
cdo
<H
. o
tO
- po
0
0
0
£
- p
d
0
0
£
- p
0
,Q
0
o
d
0
d
0
<H
•rl
TS
P
d
cdo
•rl
•rl
dbO
•rl
•tQ
O
d
to
cd
&
0
d0
£
SH
p
•rl
>
•rl
PO
cd
0
rd
P
do
0
d
dp
K
•H
g
0
•rl
do
H
£o
cd
dp
0
P
do
&
d
cdo
\
0
d
cd
£p
0
£o
dO
d
rH
<H
O
do
H
£o
•H
d
P
0
rd
P
•H
+>
•H
> to
•H +>
-P cO
O d
cO
0
CD d
to •rl
CM <0 &
rH rH H
• cO
VO X
0 d
CD u cO
H d -P
rQ to
cO •rl
CD
£
d CD
•rl rH
£ cOcO B
rH
0 CA
tQ
CO d
K •rl
0 >w/
S3
P 
(c
om
pa
re
d 
to
 
co
nt
ro
l)
1
0
.0
0
2
0
.0
2
0
.0
1
•
iS• LA CA CO CA
• * • •
• • O o o rH
d i n
•rl + 1 +  1 + 1 +  1
B + i\ o CO CA ON
d d t • • •CD 0 o VO A-
t> 0 rH
•rl s
rH
bO
Xd •0
£
d 'to IA LA
d o • t • •0 .o VD IN- CAo rH
o
d•rH
sCO
rH
0tQ
cO •H VO LA
X CQ • • . •0 ON S- CO [N-tQ
rH
0
B
d
CM CO A-
< • • « •O VO LA CA
rH
d0 /—\
•H d■P 0
cO •rl
,Q -Pd •rlo d CA
d d Cd
•rl cO fo CA
CA rH
0 0 rH o rH
-P d o O] O
v-/ o O o
d0 rH rH H H
•rl
-P
0
d
•rl ■P o o Od d rH rH rHd 0C o + + +
clo
•H
-P
co
*§0 
d
•rl
\
H
OK1
CD
d•Hs
cO
rH
O
S3
cO
XotQ
d d . d
0 0 O H
•H •H •H o
-P -P ■P s
(0 cO cO d
rQ rQ &
d d d o
o o o LA
d d d • H
•H •H •H |
d d d
1
•H •rl •H 0
e s s -P
cO
o o O d
-=f CF -VO -p
to
i 1 1 rQ
d
< CQ o to
Trichlorofluoromethane, 1,1,2-trichloro-1,2,2-
trifluoroethane and carbon tetrachloride formed spectra
similar to the cytochrome P-A^O-CO spectrum in Na^S^O^-
reduced microsomal preparations. This spectral change
was time dependent and was not abolished by extraction
or digestion of the microsomal phospholipid. A
'spectral K 1 was derived for trichlorofluoromethane, m
and was found to be approximately 1 .3 3 mM, compared to
the spectral constant (K ) of 2.7^ mM.s .
Both types of spectral interaction were shown to 
occur in microsomal suspensions obtained from the rat, 
mouse, hamster, guinea-pig and chicken.
Hexobarbital sleeping times were increased by an 
oral dose of lg trichlorofluoromethane/kg body weight 
10 min before the hexobarbital injection.
Type I substrate metabolism was not inhibited by 
trichlorofluoromethane. Metabolism of type II substrate 
was increased (aniline and aeetanilide hydroxylations) , 
unaffected (thiabendazole hydroxylation) or inhibited 
(zoxazolamine hydroxylation) by addition of trichloro- 
fluoromethane in vitro.
CHAPTER 7 
DISCUSSION.
Distribution.
The aerosol propellant chlorofluoroalkanes have 
been reported to be of* very low toxicity (see 1.4) after 
both acute and chronic exposure. However, little work 
has been published on the absorption, distribution or 
excretion of these compounds. Dollery et al. (1970)
showed absorption of chlorofluoroalkanes after inhalation 
of aerosol propellants by humans, but made the false 
assumption that, because the g.I.e. peak for 1 ,2 -dichloro-
1 .1 .2 .2-tetrafluoroethane was only 10% of the height of 
the g.l.c. peak of trichlorofluoromethane, little
1 .2 -dichloro-1 ,1 ,2 ,2 -tetrafluoroethane was absorbed. 
However, as shown in Chapter 2 (2.6), detection of 
trichlorofluoromethane by electron-capture techniques is 
about 100 times more sensitive than the detection of
1 .2-dichloro-1 ,1 ,2,2-tetrafluoroethane. This would 
suggest that, in the studies of Dollery e t  al. , 
approximately 10 times more 1 ,2-dichloro-l,1 ,2 ,2-tetra- 
fluoroethane was absorbed than trichlorofluoromethane.
This would bring the blood level of the former compound 
considerably closer to the concentrations of chloro- 
fluoroalkane which were found by Jack (1971) to cause 
cardiac sensitisation to adrenaline.
The distribution studies in Chapter 3 were 
conducted after oral dosing of rats with chlorofluoro- 
alkane dissolved in ethyl oleate. The results cannot 
therefore be used to predict tissue levels after 
inhalation of chlorofluoroalkanes. However, the
results can give an indication of the levels that might 
be expected, as well as showing tissues with particular 
affinity for chlorofluoroalkanes.
1 ,2-Dichloro-1,1,2,2-tetrafluoroethane (560 mg/kg 
body weight) was absorbed slowly from the gastro­
intestinal tract, the maximum blood level being reached 
60 minutes after dosing (Table 3*2). The liver 
concentration closely paralleled the blood level, and 
the liver to blood ratio remained fairly constant (about 
70) between 20 minutes and 3 hours after dosing. This 
suggests that the concentration found in the liver is 
the result of a passive partitioning process of the 
chlorofluoroalkane between lipids or binding proteins 
of liver and blood. The high lipid solubility of the 
chlorofluoroalkanes and the very high ratio of 
•concentrations in adipose tissue to blood achieved 4 
hours after dosing suggest that the areas of high 
affinity for these compounds are lipid in nature. The 
concentration of 1 ,2-dichloro-l,1 ,2 ,2-tetrafluoroethane 
in lung tissue reached a maximum at 30 minutes, although 
there was no significant difference (P>0.10) between 
the concentrations at 30 minutes and at 60 minutes.
These observations indicated that pulmonary excretion 
achieved its maximum rate at about 30 minutes and that 
lung uptake and excretion occurred at the same rate at 
approximately 60 minutes after dosing. 1 ,2-dichloro-
1 ,1 ,2 ,2-tetrafluoroethane was shown to cross the blood- 
brain barrier, but the concentrations in both brain
and cardiac muscle were low (approx. 2 . 5  fAg/g* 
representing about 0.002% of the dose). The occurrence 
of a maximum in the level of 1 ,2-dichloro-1 ,1 ,2 ,2 - 
tetrafluoroethane in the adipose tissue only after 4 
hours was probably a reflection of the poor vascularity 
of the tissue as well as the repartitioning of compound 
from other tissues. Although highly lipid soluble, 
the compound was rapidly cleared from the tissues and 
only traces (2 . 5  /xg/g) were found in adipose tissue after 
19 hours. The half-life■in blood was approximately 
50 minutes.
In distribution studies with trichlorofluoromethane 
( 5 0 mg/kg body weight), the scatter of values at 
particular time points was reduced a little by starving 
the rats for 18 hours prior to the experiment. This 
suggested that absorption of trichlorofluoromethane, and 
possibly the other chlorofluoroalkanes, by the gastric 
route was dependent on the amount of material present in 
the gastro-intestinal tract. In male rats, the liver 
showed a maximum concentration of trichlorofluoromethane 
within 5 minutes, which was maintained for at least a 
further 25 minutes. The blood level was still rising 
at 15 minutes, after which time, unfortunately, no 
further estimations were made. In female rats, however, 
the blood and liver concentration curves each showed two 
similar peaks, at 7 minutes and at about 45 - 60 minutes. 
There are several possible explanations for this double 
peak. Firstly, some vapour might have escaped from the 
stomach during oral dosing to be absorbed through the
buccal and bronchial mucosae. However, after dosing a 
rat with a solution of chlorofluoroalkane in ethyl oleat 
the stomach was considerably distended by the volatilise 
compound for a period of up to 20 - 30 minutes, 
suggesting that the oesophageal opening was closed. 
Secondly, accidental introduction of some material into 
the pulmonary tract could account for rapid absorption, 
but as this double peak was consistently observed, and 
apparently only in females, accidental dosage into the 
lungs can be discounted. Thirdly, enterohepatic 
recirculation, resulting from biliary excretion of the 
compound, could give blood level curves with two 
maxima, as in the case of carbenoxolone (Downer et al., 
1 9 7 0)? but biliary excretion of trichlorofluoromethane 
was considered to be most unlikely. It is thus 
difficult to find a reasonable explanation for this 
phenomenon without assuming that the gastric absorption 
of trichlorofluoromethane is biphasic.
Measurement of the concentration of trichloro- 
fluoromethane in consecutive samples of blood from each 
of six female rats gave six curves, five of which 
showed a double peak. The first peak was somewhat 
later than previously observed, but the second peak 
again occurred at about 45 - 60 minutes. A plot of 
the mean values of these curves yielded a much flatter 
plot (Figure 3*9)• From this curve, the blood half- 
life was estimated to be about 60 minutes, which was 
considerably longer than that reported in human studies 
(0.3 - 1.5 minutes) by Paterson _et al. (l97l)«
The difference between male and female rats in 
adipose tissue levels of trichlorofluoromethane was 
probably due to differences in vascularity. The 
epididymal fat pad of the male rat receives a better 
blood supply than the supra-renal fat in the female.
Excretion.
Excretion of trichlorofluoromethane occurred 
primarily through the lungs. In three experiments,
92 + of the dose was exhaled unchanged within 6 hours. 
This was very much more rapid than the pulmonary 
excretion of unchanged carbon tetrachloride, which Paul 
and Rubinstein (1 9 6 3) reported took 18 hours for 80% 
excretion.
At six hours the total trichlorofluoromethane 
retained in the tissues amounted to much less than 
1% of the dose, thus leaving approximately 4-7% 
unaccounted for. A small percentage of this may have 
been present in the tissues not examined, e.g. muscle. 
Excretion in the bile or urine would most probably 
require some metabolism to occur in order to make the 
compounds water soluble. As reviewed in Chapter 1 (l.7)» 
some halogenated compounds are metabolised and are 
excreted as glutathione conjugates or as mercapturic 
acids. However, it was considered that the detection 
of sulphydryl compounds or increased halide ion 
excretion in the urine at the concentration expected, 
i.e. 5% dose or less, would not be possible using
standard chemical techniques or methods such as ion- 
specific electrode coulometry. In order to detect 
metabolism in vivo, radioactively-labelled chlorofluoro­
alkanes of high activity would be required. As these 
were not available, the in vivo metabolism was not 
studied.
Metabolism.
Attempts at detecting in vitro metabolism of tri­
chlorof luoromethane gave negative results. No attempt 
was made to detect metabolism of the other chlorofluoro­
alkanes because of their greater volatility and their 
greater content of fluorine atoms. Dichlorofluoromethane,
which is analogous to chloroform, was not studied 
because of the difficulties in trapping the highly 
volatile possible metabolites and in obtaining adequate 
separation in the g.l.c. assay. With trichlorofluoro­
methane , the most probable metabolite was considered to 
be the reductive dechlorination product, dichlorofluoro­
methane . This latter was detectable when 1-10 j x X of 
a mixture of trichlorofluoromethane (9 9 -8%) and dichloro- 
fluoromethane (0 .2%) was added to a liver microsomal 
system (3 ml) in vitro. However, following incubations 
of trichlorofluoromethane with liver microsomes, no 
dichlorofluoromethane could be detected. This result 
was obtained with all the species tested, including 
phenobarbital-induced mice, which show one of the 
highest rates of general metabolism. Thus the extent
to which any in vitro metabolism of trichlorofluoromethane 
occurred was certainly less than 0 .2%, and possibly less 
than 0 .0 5%.
Results of attempts to detect free-radical formation 
from trichlorofluoromethane by measurement of its 
effects on lipid peroxidation were equivocal. In one 
experiment increases in peroxidation were noted, in 
other experiments the principal effect was depression 
of endogenous peroxidation in vitro. Carbon tetra­
chloride, however, reliably enhanced lipid peroxidation 
by its addition (l j x l / m l )  to microsomal incubations.
Slater (197la) was able to show only slight stimulation 
of in vitro lipid peroxidation by trichlorofluoromethane.
The measurement of stimulation or depression of 
microsomal peroxidation was not easy as the degree of 
stimulation depended on the level of endogenous 
peroxidation. Duplicate analysis of at least three 
incubations was necessary to obtain any sort of reliable 
quantitative determination. Even so, the differences 
from the level of endogenous peroxidation were often too 
small to permit significance to be found. However, the 
changes found in most experiments with trichlorofluoro­
methane were decreases in peroxidation, suggesting an 
anti-oxidant capacity. The mechanism is not likely to 
be a solvent effect, as this would be expected to cause 
increased peroxidation by exposing the microsomal 
phospholipids to metal ions and oxygen to an increasing 
extent. At the higher levels of addition of trichloro-
fTuoromethane to incubations (20 j x L / m L  upwards) it is 
possible that the vaporised compound may have decreased 
the availability of oxygen to the microsomal suspensions 
by decreasing the partial pressure of oxygen. However, 
this would probably have played only a minor role. Thus,
from these results, it must be concluded that there is 
no evidence for the formation of a free radical 
analogous to that postulated to be formed from carbon 
tetrachloride. Therefore, if metabolism of trichloro- 
fluoromethane takes place it probably occurs by a 
different mechanism.
Indication that metabolism of the chlorofluoroalkanes
might occur, but at a level below the sensitivity of the
methods discussed, was given by the fact that these
compounds bound to cytochrome P~4f>0 (observed by the
spectral interaction) in a manner identical to the
chlorinated hydrocarbons, which are known to be
metabolically degraded. The affinities for cytochrome
P-450 of the less volatile chlorofluoroalkanes are
comparable with the affinities measured for the chlorinated
hydrocarbons. If there is any basis for the correlation
between the spectral constant (K ) and the Michaelis r  s
constant (K ), metabolism of trichlorofluoromethane m
might be expected to occur at a rate only a little less 
than the rate of degradation of carbon tetrachloride.
Detection of in vitro metabolism of trichlorofluoro­
methane would be made considerably easier if it were 
possible to separate metabolite and parent compound
before g.l.c. analysis. In addition, the use of 
P 6Cl] chlorofluoroalkanes in techniques similar to that 
described for studies of the metabolism of chlorinated 
ethanes and propanes (Van Dyke and Wineman, 1971) would 
permit detection of any dechlorination reaction that may
occur with these chlorofluoroalkanes. Chlorofluoro-
l4 l4alkanes labelled with C would allow detection of C0o
formed by oxidative degradation, as separation of carbon
dioxide and chlorofluoroalkane could be easily achieved
by passing the expired air first through NaOH and then
through n-heptane.
The extent of metabolism of trichlorofluoromethane 
that might be expected, by analogy with the findings for 
carbon tetrachloride, is about 1%. Metabolism in excess 
of 0 . 2 %  was not however detected. The reason for this 
may be found in the characteristics of the C-Cl bond in 
trichlorofluoromethane compared to the C-Cl bond in 
carbon tetrachloride. Table 1.3 shows that the bond 
energy term (calculated from the heat of formation) for 
a C-Cl bond in trichlorofluoromethane is 0.6% less than 
.in carbon tetrachloride, and that the C-Cl bond length 
is increased by about 3 % .  This would suggest that 
trichlorofluoromethane would be dechlorinated as easily 
as carbon tetrachloride. However, the C-Cl bond 
dissociation energy in trichlorofluoromethane, calculated 
by Gregory (1 9 6 6) from the C-Cl dissociation energies 
measured for carbon tetrachloride and chlorotrifluoro­
methane , is 9 • 5 % >  greater than in carbon tetrachloride.
If t h i s  extrapolated value is correct, the greater 
stability of the C-Cl bond in trichlorofluoromethane 
could account for the observed lack of metabolism.
The low toxicity of the chlorofluoroalkanes may 
thus be due to two factors, the lack of any significant 
metabolism and the very rapid clearance from the body, 
even after ingestion of the compounds orally. Although 
these compounds were detectable in adipose tissue after 
24 hours, the amount present could only account for 
less than 0 .1% of the dose.
Toxicity.
The low toxicity of trichlorofluoromethane and
1 ,2-dichloro-l,1 ,2 ,2-tetrafluoroethane was confirmed by 
experiments described in Chapter where no significant 
effect was found on body and tissue weights after a 
series of large, repeated doses.
p In contrast to the massive accumulation of tri­
glycerides in the liver during carbon tetrachloride 
intoxication (Ogata et al., 1968) and the increase in
neutral lipid after halothane inhalation (Kunz et al.,
1 9 6 6 ), trichlorofluoromethane (0.4 g/kg i.p. for 37 days) 
caused no accumulation of lipid, measured gravimetrically 
or colorimetrically (5•3 ) • However, a significantly 
lower level of * saturated* lipid was found in animals 
receiving trichlorofluoromethane. Ethyl oleate, used 
as the vehicle for trichlorofluoromethane, increased both 
the liver total-lipid and the liver * oleic acid1,
compared to rats receiving saline (containing sodium 
phenobarbital) , but did not affect the content of 
1 saturated lipid*.
The decrease in * saturated lipid’ in the livers 
of rats that is attributable to trichlorofluoromethane 
may be interpreted in one of two ways: either the ratio 
of ’saturated* to *unsaturated1 lipid was altered, or the 
content of total lipid was decreased. Since the 
concentration of total lipid was not not significantly 
changed by trichlorofluoromethane, the.former case is 
more likely. This'is because, although the determination 
of total lipid is reliable and well defined, .
’unsaturated* lipid, as measured, is an entity not 
capable of precise definition. However, a significant 
increase (P-C0.05) in total serum lipid has been 
reported (Hair, 1972) following the oral dosing of male 
rats with trichlorofluoromethane (lg/kg body weight/ 
day for 40 days). This increase was in part due to 
an increase in non-ester if ied fa:tty acids, which 
suggested the mobilisation of depot fat. Of relevance 
to these findings is the concentration of chlorofluoro­
alkanes reported to occur in the adrenals (Davies, D.S., 
unpublished work), which may affect the release of 
adrenal hormones, resulting in an alteration in lipid 
mobilisation. The results reported here suggest that 
the degree of unsaturation of the liver lipid was raised 
by feeding trichlorofluoromethane and that this could be 
attributed to the use of ethyl oleate as vehicle. The 
significance of these several results is not clear, but
no deleterious effects of trichlorofluoromethane were
shown.
Binding with cytochrome P-450.
As suggested above, the binding of chlorofluoro­
alkanes with cytochrome P-450 in microsomal preparations 
indicates that there is a potential for metabolism.
The Kg value for trichlorofluoromethane is only a factor
of two greater than the K for carbon tetrachloride.s
The breaks observed in the K plots were nots
reproducible. This was probably due to the actual 
concentration of these volatile compounds in the 
microsomal suspension being lower than the calculated 
concentrations, due to small losses of vapour.
However, when a break was found in the K plot, the two
S
intercepts with the abscissa gave K values approximately
5
one order of magnitude apart, the higher value being the 
one obtained when no break was observed in the plot.
The alteration in slope was not due to the presence of 
insufficient substrate, as even at the lowest substrate 
concentration used ( 1 0 0 nmol/ml), substrate exceeded 
cytochrome P-450 by a factor of 50. A possible 
interpretation of the two values obtained is that 
the substrate is binding at two sites of different 
affinities. Schenkman (1970) found this type of plot 
with the aniline-induced spectral change and suggested 
that the binding of the substrate to the cytochrome was 
facilitated by the presence of higher amounts of substrate 
due to a solvent effect.
The interaction of trichlorofluoromethane and other 
chlorofluoroalkanes and chlorinated hydrocarbons with 
aerobic cytochrome P-450 is predominantly with the 
phospholipid fraction, and the evidence for this is as 
follows. Removal of the phospholipid component by 
isooctane treatment abolished the type I spectrum 
without damaging the type II site, the aniline spectrum 
(type II) in fact being enhanced. Quite how much 
phospholipid was extracted by this procedure was not 
determined and attempts to reproduce the thin-layer 
chromatography results of Leibman and Estabrook (l97l) 
showed only one phospholipid spot, the'R^, value of which 
did not correspond to the R_^  values given for either 
phosphatidylcholine or phosphatidylethanolamine.
However, sufficient information to repeat exactly their 
system was not given in the paper. Their reported 
recovery of protein and cytochrome P-450 after isooctane 
extraction was poor, but by simply increasing the 
length and force of centrifugation it was possible to 
achieve recoveries of protein and cytochrome P-450 
approaching 100%. Phospholipase C digestion of the 
microsomal preparation was also reported to prevent type 
I binding. The type I binding spectrum of trichloro- 
fluoromethane was modified in preparations digested with 
this enzyme, but was not completely abolished.
Further evidence for the lipid nature of the type 
I binding site is given by the spectral constants for 
various polyhalogenated compounds (Table 6 .l).
Increasing substitution of chlorine for hydrogen in these
compounds (all type I substrates) resulted in an increase
in the non-polar character and a decreased K value, i.e.s ’
a higher affinity:
iriM
ch2ci2 1 0 . 3
CHC13 2.9
CC14 1.3
CHC12-CH3 11.0
CHC12~CH2C1 3.7
CHC12-CHC12 2.8
CHC12-CC13 .1.1
CC13 -CC13 0.8
Similarly, carbon tetrachloride, hexachloroethane and 
octachloropropane showed increased affinity for the 
cytochrome with increased chlorine content (Kg values: 
l.»5i 0.8, 0.4 mM respectively). The effect of the 
substitution of fluorine for chlorine on the spectral 
constants was to cause an increase:
mM
cci3-cci3 0.8
CC12F-CC1F2 3-1
c c i f2-c c i f2 8.1
Substitution of fluorine for hydrogen generally 
decreased the affinity for the cytochrome, one exception 
being CC1F -CC1F in comparison to CH Cl-CH Cl, as the
<L cL d* tL
latter gave no observable spectral interaction.
Pretreatment of rats with phenobarbital, trichloro- 
fluoromethane or carbon tetrachloride affected the K
values for trichlorofluoromethane and carbon tetrachlori
Carbon tetrachloride pretreatment increased the K values
for both compounds. This may have been due to the
presence of low concentrations of carbon tetrachloride
retained in the microsomal preparations and inhibiting
interaction with other substrates. Pretreatment with
trichlorofluoromethane or phenobarbital, however,
decreased the value of K for both carbon tetrachlorides
and trichlorofluoromethane. It is possible that this
represents either the .formation of a slightly different
cytochrome V - k ^ O  molecule or the modification -of the
existing cytochrome P-450.
As with many other parameters, species differences
were found in K values (Table 6 .3)- However, all thes
K values for trichlorofluoromethane lay within one s J
order of magnitude, suggesting that the differences 
were probably of little significance. The only species 
of particular interest was the mouse, which showed the 
lowest spectral constant for trichlorofluoromethane.
This fact, in addition to the high metabolic rates 
shown in mouse liver, suggests that the in vitro 
metabolism experiments with phenobarbital-induced 
mouse liver were the most likely to show positive 
evidence of metabolism, if it occurred. This reinforce 
the contention that reductive dechlorination of tri­
chlorof luoromethane is probably not the mechanism of 
any possible metabolism in the systems used.
In terms of the type I nature of the spectral
interaction shown by trichlorofluoromethane with 
microsomal suspensions, it is interesting to note that 
this compound interferes with the type II spectrum of 
aniline, when added at a concentration of 2 mM. This 
is opposed to the findings of Schenkman (1970), who 
showed that the presence of low concentrations (2 . 5  kiM) 
of hexobarbital (type I) enhanced the spectral interaction 
produced by aniline Cl.9 and 20.5 mM). This interference 
by trichlorofluoromethane indicates that it shows some 
type II binding capacity, perhaps not spectrally 
observable, or that it modifies the type II site in some 
way.
Further evidence that trichlorofluoromethane and
carbon tetrachloride are not binding to the type I site
of cytochrome P-450 is provided by their formation of
reduced spectra closely similar to the spectrum of the
cytochrome P-450-CO complex. Both these compounds
interfered with the measurement of cytochrome P-450.
The lowering of the cytochrome P-450-CO spectrum could
not be reversed by prolonged bubbling with CO, suggesting
that the binding of carbon tetrachloride and trichloro-
fluoromethane was of a similar affinity to the binding
of CO and probably occurred at the same site. This
conflicts with the concept that the K value is as
measure of affinity for cytochrome P-450, but Kutt et al.,
(1 9 7 0) had previously described a similar lack of
correlation from results obtained with diphenylhydantoin.
—6This compound showed a very low ICg value (27 x 10 M)
but was found to be displaced easily by other substrates. 
The reverse would appear to be the case for trichloro- 
fluoromethane and carbon tetrachloride (Kg values approx.
_ o
2 x 10 M) as binding of these compounds to Na^S^O^-
reduced cytochrome P-450 was not reversed by CO, which
-6has a fK 1 of about 3 x 10 M (Omura and Sato, 1964a).
S
In incubations of microsomal suspensions, cytochrome 
P-450 was degraded with time to a spectrally unobservable 
product. A substrate such as zoxazolamine afforded 
protection to the cytochrome, but did not affect the 
increased degradation due to trichlorofluoromethane 
or carbon tetrachloride. The latter compound caused 
a greater reduction in the concentration of cytochrome 
P-450 than did trichlorofluoromethane, and this difference 
was presumably due to peroxidative damage initiated by 
metabolism of carbon tetrachloride. Archakov et al. 
(1 9 7 2) have shown that substrates for demethylation 
block peroxidation and give binding spectra with 
cytochrome P-450. It seems possible therefore that 
the. inhibition of endogenous microsomal lipid peroxidation 
by chlorofluoroalkanes may be mediated in some way by 
their interactions with cytochrome P-450. This may 
explain the anomaly, reported in Chapter 4, concerning 
the apparent anti-oxidant effect of trichlorofluoro­
methane .
Effects on drug-metabolising enzymes.
In view of these spectral interactions in aerobic
and Na^S^O^-reduced microsomal suspensions, and the 
observed effect of halothane on drug-metabolising 
enzymes (Van Dyke and Rikans, 1970; Brown, 1971)? 
chlorofluoroalkanes might be expected to affect drug 
metabolism. However, the metabolism of type I binding 
substrates (biphenyl, ethylmorphine, hexobarbital and 
nitroanisole) was not affected. This may be explained
by the difference in the measurable affinities of
— 5 —4substrates (5 x 10 J  to 5  x 10 M) and chlorofluoro-
— 3 — 2alkanes (10 to 5 x 10 M). Competitive inhibition by 
the chlorofluoroalkanes would have only a minimum effect 
on the enzyme activity. On the other hand, no solvent 
effect (similar to that of acetone), resulting in 
activation of enzyme activity (Anders, 1971)» was 
apparent.
The observed increase of hexobarbital sleeping 
times cannot be explained therefore by inhibition of 
metabolism. It seems likely that.this effect may be 
centrally mediated. Some weak local anaesthetic 
activity was noted in experiments involving intra- 
peritoneal injection of chlorofluoroalkanes, which 
resulted in temporary paralysis of the animal1s hind 
limbs.
Metabolism of some type II substrates in vitro was 
altered by addition of chlorofluoroalkanes to the 
incubation media. Thiabendazole 5-hydroxylation was 
unaffected. Zoxazolamine hydroxylation was apparently 
significantly inhibited, but this may possibly have been
due to the decreased availability, or increased 
destruction, of cytochrome P-450, due to binding of 
trichlorofluoromethane or carbon tetrachloride, over the 
long period of the incubation (40 to 60 minutes).
Unfortunately, it was not possible to reduce the 
incubation time to less than 40 minutes, as the rate of 
hydroxylation was relatively low. Aniline and 
acetanilide 4-hydroxylations were, however, increased 
by the addition of trichlorofluoromethane. Van Dyke 
and Rikans (1970) observed a similar effect on aniline 
hydroxylation, using either halothane or 1 ,1 ,1-trichloro- 
ethane. The activation of aniline and acetanilide 
metabolism by trichlorofluoromethane did not appear to 
be a solvent effect, as addition of ethanol caused a 
30% inhibition of this activity, and 1 ,1 ,2-trichloro-
1 ,2 ,2 -trifluoroethane did not produce such large 
increases. Anders (1 9 6 8) found enhancement of aniline 
4-hydroxylation by acetone (0.045 - 1.8 M), but not by 
similar ketones, and suggested that the mechanism of 
activation was some alteration of the enzyme, and not 
simply a solvent effect.
Spectral interactions as an indication of metabolism.
The type of reduced binding spectrum produced with 
trichlorofluoromethane and carbon tetrachloride has been 
found with a number of compounds, including hydralyzines 
such as *Nardilf (Netter, 1972), fluorene and 2-nitro- 
propane (Ullrich, 1973)i ethyl isocyanide and carbon 
monoxide (Omura and Sato, 1964a). Aniline gives an
extremely weak interaction, of this type (imai and Sato,
1967).
In the case of trichlorofluoromethane and carbon 
tetrachloride, the formation of the reduced spectrum was 
time-dependent, and slow relative to CO binding (Omura 
et al., 1 9 6 5 )1 possibly suggesting an electron-transfer
reaction or an allosteric alteration of the cytochrome 
P-450. The latter alternative would be the probable 
mechanism if this spectral interaction was found to 
occur using crystalline haem. The formation of the 
reduced spectrum was not abolished by any of the 
treatments to remove phospholipid from the microsomal 
suspension; phospholipase C reduced the rate of formation 
of the peak, which suggests that the digestion of the 
microsomal phospholipid made access to the haemoprotein 
more difficult, whereas isooctane may increase the 
accessibility by more complete removal of the phospholipid. 
These observations indicate that trichlorofluoromethane 
binds to a second site within cytochrome P-450 similar 
to the type II binding site observed in aerobic 
preparations. The activation of aniline and acetanilide 
4-hydroxylations would indicate that this second site is 
close to, but not identical to, the type II substrate 
binding site, as otherwise inhibition of all type II 
drug metabolising activity would be expected.
Another possibility is that trichlorofluoromethane binds 
to a site which allosterically affects the type II 
binding site of cytochrome P-450.
The meaning and importance of the reduced binding 
spectra observed with trichlorofluoromethane and 1 ,1 ,2-
trichloro-1,2,2-trifluoroethane is open to considerable 
speculation. Similar spectral changes have been 
observed in microsomal preparations incubated with 
substrates and NADPH. Piperonyl butoxide (Philpot and 
Hodgson, 197l) 5 safrole and isosafrole (Lake and Parke, 
1972) and hexobarbital (Estabrook et al., 1971) 
incubated with microsomal preparations in vitro, with 
an NADPH generating system, resulted in the formation of 
spectral intermediates showing maxima between 440 nm and 
4.55 11m • These spectra are believed to be the result of
the binding of metabolites to cytochrome P-450.
Schenkman et al. (1972) have shown that active metabolism
of SKF 525A in vivo and in vitro resulted in the 
formation of a stable oxygenated complex of cytochrome 
P-450, with an absorption maximum at 455 nm. This 
-complex may be responsible for the known non-competitive 
inhibition of drug metabolism by SKF 525A.
The implication of this work and recent observations 
on the reduced binding of carbon tetrachloride is that 
trichlorofluoromethane may in fact be metabolised to 
a small extent. Reiner and Uehleke (unpublished work) 
have shown that the anaerobic formation of the NADPH- 
reduced spectrum of carbon tetrachloride is almost 
exactly paralleled by the formation of chloroform, and 
they have postulated a two-step mechanism, involving 
the anaerobic binding of carbon terachloride to the 
cytochrome and the first electron transfer, followed by 
metabolism by the mixed-function oxygenase and the second
electron transfer, chloroform being released at this 
step. The trichlorofluoroinethane-cytochrome P-450 
reduced spectral intermediate may thus indicate the 
possibility of the formation of dichlorofluoromethane 
under anaerobic and reducing conditions.
The formation of the reduced spectrum of tri­
chlorof luoromethane in microsomal preparations, on the 
other hand, may reflect a ligand interaction as the 
first step in metabolism, which cannot be followed by 
the formation of free metabolite in the case of
trichlorofluoromethane. The * spectral K 1 (Figure 6.15)m
of cytochrome P-450 for trichlorofluoromethane may thus 
be an expression of the affinity of cytochrome P-450 for 
this compound in reducing conditions or of the 
concentration of trichlorofluoromethane methane required 
for half-maximal rate of metabolism.
Ligand interactions producing similar spectral 
changes have been observed between ferrihaemoglobin and 
the chlorinated methanes (Bucher and Brown, 1971)- 
Various polyhalogenated methanes, including dichloro- 
difluoromethane, have been combined with reduced vitamin 
B (cobalamin)(Wood et al., 1968) to form crystallisable
derivatives. These complexes were shown to involve a 
ligand interaction between the halogenated methanes and 
the cobalt atom of cobalamin. Photolysis of the 
chlorinated methane derivatives under hydrogen yielded 
chloromethane and hydrogen chloride. Photolysis of the 
chlorofluoroalkane derivative of cobalamin was not
reported.
Thus it might be postulated that metabolism of 
trichlorofluoromethane may occur by two possible routes
J CC12F] .
s - a
CHCl^F
✓
CCl^F
Any metabolism of trichlorofluoromethane in aerobic 
conditions, such as those described in Chapter 4, may 
result in some oxidised product (fX !), and not dichloro 
fluoromethane. It may only, be possible to form this 
latter metabolite under completely anaerobic conditions
'From these studies,.the low toxicity of the 
chlorofluoroalkanes would appear to be due to a 
a combination of the rapid clearance of the compounds 
from the tissues and the very low level, or lack, of 
metabolism.
However, the binding of the chlorofluoroalkanes to 
cytochrome P-450, and the effects on in vitro drug 
metabolism, lead one to the suggestion that further 
studies should be undertaken to determine whether these 
effects could occur in vivo.
Further metabolic studies require, ideally, the use 
of radioactively-labelled compounds. It would seem 
to be of particular interest to determine whether any 
metabolism occurs in anaerobic, reducing conditions.
If metabolism does not occur under these conditions, 
trichlorofluoromethane may prove to be a useful tool in 
separating the two steps of Uehleke!s postulated 
mechanism for the metabolism of carbon tetrachloride.
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Table A.5
Concentration of trichlorofluoromethane in blood (/^g/ml)
against time (minutes).
Values obtained from blood samples of 6 female Wistar
albino rats after an oral dose of 50 mg/kg.
Time Individual values Mean 4 £>.E.M.
(mins) (^ xg/ml) (^g/ml)
3 0 . 0 5 8 0 . 0 7 7  o.o4o 0 . 0 2 6  0 . 1 0 0 0 . 0 6 0 + 0.013
7 0 . 0 5 6 0 . 2 6 6  0 . 0 7 9  0 . 0 6 2
- 0 . 1 1 6 4 0 . 0 5 0
9 0.249 0.133 0.191 + 0 . 0 5 8
l4-l6 0 . 2 7 8 0 . 2 1 0  0.099 0.295 0 . 2 2 0 + 0.044
19 0.332 0.332
24-25 O . 8 1 6 0 . 1 0 5  0 . 5 7 6  0 . 1 3 0  0 . 2 6 2 0.378 + 0 . 1 3 8
40-42 0 . 2 2 2 0.207 0.552 0.313 0.323 4* 0 . 0 8 0
46 0.469 O . 3 6 6 0.417 + 0.073
6 i 0.423 0.378 0.238 0.574 0.403 4 0 . 0 7 0
6 5 - 6 6 0 . 1 9 8 0 . 5 2 8 0.363 4 O . 1 6 5
90-93 0.458 0 . 2 0 0  0.284 0.314 + 0 . 0 7 6
9 8 - 1 0 0 0.474 0 . 1 8 0 0.327 4- 0.147
120 0.256 0 . 2 5 6
150 0.145 0.124 0.134 4 0 . 0 1 0
l80 0.105 0 . 1 2 8  0.071 0 . 1 0 1 4 0 . 0 1 7
